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Lay Summary of Thesis 
Blood cells provide nutrition to different parts of body, immune cell helps us to fight 
bugs inside our body. They all come from cells called haematopoietic stem cells 
(HSC). HSC are adult stem cells that reside in our bone marrow. Sometimes, these 
stem cells become faulty, then patients got leukemia. A lot effort is made to discover 
means of replace those faulty cells and return patients a normal life.  
In 2006, one method to derive pluripotent stem cell from skin cells was discovered. 
Such method provides a source of cells that have potential to become all kinds of 
cells in our body. To unleash such potential, right environment signal must exists to 
“educate” that pluripotent cells to become HSC. This study is aimed at discovering 
signals that is critical for maturation of HSC in a critical stage of embryonic 
development. It is hoped eventually we could translate such discovery into protocol 






Embryonic haematopoiesis is a complex process under intensive research. Murine 
definitive Haematopoietic Stem Cells (HSCs) originates from the 
Aorta-Gonad-Mesonephros (AGM) region of E10.5 embryo. It is thought that 
definitive HSCs arise from endothelial lining of dorsal aorta. However, detail of 
HSC specification in the developing embryo remains elusive. One way to 
deciphering events occurred during HSC specification is to derive cell lines from the 
developing HSC niche. Previous work by Oostendorp et al. showed the AGM and 
fetal liver derived lines could maintain HSCs in vitro (Oostendorp, Harvey et al. 
2002). In this study, I established a more robust immortalization system using 
normal SV40 large T antigen delivered via Neon™ electroporation system. The new 
immortalization system achieved direct immortalization without going through crisis. 
And it is compatible with small number of primary cells dissected from different 
haematopoietic niches. With my new system, multiple cell lines from different 
haematopoietic sites at different developmental points are derived. Moreover, some 
of these lines demonstrated ability to mature precursors from E9.5 embryo 
(pro-HSCs) to definitive HSC without help of growth factors. This result is better 
compared to OP9 stromal lines. Such data proved usefulness of using stromal cell 
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1. Chapter 1: Introduction  
Haematopoietic Stem Cells (HSCs) were cells that replenish cells of all blood 
lineage (Osawa, Hanada et al. 1996). To do this throughout the life span of the 
organism, HSCs must be able to self-renew and differentiate. Self-renewal assured 
that a stable pool of HSC was maintained during entire life span of the organism. 
Previously, it was though that the majority of HSCs reside near osteoblasts that 
formed boundary between bone and marrow at trabecular bone (Wilson and Trumpp 
2006, Kiel and Morrison 2008). However, recently S. Morrison’s group published 
two elegant studies demonstrating HSCs were more related to perivascular niche 
formed by endothelial and mesenchymal stromal cells. Usually these cells were 
located near sinusoids or other blood vessels presented in bone marrow. The 
osteoblast niche was more related to downstream progenitors (Ding, Saunders et al. 
2012, Ding and Morrison 2013). Perivascular niche regulated HSC with secreted 
molecules (e.g. CXCL12) (Lo Celso, Fleming et al. 2009) and direct cell to cell 
interactions (e.g. Notch/Jagged signalling). Environmental conditioning like hypoxia 
also might contributed to HSC maintenance and regulation (Takubo, Goda et al. 
2010). The HSCs travelled between bone marrow and extramedullary sites, allowed 
efficient response to external environmental signals, including stress. Recent 
research suggested HSC pool was a heterogeneous population, with slow cycling 
latent long-term HSC (LT-HSC) and more active short-term Haematopoietic Stem 
Cells (ST-HSC). ST-HSCs gave rise to more proliferative progenitors that 
differentiated into all myeloid and lymphoid cell types. Several paradigms of HSC 
differentiation had been proposed, the most commonly accepted paradigm suggested 
that HSC first differentiate into a multipotent progenitor (MPP) than differentiate 
into distinct common myeloid progenitor (CMP) and common lymphoid progenitor 
(CLP) (Kondo, Weissman et al. 1997, Akashi, Traver et al. 2000). The recent 
discovery of other types of progenitors added new element to paradigm of HSC 
2 
 
differentiation. In new paradigm, HSC differentiated into megakaryocyte and 
erythrocyte progenitor (MEP) and lymphoid primed multipotent progenitors (LMPP) 
(Adolfsson, Månsson et al. 2005). Progress had been made to characterize and 
enrich HSCs from adult bone marrow. It was discovered that murine adult HSCs 
were enriched in Lineage-Sca1+c-Kit+ population (Spangrude, Heimfeld et al. 1988, 
Ogawa, Matsuzaki et al. 1991). Later studies showed that Lin-CD41-CD48-CD150+ 
(signalling lymphocyte activation, SLAM) marker could provide better enrichment 
of HSC from adult bone marrow (Kiel, Yilmaz et al. 2005). 
 
Figure 1-1. Differentiation of Haematopoietic Stem Cell (HSC). 
Differentiation of HSC was stepwise, involved external signalling and 
internal decision making. This figure was reproduced from Cedar and 
Bergman (2011) with permission.  
If HSCs or their progenies became oncogenic, the organism would experience a 
wide variety of haematopoietic disorders. It was determined that leukaemia is the 
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most prevailing childhood cancer in most parts of world, except Africa (2011). To 
treat leukaemia and other haematopoietic disorders, bone marrow transplantation is 
often required. Current difficulties of finding Human Leukocyte Antigen (HLA) 
matched donors and expanding HSCs in vitro limit the number of patient receiving 
bone marrow each year. To resolve this issue, researchers started to look for ways of 
generating patient specific HSC in vitro. Several groups attempted to differentiate 
embryonic stem cell (ES) into adult HSCs either using a co-culture system with 
stromal cells (Ledran, Krassowska et al. 2008) or by adding haematopoietic 
cytokines (Wang, Li et al. 2004). After generation of iPS cells, attempts have been 
made to generate HSC from iPS cell generated teratoma (Suzuki, Yamazaki et al. 
2013) or by direct re-programming of differentiated haematopoietic cells (Riddell, 
Gazit et al. 2014). 
Limited success of generating adult HSC in vitro from ground pluripotent state 
indicates there is something missing in our understanding about haematopoiesis in 
general. To work around that problem, researchers start to look into embryonic 
haematopoietic development. It is thought that adult HSC can be generated ex vivo 
by mimicking in vivo developing processes.   
1.1. Overview of embryonic haematopoiesis  
Haematopoiesis during embryonic development is somewhat different with adult 
haematopoiesis described above. Adult haematopoiesis generates cells of blood, 
myeloid and lymphoid lineages while maintaining a stable pool of HSCs. But in 
embryonic haematopoiesis, developing haematopoietic system need to provide pools 
of haematopoietic cells serving other embryonic systems while generating HSC pool 
for adult life hood. Haematopoietic system was a conserved feature of different 
species in the animal kingdom. In acoelomates, free moving cells with digestive or 
other functions had been observed. In more advanced coelomates, free flowing 
haemocytes were present in coelom cavity or vascular system (Hartenstein 2006). 
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Such conservation was useful to use animal models to study embryonic 
haematopoiesis in general. Historically, several animal models had been of much 
interest, including amphibian, avian, fish and mouse. With the discovery of ES and 
iPS cells, they had also been used to model embryonic haematopoiesis.   
1.1.1. Embryonic haematopoiesis in amphibian model 
Research in amphibian models initially concentrated on ventral blood island (VBI), 
because removing VBI at tail bud stage of embryonic development reduced the 
number of circulating erythrocytes (Goss 1928). In amphibian embryos, cells in 
marginal zones were specified with a mesodermal fate by secreted factors like 
BMP-4, members of FGF family or Noggin (Jones, Dale et al. 1996). After 
extensive reorganization, cells at the ventral tip of marginal zone (Ventral Marginal 
Zone, VMZ), opposite to Spemann Organizer, were induced by local mesodermal 
signals to form ventral blood island (Kumano, Belluzzi et al. 1999, Hartenstein 
2006). Later in development, VBI cell formed progenitors that gave rise to 
haematopoietic cells that enter circulation. However, later experiments showed that 
the reduction of erythrocytes was temporary. By grafting Xenopus embryos from 
different species Maeno et al. showed that haematopoietic cells Xenopus late larva 
and adult stage are also from dorsal lateral plate (DLP) mesoderm (MaÉNo, Todate 
et al. 1985). Combined with other data, it was concluded that there are two distinct 
waves of haematopoietic cell generation in amphibian embryonic development 
(Turpen 1998). The first wave of primitive haematopoietic cells originated from VBI 
while the second wave of more definitive haematopoietic cells originated from DLP. 
1.1.2. Embryonic haematopoiesis in avian model 
Initial research about haematopoiesis in the avian model is also concentrated in yolk 
sac, the avian equivalent of VBI. A key enabling technology for haematopoietic 
research is the chicken/quail labelling system. By making chick/quail chimera of 
various compositions, decedents of different region of primitive embryo are studied 
(Francoise-Lievre 2005). Moore and Owen proved that haematopoietic cells 
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massively circulate in developing embryos before seeding bone marrow and spleen 
by parabiosis (Moore and Owen 1965), later they proposed origin of such circulating 
HSC to yolk sac (Moore and Owen 1967). However, Dieterlen-Lievre et al. 
generated quail embryo body-chick yolk sac chimeric embryo to show that yolk sac 
originated cells are only transient while definitive HSCs arise from intra-embryonic 
sites (Dieterlen-Lievre 1975). Later, her group proposed that the ventral wall of 
aorta is the likely source of adult haematopoietic stem cells in the avian embryo 
(Dieterlen-Lievre and Martin 1981). Their work suggested that there are at least two 
waves of haematopoiesis in avian embryonic development, one extra-embryonic 
wave which provide primitive haematopoietic cells and one intra-embryonic wave 
which provides adult (definitive) haematopoietic cells. Their group also used chick 
quail chimera experiments to demonstrate that that allantois in avian embryo can 
produce haematopoietic cells (Caprioli, Jaffredo et al. 1998).  
1.1.3. Embryonic haematopoiesis in zebrafish model 
Another commonly used model organism in embryonic haematopoietic development 
was zebrafish. Zebrafish had several advantages for haematopoietic studies. Its 
embryo was transparent, made real time non-invasive observation possible. A large 
quantity of zebrafish embryos could be easily generated, plus robust forward (using 
1-ethyl-1-nitrosourea, ENU) and reverse (using morpholino) genetic tools were 
available. These properties allowed massive parallel genetic screening to be 
conducted. In zebrafish, there were also two waves of haematopoiesis. The primitive 
wave was also developed from ventral mesoderm like other organisms. However, 
primitive haematopoietic precursors did not migrate to extra embryonic sites, instead 
they moved to intermediate cell mass (Detrich, Kieran et al. 1995). Subsequently, 
definitive HSCs started to bud off from endothelium at ventral wall of dorsal aorta 
(Bertrand, Chi et al. 2010). Such observation strongly supported the notion that HSC 
had an endothelial origin and highlighted importance of Endothelial to 
haematopoietic transition (EHT) (Kissa and Herbomel 2010). After HSCs entered 
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circulation, they moved into caudal haematopoietic tissue (CHT). The CHT was 
located near tail of embryo. Later, at around 4 days post fertilization, definitive 
HSCs seeded into kidney marrow, the zebrafish equivalent of bone marrow (Paik 
and Zon 2010). 
1.1.4. Embryonic haematopoiesis in rodent model 
Mus musculus was another heavily studied model organism. Researchers favoured it 
because of its similarity with Homo sapiens. In Mus musculus, germ layer 
differentiation usually started around the early streak stage (Embryonic Days 6.5, 
E6.5). Later, some cell from the distal proximal region of the primitive streak 
migrated to extra-embryonic mesoderm and becomes yolk sac primitive 
haematopoietic cells. Then at the late streak stage, lateral mesoderm developed. 
Some cells appear at dorsal lateral plate mesoderm. They were destined to become 
AGM cells. At neural plate stage (E7.25 to E7.5), yolk sac blood island appeared, it 
contains primitive haematopoietic cells (Ueno and Weissman 2010). Yolk Sac 
Blood Island produced primitive haematopoietic cells, mainly nucleated 
erythrocytes. At around E8.25 circulation between yolk sac and embryo proper is 
established.  
Definitive haematopoiesis in mouse embryonic development appeared within the 
embryo proper (Medvinsky and Dzierzak 1996). Some cells with the potential to 
become definitive HSCs appeared in para-aortic splanchnopleura around E8.5 
(Cumano, Ferraz et al. 2001). HSCs that could be transplanted into irradiated 
recipients and maintain long term engraftments first appeared in AGM region at 
around E10.5 (Muller, Medvinsky et al. 1994). Later definitive HSCs generated in 
AGM region circulated to foetal liver at around E12.5 and expanded rapidly in there 
(Morrison, Hemmati et al. 1995). At last, adult HSCs seeded their final destination, 
bone marrow, shortly before birth (Christensen, Wright et al. 2004, Mikkola and 
Orkin 2006, Ueno and Weissman 2010).      
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The origin of definitive HSCs during mouse development was a debated question. 
Several organs had been found containing HSC at various stages during embryonic 
development, included placenta (Ottersbach and Dzierzak 2010) and later umbilical 
cord (de Bruijn, Speck et al. 2000, Dieterlen-Lievre, Corbel et al. 2010, 
Gordon-Keylock, Sobiesiak et al. 2013). Even the embryonic head was considered 
to have some haematopoietic potential (Li, Lan et al. 2012). But the main research is 
still focused on AGM and yolk sac.  
Yolk sac blood “islands” were the first haematopoietic related structure which 
appear during embryonic development (Palis, McGrath et al. 1995). In embryo 
sections, yolk sac blood islands usually appeared as two clusters of primitive 
haematopoietic cells with endothelial cells surrounding them. However, whole 
mount staining showed that primitive haematopoietic cells forms a band like 
structure; the two “classical” islands are formed by slicing the “blood band” 
(Ferkowicz and Yoder 2005). Contrasting previous theories, chimera experiments 
showed that cells forming the blood band are not monoclonal, but from multiple 
progenitors (Ueno and Weissman 2006). Functional in vitro assays showed that 
erythroid colony forming (EryP-CFC) or macrophage colony forming (Mac-CFC) 
cells could be detected as early as in mid-primitive steak stage (E7.0-E7.25) at 
presumptive extra-embryonic tissue. At E7.5 nucleated primitive erythrocytes 
appeared in the yolk sac blood belt. Such wave of primitive progenitors was 
transient. Primitive haematopoietic cells quickly disappeared at around the 20sp 
(somite pair) stage (around E9.0) (Palis, Robertson et al. 1999). Because definitive 
HSCs appeared in developing embryos after the yolk sac was connected to embryo 
proper, extensive research was focused on the potential of early yolk sac cells to 
contribute to definitive haematopoiesis after education by various niches. It was 
shown that E8.0 yolk sac cells (and p-SP cells) can generate definitive HSC after 4 
days of co-culture with E10.5 AGM derived cell line AGM-S3 for 4 days (Matsuoka, 
Tsuji et al. 2001). However, this study was not repeated. To provide the necessary 
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maturation environment of yolk sac haematopoietic cells, Yoder’s group 
transplanted E9 (Yoder, Hiatt et al. 1997) and E10 (Yoder and Hiatt 1997) yolk sac 
cells into irradiated neonatal recipients which resulted in long-term engraftment.       
The view point that the mammalian AGM region was the source of true definitive 
HSC was uphold by many researchers. In the early 90s, Medvinsky et al. found high 
CFU-S (colony forming unit-spleen) numbers at E10 AGM region (Medvinsky, 
Samoylina et al. 1993). Later, they demonstrated that the E10 AGM region could 
generate definitive HSCs in organ explant culture while yolk sac cells at similar 
stage failed to do so (Medvinsky and Dzierzak 1996). Definitive HSCs from E10 
AGM were c-kit+, and mainly CD34+. Mac-1 did not significantly enrich AGM 
derived definitive HSC (Sanchez, Holmes et al. 1996), this was different compared 
to the case in foetal liver (Morrison, Hemmati et al. 1995). In 2000, Marella de 
Bruijn et al. demonstrated that definitive HSCs first appeared in the dorsal aorta and 
later appeared in urogenital ridges (UGR) by transplanting sub-dissected AGM 
tissues (de Bruijn, Speck et al. 2000). Two years later Medvinsky et al. 
demonstrated with serial dilution assay that around E11, AGM, yolk sac or foetal 
liver each possessed around 1 definitive HSC (Kumaravelu, Hook et al. 2002). The 
pool of definitive HSCs was drastically expanded between E11 to E13. The capacity 
of definitive HSC generation was high on E11 while yolk sac harboured definitive 
HSC only on E12. Cells generated in AGM and yolk sac colonized foetal liver on 
about the same day. Dzierzak and colleague showed that the Sca-1-GFP marker 
could be used to label HSCs in the AGM region. Sca-1-GFP positive cells were 
localized to the endothelial aorta wall of the E11 AGM (de Bruijn, Ma et al. 2002). 
This finding implied that emerging HSCs had close relationships with endothelial 
cells (Yokomizo and Dzierzak 2010). Recent advances in in vivo imaging showed 
that in unfixed slices of the aorta, HSC might bud off from the aortic endothelium 
(Boisset, van Cappellen et al. 2010), supported the notion that HSCs go through 
Endothelial to Haematopoietic Transition (EHT) during maturation. Another strong 
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support of endothelial origin of HSC came from characterization of its immediate 
precursor, named as pre-HSC. In one study, the Medvinsky group developed a 3D 
liquid-air interface aggregation culture system which allowed maturation of 
definitive HSC from pre-HSCs. By aggregating cells with different markers from 
GFP AGM with native (CD45-) counterparts, they determined those pre-HSC bear 
VE-Cadherin marker (Taoudi, Gonneau et al. 2008). Later they discovered that two 
types of pre-HSCs appeared sequentially with distinct markers: pre-HSC I with 
VE-Cad+CD45-CD41+ marker appeared first, later they matured into the 
VE-Cad+CD45+ pre-HSC II phenotype. Pre-HSC II cells later matured into 
definitive HSC and migrated out of the AGM region at E11.5 or earlier (Rybtsov, 
Sobiesiak et al. 2011).  
 
Figure 1.1.4-1. Embryonic haematopoiesis in rodents. A) Primitive 
haematopoietic cell originated from extra-embryonic structures. Yolk 
sac was the most prolific haematopoietic structure at that time. 
However, chorion and allantois were also implied in embryonic 
haematopoiesis. B) In E11.5 embryo, multiple tissues contained HSC, 
including placenta, yolk sac, umbilical cord and AGM region. HSCs also 
started to colonize foetal liver. These sites were linked by blood vessel. 
C) A schematic representation of haematopoietic development 
sequence. From E7.5 to E11.5, haematopoietic cells appeared in yolk 
sac, placenta, Umbilical cord and AGM, After E11.5, these HSCs started 
to colonize foetal liver and rapidly expand there. Later, they colonized 
thymus, spleen and bone marrow. This figure was reproduced from 
(Medvinsky, Rybtsov et al. 2011) with permission.      
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Based on the close relationship between endothelial and haematopoietic lineages, 
some researchers suggest that they shared a common ancestor-the haemangioblast. 
By definition, haemangioblast cells should have a mesodermal origin and could only 
generate endothelial and haematopoietic lineages. This notion was first proposed 
because in early 20th century because of morphological observations of endothelial 
cells specified near blood cells in Yolk Sac Blood Island. But later observations 
suggested that yolk sac blood “islands” were not islands and they were not 
monoclonal (Ferkowicz and Yoder 2005, Ueno and Weissman 2006). 
Haemangioblasts had been demonstrated in an ES differentiation system (Choi, 
Kennedy et al. 1998, Nishikawa, Nishikawa et al. 1998), but cells isolated from 
developing embryos displayed potential to also differentiate into smooth muscle 
cells (Huber, Kouskoff et al. 2004). Such observation caused the alternative theory 
of haemogenic endothelium to gain momentum (Hirschi 2012). The haemogenic 
endothelium was defined as a special kind of endothelium with haematopoietic 
potential. Haemogenic endothelium was first observed in chicken embryo almost 
100 years ago (Reprinted in Sabin (2002)). Given all evidence about haematopoietic 
budding in embryonic aorta mentioned before, it seemed that definitive 
haematopoietic cells were generated from endothelial cells of the dorsal aorta. The 
process of budding involved endothelial to haematopoietic transition (EHT). 
Cellular signals controlling the EHT would be discussed in later sections.             
1.1.5. Embryonic haematopoiesis in human 
Studies of human embryonic haematopoiesis were constrained by the lack of 
available tissues and experimental limitations. Early observations of human embryos 
focused on primitive haematopoiesis at the yolk sac. Functional studies detected 
CFU (colony forming unit) activity in the yolk sac at 4.5 weeks after conception 
(Migliaccio, Migliaccio et al. 1986). Blood circulation between yolk sac and embryo 
proper might happen as early as 21 days after conception, manifested by presence of 
Gly-A expressing erythroblasts in the cardiac cavity (Tavian, Hallais et al. 1999). 
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However, yolk sac haematopoiesis in human was transient, haematopoietic 
progenitors disappeared in yolk sac after 6 weeks of gestation (Tavian and Peault 
2005). Definitive HSCs in the human embryo emerged from the AGM region. 
Similar to mouse, haematopoietic cells attached to aortic endothelium were also 
observed in 27 day post conception (dpc) inhuman embryos (Tavian, Coulombel et 
al. 1996). Such cell cluster formation gradually extended into the umbilical cord 
region and the vitelline artery until about 35 days post conception. They disappeared 
at around 40 days post conception (Tavian, Hallais et al. 1999). Functionally, highly 
proliferative definitive HSCs appeared in the human AGM region at Carnegie Stage 
14-15 (around 38 to 48 dpc), sub-dissection of AGM region pinpointed its source to 
be the dorsal aorta (Ivanovs, Rybtsov et al. 2011). Further experiments showed that 
the ventral wall of dorsal aorta was the source of definitive HSCs. These definitive 
HSCs were CD34+VE-Cadherin+CD45+C-KIT+THY-1+RUNX1+CD38-/loCD45RA+ 
(Ivanovs, Rybtsov et al. 2014).         
1.2. Regulation of embryonic definitive haematopoiesis  
The development of definitive HSCs was a highly dynamic process. Various 
intrinsic and extrinsic factors acted in a coordinated manner to determine HSC 
identity. The development of HSC occurred in different niches. Cells with the 
potential to become HSC appeared in mesoderm, then developed within the 
endothelial lining of the dorsal aorta. In the dorsal aorta, these cells initiated the 
haematopoietic program and some of them became definitive HSC. Later they 
migrated to the foetal liver and finally colonized the bone marrow, the HSC 
maintenance niche throughout the animal’s life span.  
In ventral wall of dorsal aorta, initially all endothelial cells are of similar origin and 
identity, but after extensive cell to cell interactions and internal decision making, a 
small fraction of endothelial cells acquired the haemogenic endothelium fate. They 
formed specialized cluster-like patterns. Capacity to facilitate de novo specification 
of definitive HSC was what made aortic niches different with perivascular niches in 
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bone marrow. To figure out how HSCs acquired stem cell identity during 
specification, researchers must identify all intermediate cell state between totipotent 
ICM (Inner Cell Mass) cell and HSC, and work out rules governing each transition. 
Such rules included extrinsic factors and internal gene regulatory networks involved 
in major cell states transitions (Swiers, Patient et al. 2006). So far, several major 
steps of stem cell specification had been identified. A totipotent ICM cell went 
through mesodermal specification, acquired endothelial fate, acquired haemogenic 
potential, became a pro-HSC, then pre-HSC and finally matured with a definitive 
HSC phenotype. Both intermediate cell states and transition from one to the next 
would be discussed in following section.               
1.2.1. Endothelial specification 
The first step of definitive HSC specification was the induction of the primitive 
streak. After induction of primitive streak, some posterior primitive streak cells 
became Flk1 positive (also known as KDR, VEGFR2), a sign of haematopoietic 
mesoderm commitment. Next, precursors of HSC further acquired endothelial fate. 
The Wnt pathway was critical for early specification of primitive streak cells. 
Disruption of Wnt signalling had profound negative effects on endothelial 
specification in embryonic development (Bigas, Guiu et al. 2013). Suppression of 
the Wnt pathway by deletion of β catenin caused alteration of vascular patterning 
and formation of lacunae at bifurcations and haemorrhages (Cattelino, Liebner et al. 
2003). Similarly, disruption of the Wnt pathway by disruption of Frizzled-5 (Fzd5, 
one of the Wnt receptor) leaded to defect in angiogenesis (Ishikawa, Tamai et al. 
2001). Work with pluripotent stem cells demonstrated that Wnt had distinct 
functions at different stage of haematopoietic specification. Wnt was also critical for 
induction of primitive streak like cells in ES cultures (Jackson, Schiesser et al. 
2010).  
Another well studied mesodermal fate inducer was BMP4, a member of TGF-β 
family. It activated the SMAD pathway (Larsson and Karlsson 2005). BMP4 
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signalling was related to generation of both the Ventral Blood Island (VBI, 
associated with primitive haematopoiesis) and dorsal lateral plate mesoderm (DLP, 
associated with definitive haematopoiesis) in Xenopus embryos (Sadlon, Lewis et al. 
2004). Mouse embryos with disrupted BMP function had reduced mesoderm 
development and died early. On a few special genetic backgrounds, BMP4 null 
embryos could survive a little longer, but had abnormal yolk sac and reduced 
primitive haematopoietic cells (Winnier, Blessing et al. 1995). Work on pluripotent 
stem cells indicated that BMP4 induces ventral posterior mesodermal fate by 
upregulating Wnt3a and Cdx-Hox genes (Lengerke, Schmitt et al. 2008). Further 
studies demonstrated an importance of orchestrated signalling of BMP4 and other 
molecules like Activin/Nodal or Wnt in the induction of primitive streak like cells 
(Kennedy, Awong et al. 2012) and haematopoietic mesoderm (Sumi, Tsuneyoshi et 
al. 2008, Jackson, Schiesser et al. 2010). Besides Brachyury, BMP induced primitive 
streak cells primarily expressed HoxB1 and MesP1 (Saga, Hata et al. 1996). 
Expression of FoxA2 was low to negative in BMP induced primitive streak cells. 
BMP4 positive cells were restrained to posterior part (Saga, Hata et al. 1996, Nostro, 
Cheng et al. 2008).    
Another important factor of TGF-β family, Nodal, was involved in mesodermal 
formation and body axis speciation of vertebrate development. In early embryonic 
development, sometimes effects of Nodal were similar to Activin, and were usually 
referred to as Activin/Nodal pathways (Shen 2007). Activin/Nodal signalling was 
required for induction of primitive streak like cells in ES culture. Such cells were 
marked with expression of Brachyury (Gadue, Huber et al. 2006, Nostro, Cheng et 
al. 2008). Inhibition of Nodal or Wnt signalling completely blocked formation of 
Brachyury cells induced by BMP signalling. Addition of ACTIVIN A and WNT3A 
induced primitive streak cell like phenotypes, but not all of them expressed posterior 
markers which were haematopoiesis related, some of induced cells expressed high 
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level of FoxA2, suggested anterior primitive streak identity (Nostro, Cheng et al. 
2008).  
Flk1, a receptor for VEGF signalling, was generally accepted as a marker for cells 
committed to mesodermal fate. Expression of Flk1 was critical to normal endothelial 
development and haematopoiesis (Vieira, Ruhrberg et al. 2010). Flk1 knockout ES 
cells could not contribute to the endothelial lineage. In chimera experiments, Flk1-/- 
ES cells did not contribute to yolk sac primitive haematopoiesis. Definitive 
haematopoietic cells of adult chimeras were derived only from Flk+/+ wild type cells 
(Shalaby, Ho et al. 1997). Experiments with Flk1+/Cre, Rosa26R-LacZ embryos 
showed extensive staining of endothelial and haematopoietic cells at dorsal aorta 
and yolk sac. Analysis of bone marrow of adult Flk1+/Cre, Rosa26R-EYFP mice 
showed that almost all myeloid, T cell, B cells and haematopoietic cells are labelled 
by EYFP, suggesting they came from Flk1 expressing cells (Lugus 2008).  
The emergence of Flk1+ cells in pluripotent differentiation cultures could be 
efficiently induced by BMP signalling prior to Brachyury expression. However, 
BMP added to Brachyury+Flk1- population did not induce Flk1 expression as robust 
as Activin A (Nostro, Cheng et al. 2008).  
One critical downstream factor of coordinated BMP, WNT and NOTCH induction of 
Flk1 was ER71 (Etv2). In ES culture systems, forced expression of ER71 rescued 
Flk1+ expression from BMP, Notch and Wnt inhibition. Such observations suggested 
existence of Flk1-ER71 auto-regulatory loop. And ER71 deficient mice displayed 
phenotype highly resembled Flk1 deficient mice (Lee, Park et al. 2008). Additional 
research showed that ER71 expression was only restricted to a subset of Flk1+ cells 
at primitive streak stages, and ER71 expression was significantly reduced in Flk1 
deficient embryos while Flk1 expression was only modestly affected in ER71 
deficient embryos (Rasmussen, Shi et al. 2012). ER71 regulate Wnt downstream 
factors in Flk1+ mesoderm induction was observed (Liu, Kang et al. 2012). Work on 
embryonic stem cells by Gordon Keller et al. demonstrated that Wnt signalling 
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promoted the generation of haematopoietic colonies after Flk1+ mesoderm induction 
(Nostro, Cheng et al. 2008). Above works suggested complex context dependent 
effects of different signals at different stage of Flk1+ mesoderm specification.   
Scl was a transcription factors that was highly critical for normal haematopoietic 
development (Bloor, Sanchez et al. 2002). This could be demonstrated by the fact 
that Scl knockout mice died at E9.5 due to lack of primitive haematopoietic cells 
(Robb, Elwood et al. 1996). Scl knockout ES cells failed to produce haematopoietic 
colonies upon haematopoietic differentiation; this could be rescued by Scl cDNA 
expression (Porcher, Swat et al. 1996). Studies had shown that Scl had 
complex-context dependent functions during haematopoiesis. Scl expression 
initiated a transition from mesodermal to endothelial identity (Lécuyer and Hoang 
2004). Scl expression was required for definitive haematopoiesis prior to 
VE-Cadherin expression (Endoh 2002). Furthermore, chimeras with normal and 
Scl-/- ES cells demonstrated that Scl was required for vascular remodelling (Visvader, 
Fujiwara et al. 1998).  
After induction of endothelial cells during development, VEGF signalling was 
responsible for its maintenance and expansion. Deletion of one VEGF allele resulted 
in abnormalities in blood vessel formation and premature death of embryos 
(Carmeliet, Ferreira et al. 1996, Ferrara, Carver-Moore et al. 1996). VEGF 
signalling was also critical to establishing arterial identity by inducing arterial 
markers like EphrinB2 (Mukouyama, Gerber et al. 2005).    
1.2.2. Endothelial to Haematopoietic transition (EHT) 
One of major milestones of haematopoietic specification was the initiation of the 
haematopoietic program. Endothelial cells with haematopoietic potential were called 
the haemogenic endothelium. It was specified from endothelial cells via a process 
called Endothelial to Haematopoietic Transition (EHT). With advanced in vitro 
imaging, EHT had been visualized in real-time in development (Kissa and Herbomel 
2010) (Bertrand, Chi et al. 2010) (Boisset, van Cappellen et al. 2010). A fate tracing 
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experiment involved VE-Cadherin-Cre mediated selective labelling of endothelial 
compartment during development showed that HSC had endothelial origin (Zovein, 
Hofmann et al. 2008, Chen, Yokomizo et al. 2009). 
Specification of haemogenic endothelium involved multiple pathways. The Notch 
pathway was critical for normal specification of haematopoietic stem cells (Chen, 
Yokomizo et al. 2009). Kumano et al. demonstrated that knocking out of Notch1 in 
mouse embryos severely impaired definitive haematopoiesis while knocking out 
Notch2 had no profound effect to haematopoiesis (Kumano, Chiba et al. 2003). 
Notch signalling regulated expression of a wide variety of haematopoietic related 
genes, included Runx1, Gata2 and Scl (Robert-Moreno, Espinosa et al. 2005). Work 
in zebrafish suggested that Notch-dependent expansion of haematopoietic cells 
could be inhibited by knocking out runx1 (Burns, Traver et al. 2005), thus suggested 
Runx1 was a downstream target of Notch signalling. This was further confirmed by 
the fact that the haematopoietic function of cells from Notch1-/- embryos was 
partially rescued after retroviral expression of Runx1 (Nakagawa, Ichikawa et al. 
2006).   
Runx1 was a critical haematopoietic transcriptional factor. Runx1-/- embryos died 
early during embryonic development with no definitive haematopoietic progenitors 
present in the foetal liver(de Bruijn and Speck 2004). It had two promoters, one 
proximal (P2) and one distal (P1). Experimental data suggested that the proximal 
promoter was related to primitive haematopoiesis while distal promoter was related 
to definitive haematopoiesis (Sroczynska 2009). It had been noticed that Runx1 was 
required in VE-Cadherin positive stage of HSX specification but not in later Vav1 
positive stage (Chen, Yokomizo et al. 2009). This finding suggested that Runx1 was 
critical for the haematopoietic development before the EHT.  
Several important transcription factors were regulated by Runx1, one of them was 
PU.1 (Huang, Zhang et al. 2008). PU.1 regulated Common Myeloid Progenitor 
(CMP) fate decision and affected macrophage differentiation by modulating 
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expression of receptor of Colony-stimulating factor 1 (Csf1r) (Tagoh, Himes et al. 
2002, Hoogenkamp, Krysinska et al. 2007). During haematopoietic specification, 
PU.1 interacted with other haematopoietic transcription factors like Gata1. Both 
Gata1 and PU.1 gene had auto regulatory loops and they directly suppressed each 
other. Such gene regulatory network structure allowed efficient bi-state switch of 
erythroid and myeloid lineages (Chickarmane, Enver et al. 2009). Recent advances 
in Gata1/PU.1 research suggested that additional factors were present in Gata1/PU.1 
gene regulatory network that affect lineage selection (Monteiro, Pouget et al. 2011).       
Gata1 and Gata2 were critical transcription factors involved in the specification of 
the haematopoietic program. Gata1 knock out cells could not develop into red blood 
cells in chimeric mice (Pevny, Lin et al. 1995) and Gata1 null mouse embryos died 
around E10.5 due to anaemia (Fujiwara, Browne et al. 1996). Gata1 could bind to its 
own promoter and up regulated its own expression (Tsai, Strauss et al. 1991). Such 
auto-regulatory loop was critical to the initiation of downstream gene regulatory 
networks. Gata1 expression was high in primitive erythrocytes, but in definitive 
haematopoiesis, expression of Gata1 was gradually replaced with Gata2. Gata1 
expression was regained at the later stages of erythropoiesis (Moriguchi and 
Yamamoto 2014).  
Gata2 was expressed in the p-SP and AGM region of the developing mouse embryo 
(Minegishi, Ohta et al. 1999). Gata2 expression marked of definitive haematopoiesis. 
Early work on Gata2 knock out ES and chimeric embryos showed its critical 
function in definitive haematopoiesis (Tsai, Keller et al. 1994). Even knocking out 
just one Gata2 allele in embryo caused significant reduction of HSC activity in the 
AGM region and reduced HSC quality (Ling, Ottersbach et al. 2004). Gata2 also 
auto regulated its own promoter (Swiers, Patient et al. 2006). Such auto-regulation 
might be important for Gata2 to quickly initiate its expression and replace Gata1 in 
the switch from primitive haematopoiesis to definitive haematopoiesis.  
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Scl had multiple roles in haematopoiesis besides regulating haematopoietic 
mesoderm specification (Mead, Kelley et al. 1998). Sanchez et al. demonstrated that 
haematopoietic defect of Scl knockout could be rescued by expression of Scl in a 
haematopoietic stem and progenitor cell population (Sánchez, Bockamp et al. 2001). 
In ES culture systems, Scl over-expression could rescue haematopoietic defects 
induced by blocking Hedgehog and Notch pathways during the EHT (Kim, Albacker 
et al. 2013). These finding highlighted that function of Scl was context dependent 
and affects multiple stages during of haematopoiesis.  
Besides important function in the specification of the primitive streak, Wnt 
signalling also regulated haematopoiesis after expression of Flk1. It was observed 
that some non-haematopoietic cells in AGM region were active in Wnt/β-Catenin 
signalling and such signalling from developmental HSC niche was indispensable 
(Ruiz-Herguido, Guiu et al. 2012). Another example of context dependent signalling 
was BMP signalling. Besides played a critical role of haematopoietic mesodermal 
specification, BMP was also required in zebra fish for Runx1 expression in the 
ventral wall of dorsal aorta (Wilkinson, Pouget et al. 2009). Similarly, inhibiting 
BMP activity in mouse AGM explant cultures abolished HSC generation (Durand, 
Robin et al. 2007). Polarized BMP4 expression had also been discovered in human 
AGM region (Marshall, Kinnon et al. 2000), suggesting it was a conserved 
mechanism.    
1.2.3. Maturation of pre-HSCs to definitive HSC 
After initiation of definitive haematopoietic program, precursors of HSC were 
specified in endothelial lining of dorsal aorta of AGM region. HSC emergence was 
polarized and localized to the ventral wall of dorsal aorta, suggested that HSC 
maturation was heavily influenced by external signalling. 
Besides BMP4 signalling mentioned in the last section, emergence of HSC in the 
AGM region depended on several factors from adjacent tissues. Ventral embryonic 
tissue support HSC emergence by providing Hedgehog (Hh) signalling, which was 
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demonstrated by the fact that addition of Indian hedgehog (Ihh) or Desert hedgehog 
(Dhh) enhanced HSC production in AGM explant while addition of anti-Hh 
antibody blocked HSC generation (Peeters, Ottersbach et al. 2009). Research also 
showed that Sympathetic Nervous System (SNS) was critical for HSC emergence. 
Gata3 regulated SNS formation by controlling biosynthesis of catecholamine. Loss 
of SNS formation reduced HSC content in AGM region (Fitch, Kimber et al. 2012).  
One novel signalling involved in this stage of haematopoietic specification was 
biomechanical force. Initially, Yoder et al. established an Ncx1-/- mouse model that 
did not initiate heartbeat. In that model, no haematopoietic progenitor activity was 
detected in AGM region, thus suggested the significance of blood flow in HSC 
maturation (Lux, Yoshimoto et al. 2008). Later, Leonard I. Zon et al. demonstrated 
that HSC maturation was regulated by blood flow through NO (nitric oxide) 
signalling in zebrafish (North, Goessling et al. 2009). Daley et al. further 
demonstrated that biomechanical force was critical to haematopoiesis in mouse 
embryo (Adamo, Naveiras et al. 2009). Expression of Runx1 and CFU activity in 
cells from Ncx1-/- embryo could be restored by artificially induced shear stress. 
Several receptors could sense biomechanics force and activated signalling affecting 
haematopoiesis (reviewed in Lee, Li et al. (2013)).    
Mll (Kmt2a) was another factor involved in HSC emergence. Knocking out Mll 
resulted in ablation of AGM HSC activity although progenitor activity of HSC was 
maintained (Ernst, Fisher et al. 2004). Sox17 was a recently identified transcription 
factor required for HSC emergence, it was critical for maintenance of aortic clusters 
(Nobuhisa, Osawa et al. 2014).  
At last, it was worth mentioning that some commonly used haematopoietic 
cytokines in AGM cultures. SCF was implicated in embryonic haematopoiesis, with 
naturally occurring SCF mutant Sl did not survive to birth due to haematopoietic 
defects. Nobushisa et al. demonstrated Lnk adaptor protein could inhibit HSC 
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formation in AGM region by inhibition of SCF/kit signalling (Nobuhisa, Takizawa 
et al. 2003). SCF was also shown to regulate haematopoietic clusters in the placental 
niche (Sasaki, Mizuochi et al. 2010). Il3 was another cytokine that had critical 
function in haematopoiesis. Robin et al. demonstrated Il3 could dramatically expand 
pool of HSC in a Runx1+/- background (Robin, Ottersbach et al. 2006). Flt3l was 
another commonly used haematopoietic cytokine that had positive effect on 
haematopoiesis. Flt3l was beneficial for in vitro expansion of haematopoietic 
cultures (Tsapogas, Swee et al. 2014). However, yet no report was published 
describing its detailed function in AGM region.        
1.2.4. Seeding foetal liver and bone marrow niche 
After specification in the AGM region, HSC migrated to foetal liver. Expansion of 
HSC in mouse embryo occurred at E11-12 and peaked at E13-14 (Sasaki and 
Sonoda 2000). Foetal liver haematopoiesis went down at E19 (Sasaki and Sonoda 
2000) but continued even in new-born mice (Masaki Takeuchi 2000). Murine foetal 
liver HSCs expressed AA4.1 and Mac1, which was not expressed in adult bone 
marrow HSC (Jordan, McKearn et al. 1990). A portion of definitive HSCs expanded 
in foetal liver was constantly circulating in blood, and migrated to foetal spleen and 
thymus. Chemotaxis of foetal liver HSC was regulated by SDF-1 and SCF 
(Christensen, Wright et al. 2004). Eventually, definitive HSC colonized bone 
marrow niche and stayed there for the rest of organism’s life (Suárez-Álvarez, 
López-Vázquez et al. 2012).    
In summary, embryonic development of HSC was a dynamic process with different 
stages (Medvinsky, Rybtsov et al. 2011). Major milestones of HSC emergence 
included specification of primitive streak, induction of mesoderm with 
haematopoietic potential, endothelial specification, endothelial to haematopoietic 
transition (EHT) and maturation of definitive HSC. Then definitive HSC migrated 
into foetal liver and finally, the adult bone marrow niche. Intrinsic and extrinsic 
21 
 
factors modulating above steps were discussed. Some factors had context dependent 
effect on embryonic development.   
1.3. Dissection of HSC specification niche using in vitro models 
Beside animal models, in vitro models also played a critical role in studying 
embryonic definitive haematopoiesis. Pluripotent stem cells differentiation models 
were used to model in vivo HSC specification process. EB formation was a common 
method for early stage differentiation. Cytokines, feeder cells and conditioned 
medium/trans-wells could be used to alter property of haematopoietic populations 
derived from pluripotent stem cells. To remove interference from unwanted 
populations, population of interest could be sorted out from culture. To promote 
production of haematopoietic cells from pluripotent stem cells, a combination of 
these methods was usually employed. 
1.3.1. Utilizing ES differentiation system to study specification of 
haematopoietic cells 
It was very convenient to use ES/iPS differentiation system to examine effect of 
various cytokines on haematopoietic differentiation. In one elegant study, Pick et al. 
investigated effects of BMP4, VEGF, SCF and FGF2 on haematopoietic 
differentiation (Pick, Azzola et al. 2007). Gordon Keller’s group investigated staged 
regulation of haematopoietic differentiation by Wnt, Activin A and BMP (Nostro, 
Cheng et al. 2008). Later, they demonstrated that Wnt signalling was critical to 
switch between primitive and definitive haematopoietic differentiation programs 
(Sturgeon, Ditadi et al. 2014).  
ES differentiation models also helped to identify critical populations during 
haematopoietic differentiation. The onset of haematopoietic differentiation of ES 
cells was marked by appearance of Brachyury positive cells. Brachyury was a 
commonly accepted marker for primitive steak/mesodermal fate, its expression 
usually turned on around day 4 during differentiation (Purpura, Morin et al. 2008). 
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Shortly after, Brachyury expression was down regulated. It was replaced by Flk1 
expression. In both in vivo development (Lugus, Park et al. 2009) and ES 
differentiation (Irion, Clarke et al. 2010), haematopoietic cells developed from Flk1 
positive ancestors. Interestingly, Keller’s group discovered there were two waves of 
Flk1 expression in ES differentiation system. The first wave of Flk1+ cells was 
related to primitive haematopoiesis while a second wave of Flk1+ cells arises from 
Brachyury+Flk- population. Those secondary were related to definitive 
haematopoiesis (Irion, Clarke et al. 2010). First wave of Flk1+ cells were also 
CD235a+, a marker for erythroid fate. After a day or two, primary Flk1+ cells 
became CD34+, an indication of haematopoietic fate. Later, they differentiated into 
primitive erythroid, myeloid and NK cells. On the other hand, the more definitive 
Flk+CD235- populations would also become CD34+ later. They became progenitor 
cells that could not only produce erythroid, myeloid and NK cells, but also produce 
T lymphoid cells (Sturgeon, Ditadi et al. 2014).  
One critical contribution of ES differentiation system toward study of embryonic 
haematopoiesis was in vitro induction of haemangioblast. In a landmark study 
published in 1998, Keller et al. identified a unique blast-colony-forming cell that 
could generate both haematopoietic and endothelial progenies (Choi, Kennedy et al. 
1998). This was the first experimental evidence such cells exist, at least in culture. 
Later studies showed that haematopoietic cells were generated from haemogenic 
endothelium derived from haemangioblast (Eilken, Nishikawa et al. 2009, Lancrin, 
Sroczynska et al. 2009).   
Thus later research focused on how to generate haemogenic endothelium in ES 
differentiation cultures. Rafii and colleagues generated cell lines from human 
primary endothelial cell (EC) and used such cell lines to promote hESC 
differentiation (Rafii, Kloss et al. 2012). They used VE-Cadherin and CD41 
promoters to drive fluorescence protein to track differentiating hESCs. They 
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observed a switch between VE-Cadherin expressing endothelial fate cell and CD41 
expressing haematopoietic cells.  
After multiple factors regulating haematopoietic development were identified, it was 
natural to think about designing chemical defined differentiation system. Bhatia et al. 
developed a chemically defined differentiation system that had a profound impact on 
related research. They made EB from hESCs with presence of SCF, Flt3l, Il-3,Il-6, 
and BMP4 (Chadwick, Wang et al. 2003). Within such EBs, they isolated a 
CD45-PECAM-1+Flk1+VE-Cadherin+ (Cd45negPFV) population with both 
endothelial and haematopoietic potential (Wang, Li et al. 2004). This system 
generated progenitors with good CFU-C activity, but no transplantable HSCs were 
generated. To enhance differentiation, a staged differentiation system was used. 
Keller et al. developed a two stages system for human pluripotent stem cell 
differentiation (Kennedy, Awong et al. 2012). First induction and specification stage 
involves timed addition of BMP4, bFGF, Activin A or small molecule SB-431542, 
VEGF, DKK, IL-6, IL-11, IGF-1, SCF, EPO, TPO, FLT-3, IL-3. Second stage of 
maturation and expansion had a few days of overlap with first stage, with addition of 
bFGF, VEGF, DKK, IL-6, IL-11, IGF-1, SCF, EPO, TPO, FLT-3 and IL-3. Then 
differentiated ES cells were either co-cultured with OP9 cells with presence of 
serum or had DKK withdrawn. One major advantage of such differentiation system 
was that cells generated by it have lymphoid potential. Such potential was 
demonstrated by commonly used OP9-Dll4 co-culture assay. Successful generation 
of T cells is a major step toward generation of HSCs with the capacity to 
differentiate into all haematopoietic, myeloid and lymphoid lineages.  
To better study the intrinsic genetic network regulated haematopoietic 
differentiation, ES cells or their differentiated progenies were modified. Initial 
modifications were more concentrated on altering expression of transcriptional 
factors related to haematopoietic development. Kitajima et al. used Gata1 knockout 
ES to demonstrate that Gata1 was indispensable for erythroid differentiation, 
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without Gata1, cells had difficulty maintaining erythroid identity. (Kitajima, Zheng 
et al. 2006). Liu et al. used knockout ES cell lines to demonstrate that critical role of 
ER71 in haematopoietic specification of Flk1+ mesoderm by inhibiting cardiac fate 
(Liu, Kang et al. 2012). Gata2 was another critical transcriptional factor related to 
haematopoietic differentiation. Several groups manipulated Gata2 expression in ES 
cells to determine its function in haematopoietic differentiation. Orkin et al. used 
Gata2 knocked out ES to demonstrate Gata2 was important for maintenance of 
multipotent progenitors (Tsai and Orkin 1997). Later, Kitajima et al. used 
conditional expression Gata2 ES system to investigate function of Gata2 at each 
stage of in vitro haematopoietic differentiation. This study revealed complex 
regulatory wiring between Gata2 and PU.1, suggesting Gata2-PU.1 formed a 
critical node in gene regulatory network related to haematopoiesis (Kitajima, Tanaka 
et al. 2005). Knockout/conditional expression system was not restricted to master 
transcription factors, other genes had been knocked out in ES cells for 
haematopoiesis research, including ALL-1 (Fidanza, Melotti et al. 1996), Stat5 
(Kyba, Perlingeiro et al. 2003), and Men1 (Novotny, Compton et al. 2009). 
Knockout or conditional expression in ES system would remain a versatile tool to 
study haematopoietic specification in the future. The function of Runx1 was also 
extensively studied with ES model. Lacaud et al. tested haematopoietic 
differentiation capacity of Runx1 knock-out ES cell line. They observed alteration of 
gene expression pattern and marked reduction of BL-CFC potential (Lacaud, Gore et 
al. 2002), such deficiency could be rescued by retroviral-introduced Runx1. It was 
also observed that Runx1 deletion did not affect primitive haematopoiesis. 
Differentiation of primitive erythroid lineages was not altered. Later Medvinsky’s 
group generated a reactivable Runx1 allele (Samokhvalov, Thomson et al. 2006). 
They also observed a specific blockage of myeloid/mix lineage differentiation 
Runx1 knockouts while more primitive erythroid differentiation was not completely 
blocked. Such blockage could be partially rescued with reactivation of Runx1 allele 
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(Samokhvalov, Thomson et al. 2006). These observations reinforced the idea that 
Runx1 was pivotal for definitive haematopoiesis while not indispensable for 
primitive haematopoiesis.   
Not only ES cells themselves could be engineered, their differentiated progenies 
were also good targets for manipulation. For example, Nakajima-Takagi et al. 
screened a panel of transcription factors in ES derived endothelial cells and found 
that Sox17 was an important haematopoietic stimulator. Sox17 primed early 
endothelial cells to haematopoietic fates (Nakajima-Takagi, Osawa et al. 2012). This 
approach was very interesting. ES differentiation system was a very complex culture. 
It contained different populations interacted with each other. Such kind of in-culture 
screening might reveal factors that mediated interactions between different cell 
populations in ES differentiation culture. 
One aspect of haematopoietic differentiation of pluripotent cell research was focused 
on generation of red blood cells. Mature red blood cells had a short life span; some 
patients with haematopoietic disorder required constant infusion of freshly made red 
blood cells. Mature red blood cells did not had a nucleus, thus were devoid of 
genetic materials that might cause problem in other cell types. Such unique 
properties made red blood cell an ideal cell type for cell therapy. Oliver et al. used 
hESC derived CD34+ cells to generate red blood cells (Olivier, Qiu et al. 2012). This 
protocol achieved generation of high percentage of enucleated red blood cells but 
hESC derived red blood cells still had haemoglobin profile similar to their foetal 
counterparts. More disappointing, their protocol used foetal liver cell line to promote 
generation of CD34+ cells and murine enucleate red blood cells. Those foetal cell 
lines were difficult to meet Good Manufacture Practice (GMP) requirement. Lu et al. 
developed a chemical based method to generate red blood cells from hESC (Lu, 
Feng et al. 2010). Their protocol was more GMP friendly compared to cell line 
based method, but only about 10-30% of red blood cells generated were enucleated 
and switch to adult haemoglobin was not complete. 
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After successful derivation of iPS cells in 2006 (Takahashi and Yamanaka 2006), a 
lot of interest was devoted to apply iPS cells or its screening technology to 
haematology research. One brutal but interesting approach involved transplanting 
iPS into immuno-compromised mice and harvested HSC from teratoma and bone 
marrow of iPS recipients (Suzuki, Yamazaki et al. 2013). To facilitate 
haematopoietic development inside teratoma, they co-transplanted OP9 cell and a 
mini-pump to provide haematopoietic cytokines. They used a gamma-c corrected 
murine iPS cell line to form teratoma in X-SCID mouse model. HSC derived from 
teratoma generated normal T cells and trace amount of B cells. This experiment 
demonstrated the principle of gene correction using iPS formed teratoma. Similar 
approach with human iPS and NSG mouse model yielded detectable amount of 
hCD45+mCD45- cells in teratoma bearing NSG mice, and human originated 
multilineage engraftment was observed. Considering the fact that Japanese 
researchers were rapidly moving on to test human-pig chimera for generating human 
organs (Matsunari, Nagashima et al. 2013) (Normile 2013), it was possible that pigs 
could be used to house patient specific teratoma. Enough human HSCs for 
transplantation might be harvested from the pig. 
A more delicate approach was to screen transcription factors that allowed a direct 
change to HSC identity. In 2010, Bhatia and colleague reported conversion of 
fibroblast to multilineage blood progenitors by forced expression of Oct4 (Szabo, 
Rampalli et al. 2010). These converted cells expressed CD45 and had some myeloid 
potential when stimulated with haematopoietic cytokines. However, human Oct 
reprogrammed CD45+ fibroblasts generated only trace amount of engraftment when 
transplanted into NSG mice model, and the ability to homing into bone marrow 
niche was not tested with tail vein injection. In 2014, Riddell et al. reported 
generation of induced HSC from committed myeloid cells by forced expression of 
Runx1t1, Hlf, Lmo2, Pbx1, Zfp37 and Prdm5 (Riddell, Gazit et al. 2014). They also 
reported increase of reprogramming efficiency by additional expression of Meis1 
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and MycN. They generated relatively high level of engraftment, a marked 
improvement compared to previous studies. The iHSC generated with their system 
was capable of secondary transplantation. However, such results still awaited 
independent replication. If replicated, above experiments would be considered as 
major breakthrough in HSC biology.               
1.3.2. Utilizing cell co-culture system to study specification of HSC 
Cell co-culture system was also a frequently used system to study haematopoietic 
specification. Two kinds of co-culture studies were common. One kind was to 
co-culture of ES or iPS cells with haematopoietic feeder lines. This kind of studies 
mainly focused on how surrounding cells interacts with precursors of HSC. The 
other kind was to co-culture primary embryonic cells with feeder lines and 
investigate their maturation toward HSC. Such study was primarily focused on 
studying developmental potential and transcriptional regulation of embryonic 
primary cells that are destined to become HSC. 
1.3.2.1. Studying HSC specification using pluripotent stem cells and 
their progeny  
It was thought that cell lines were a better source of feeder cells than primary cells in 
co-culture experiments. Cell lines were culture of immortalized primary cells. These 
cells passed senescence and crisis. They could grow indefinitely. They were more 
stable compared to primary cells. To increase chance that cultured cells overcoming 
growth senescence and crisis, external immortalization factors were usually 
introduced. Immortalization factors usually interacted with multiple cellular factors, 
mainly tumour suppressors (Ahuja, Saenz-Robles et al. 2005). 
As early as 1987, Collins and Dorshkind established S17 cell line from long term 
bone marrow culture. That cell line could support B lymphopoiesis and 
myelopoiesis (Collins and Dorshkind 1987). Later in 1994, Nakano et al. reported 
establishment of cell line OP9 from bone marrow of M-CSF mutated op/op mice 
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(Nakano, Kodama et al. 1994). They demonstrated that OP9 cell line could 
differentiate ES cells toward lymphoid lineages. Later, OP9 had become one of most 
used cell lines in co-culture studies about developmental haematopoiesis, although it 
was derived from adult bone marrow, not embryonic haematopoietic sites. Slukvin 
et al. developed a chemically defined protocol to differentiate human PSCs on 
over-confluent OP9 layers (Choi, Vodyanik et al. 2012). Their system could 
generate CFU colonies.  
Oostendorp and colleagues generated cell lines from mouse embryonic AGM region. 
Details of cell lines generated were discussed in the next section (Oostendorp, 
Harvey et al. 2002, Oostendorp, Medvinsky et al. 2002, Oostendorp, Harvey et al. 
2005). Other researchers tested Oostendorp’s stromal cell lines’ ability to promote 
haematopoietic differentiation in mouse ES differentiation systems (Krassowska, 
Gordon-Keylock et al. 2006). In 2008, Lako and colleagues co-cultured these cell 
lines with human ES cell and yielded up to 16% engraftment in blood, but only 
modest engraftment in bone marrow was detected (Ledran, Krassowska et al. 
2008).They found that haematopoietic maturation signals was not completely 
secreted or reside within extracellular matrix. However, this important study often 
met scepticism and had not been reproduced by others.  
Malcolm Moore of Memorial Sloan-Kettering Cancer Center had his fellow 
researchers derived 106 cell lines from E10.5 AGM region. After derivation, they 
did similar screening of stromal lines capacity to support mouse bone marrow cells 
and human cord blood CD34+ cells. Furthermore, they tested derived line’s capacity 
to differentiate mouse ES cells. They profiled expression of surface marker and 
cytokines of those lines, select lines were analyzed with microarray (Weisel and 
Moore 2005). Interestingly, they discovered that some cell lines gradually lost 
haematopoietic supportive function as they get passaged, with AGM-S26 line lost 9 
fold CFC generation capacity as they grow from passage 5 to passage 19 (Weisel, 
Gao et al. 2006). 
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Beside AGM derived cell line, aforementioned work with Rafii (Rafii, Kloss et al. 
2012) utilized primary endothelial cell lines derived from ES cells as feeder to 
promote haematopoietic differentiation.       
In summary, research used derivation of haematopoietic supporting or maturing cell 
lines had been significantly advanced. Initial works with S17 and OP9 were derived 
from adult haematopoietic maintenance niche in bone marrow. Their capacity to 
promote haematopoietic differentiation of pluripotent cells was limited. Later work 
by Oostendorp et al. started to derive lines from embryonic haematopoiesis niche 
like AGM and foetal liver (Oostendorp, Harvey et al. 2002). By doing this, 
researches were done with stromal lines that closely resemble the microenvironment 
of embryonic haematopoiesis. Their capacity to promote haematopoietic 
differentiation of pluripotent cells was batter compared to previous lines. On the 
other hand, Rafii et al. tried to re-create necessary microenvironment by used ES 
derived cells as feeder cells (Rafii, Kloss et al. 2012). 
1.3.2.2. Studying HSC specification using haematopoiesis related 
primary cells 
The other commonly used paradigm was to co-culture primary haematopoietic 
precursor cells with already derived cell lines. As early as 1980, Gartner and Kaplan 
reported that human bone marrow derived adherent cells could support long-term 
human CFU production (Gartner and Kaplan 1980). Later, a series of 
haematopoietic related stromal lines was developed. And derived cell lines were 
tested for their ability to maintain and expand haematopoietic stem cell or 
progenitors (Issaad, Croisille et al. 1993, Nakano, Kodama et al. 1994, Wineman, 
Moore et al. 1996). Soon stromal cell lines were generated from embryonic AGM 
tissues (Ohneda, Fennie et al. 1998, Oostendorp, Harvey et al. 2002).  
At about the same time, some researchers expanded into new direction of studying 
dynamic of haematopoietic specification of early embryonic cells. In 1998, Xu et al. 
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established stromal cell lines from mouse AGM region. They derived three cell lines 
from AGM region of mouse E10.5 embryos and denoted them as AGM-S1, 
AGM-S2 and AGM-S3 (Xu, Tsuji et al. 1998). They tested these lines for their 
capacity to support mouse bone marrow progenitor by cobblestone-like colony and 
CFU-C counting assay. Subsequently, they plated LSK cells (Lin-Sca1+c-Kit+) from 
mouse bone marrow onto AGM-S3 line and detected CFU-C and CFU-S colonies. 
Next they tested their cell line’s capacity to support human CD34+CD38+ cells. The 
best performing cell line, AGM-S3, was demonstrated to support human HSC in 
culture. Finally, they profiled surface marker and cytokine expression of AGM-S3. 
Early in 2001, Matsuoka et al. applied Xu et al.’s cell line to a human stromal line 
co-culture system they developed. They co-cultured their best performing AGM-S3 
line with primary E8.5 p-SP and yolk sac cells. They claimed that they detected 
CFU-C activity and production of macrophage after 7 days of culture. After 6 day of 
co-culture, CFU-S activity and generation of definitive HSCs were also detected 
from AGM-S3 co-cultured primary E8.5 p-SP and yolk sac cells. Engraftment could 
be detected in B cell, T cell and Myeloid cell linages up to 6 months. They also 
generated definitive erythrocytes from that culture. Similar culture with E8.0 p-SP 
and yolk sac cell also generated engraftment of definitive HSC (Matsuoka, Tsuji et 
al. 2001). 7 years later, another group abandoned the system involved co-culture 
with E8.0 primary cells and reverted back to testing capacity of supporting LSK 
cells. They sub-cloned AGM-S3 to 13 sublines and tested each clone’s capacity to 
support bone marrow LSK cells and profiled gene expression of non-supportive cell 
(AGM-S3-A7) alongside with supportive lines (AGM-S3-A9 and OP9) (Nagao, 
Ohta et al. 2008). However, there was no further replication about cell line 
AGM-S3’s capacity to mature precursor of HSCs from E8.5 or E8 embryos. It 
would be highly beneficial for Nakahata’s group to repeat this study and try to 
derive more cell lines to confirm these line’s capacity to mature precursors of HSC. 
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In 2002, Oostendorp et al. generated more than 100 stromal lines from E11.5 mouse 
embryo using transgenic mice expressing an immortalization factor (Oostendorp, 
Harvey et al. 2002, Oostendorp, Medvinsky et al. 2002, Oostendorp, Harvey et al. 
2005). These cell lines came from different parts of the AGM region or foetal liver. 
Oostendorp et al. faced problems to deliver immortalization factor into small 
number of cells. To deal with that problem, they decided to knock in an 
immortalization factor into PGK or beta-actin allele and express it in a constitutive 
manner. Constitutive expression of immortalization required a delicate balance 
between increase powers of immortalization and avoid spontaneous tumour 
formation. Thus the tsA58, a relatively weak immortalization factors was selected to 
minimize tumour formation. It was a temperature sensitive version of SV40 large T 
antigen. Such weak immortalization vector required several months for cells passing 
through crisis and achieve full immortalization. Before immortalization, cultured 
primary cells would stop growing after a few passages. That was called replicative 
senescence (M1 stage of aging). After a few culture, cells reached crisis (M2 stage) 
with marked increase of cell death and chromosomal abnormalities (Lustig 1999). It 
was suggested cells had extensive transcriptome alteration as they go through crisis. 
Thus the cell lines derived in Oostendorp’s study might not preserve all 
haematopoietic specification related transcription program. 
They did a comprehensive characterization of their cell lines. They checked growth 
rate of various clones and established that the tsA58 was beneficial for cell growth. 
They co-cultured lines derived with bone marrow cells and detected progenitor (via 
CFC) or HSC content (via transplantation). The results showed some clones can 
support and expand haematopoietic progenitor, bone marrow HSC and HSC from 
E11.5 AGM (Oostendorp, Harvey et al. 2002, Oostendorp, Medvinsky et al. 2002). 
They also conducted a wide survey about surface marker expression of cell lines 
they derived, and discovered that most cell line derived bear mesenchymal marker, 
not endothelial nor haematopoietic marker, some lines demonstrated high level 
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expression of haematopoietic promoting factors (Charbord, Oostendorp et al. 2002). 
Later, it was demonstrated that Wnt5a played a critical role in the capacity of 
haematopoietic promotion of these cell lines (Buckley, Ulloa-Montoya et al. 2011). 
They tested these line’s capacity to support haematopoietic progenitors in human 
cord blood. Some lines even could support human progenitors and HSC in in vitro 
co-culture condition (Kusadasi, Oostendorp et al. 2002). Experiments with these 
lines using Transwell showed that long term maintenance of HSC did not depend on 
contact between HSC and stromal cells (Oostendorp, Robin et al. 2005).  
Later Professor Medvinsky’s group developed 3D aggregation culture system that 
float on the interface between air and medium (Taoudi, Gonneau et al. 2008). Such 
system was improved from organ-explant culture system described in (Kumaravelu, 
Hook et al. (2002), Medvinsky, Taoudi et al. (2008)). Unlike explant culture system, 
it allowed study of development of independent subpopulation isolated from primary 
tissues. Using aggregation system, they isolated two precursor populations of HSC- 
pre-HSC I and pre-HSC II (Rybtsov, Sobiesiak et al. 2011). Pre-HSC I population 
bear the marker of VE-Cad+CD45-CD41+, they developed into pre-HSC II bear the 
marker of VE-Cad+CD45+CD41+. Later, pre-HSC II further matured into definitive 
HSC. However, because inconsistent results were acquired from aggregation 
experiments with primary cells only, OP9 cells were used to provide niche signal 
necessary for haematopoietic maturation.  
1.4. Introduction to piggyBac transposon based immortalization 
system 
In previous studies, two approaches of deriving cell lines from haematopoietic sites 
were used. The first way was to harvest cells from transgenic mouse strain that 
contains immortalization factor or wild type mouse and culture them to allow 
spontaneous cell line formation as described previously (Xu, Tsuji et al. 1998, 
Kusadasi, Oostendorp et al. 2002, Oostendorp, Harvey et al. 2002, Weisel and 
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Moore 2005). Another kind of study used viral vector to deliver immortalization 
factors into target cell populations directly (Seandel, Butler et al. 2008, Rafii, Kloss 
et al. 2012). This method assured strength of immortalization, but preparing viral 
particle was a demanding work, and using viral particles on certain cell types might 
pose regulatory difficulty.  
In this study, a piggyBac transposon based immortalization system was used. The 
piggyBac transposon was one class II mobile element that was discovered from 
baculoviruses that infected certain insects (Fraser 2002). Some mutant baculoviruses 
were seen with a phenotype of generating few polyhedral occlusion bodies (FP), and 
such phenotype was a function of the host. This phenomenon was now known to be 
caused by FP locus being a preferred site for host transposable element. Several 
transposable elements were isolated from that locus. One of them, IFP2 (Insertion in 
FP mutant 2) from Trichoplusia ni was considered as the most interesting (Cary, 
Goebel et al. 1989). It was later renamed as piggyBac. Follow up research showed 
piggyBac transposon contained an ORF that encode a transposase (Fraser, Cary et al. 
1995) and was TTAA specific (Cary, Goebel et al. 1989). Based on this property, 
piggyBac transposon was developed as a gene delivery vector. It was used in 
Drosophila (Horn and Wimmer 2000), and mammalian cells (Li, Michael et al. 
2013).  
1.5. Strategy and aims   
Previous studies with haematopoietic promoting cell lines revealed their potentials 
in maintaining early haematopoietic cells in developing embryo. Several studies 
derived cell lines from embryonic AGM and FL tissues, but no cell line was 
established based on surface marker expression profile of its primary cell ancestors 
(Xu, Tsuji et al. 1998, Oostendorp, Harvey et al. 2002). Osamu et al. isolated 
primary cells from mouse AGM, stimulated expansion of endothelial population 
with endothelial cell-growth supplement, sorted out CD34+ population from culture 
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and established cell lines from them (Ohneda, Fennie et al. 1998). Rybtsov et al. 
(Rybtsov, Batsivari et al. 2014) used aggregation system to mature pro-HSC from 
E9.5 embryo to definitive HSC. In this study, I combined advantages of these 
studies to derived cell lines from primary cells isolated from AGM region and 
haematopoietic related sites of early embryos. Some cell lines were derived from 
primary cells bear different surface markers. Their capacity to maintain HPCs and 
mature pro-HSCs were tested. The experimental protocols involved were described 
in chapter 2.      
In chapter 3, the pB-PGK-TAG-CER immortalization vector constructed for this 
study was described. This vector employed piggyBac transposon as genomic 
delivery vehicle, which was better than viral vectors because it was removable. 
Immortalization was achieved through expression of SV40 large T antigen. It was 
better compared to temperature sensitive version of SV40T because it could achieve 
direct immortalization of murine cell without going through crisis.     
In chapter 4, the derivation of stromal line was discussed. In this study, I chose 
electroporation as the mean to deliver DNA into target cells. The Neon™ capillary 
electroporation system was optimized to work with sorted embryonic AGM cells. 
Afterward, cell lines were derived from sorted E11.5 AGM primary cells and from 
primary cells isolated from haematopoietic sites of earlier embryos. 
In chapter 5, the results of 4 days HPC production assay and pro-HSC maturation 
assay were discussed. Such two assays were aimed at evaluate derived stromal line’s 
capacity to promote haematopoietic maturation. It was discovered that cell lines 
derived in this study could match or even outperform the commonly used OP9 in 
capacity to promote haematopoietic maturation. 
In chapter 6, discussion was focused on gene expression profiling of some stromal 
lines. To accurately measure gene expression, a reliable qPCR platform was 
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established, then a panel of derived cell lines were analysed alongside with OP9 
control. The gene expression profiling results were analysed. 
In the last chapter, chapter 7, this study was compared with several studies done 
previously. The advantages of this study were discussed and directions for further 
improvements were mentioned. At last, result gathered in this study was interpreted 
using Multi-ordered Markov Random Field model. This model could better explain 
the stochastic nature of pro-HSC maturation discovered in this study.     
36 
 
2. Chapter 2: Material and Methods 
This project was aimed at deriving cell lines from different haematopoietic related 
primary cell populations. That included different subpopulations of E11.5 AGMs 
and earlier E8-E10 embryos. To achieve this, a piggyBac based immortalization 
vector was constructed. A protocol to electroporate vectors into primary cells 
derived from haematopoietic developmental sites was developed. Cell lines were 
established from different haematopoietic developmental sites and/or from primary 
cells bear different surface markers. Some of these cell lines were subjected to 
aggregation assays that were developed in our lab. Two assays were employed: 
E11.5 haematopoietic progenitor assay and E9.5 pro-HSC maturation assay. A 
quantitative Polymerase Chain Reaction (qPCR) protocol was established to 
determine expression of haematopoiesis related genes.      
2.1.  Construction of pB-PGK-TAG-CER and pB-PGK-CER vector 
Briefly, to make the pB-PGK-TAG-CER immortalization vector, a PGK fragment 
was amplified using Polymerase Chain Reaction (PCR) and inserted in to 
pCR-BluntII intermediate vectors (Life Technologies). PCR primers used in this 
section are listed in table 2.1-1. Dr. David Hills designed first 11 primers listed in 
that table. Reaction is carried out using Platinum Pfx DNA polymerase (Lift 
Technologies). After verification PGK fragment was inserted into pB-CAG 
piggyBac backbone to replace CAG promoter. The new vector was named as 
pB-PGK vector. Then Dr David Hills helped to introduce additional enzymatic sites 
into pB-PGK backbone using PCR, made it pB-PGK-M (M stand for “modified”) 
vector. Next, SV40T and 2A-CER fragments were generated via PCR and inserted 
into pCR-BluntII intermediate vectors respectively. After verification, both 
fragments were cut from intermediate vectors and ligated with digested pB-PGK-M 
backbone in a triple ligation reaction (recipes in appendix table 8.1.1-1). To verify 
the pB-PGK-TAG-CER vector, clones from previous experiment were screened by 
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HindIII digestion (NEB). Positive clones were sequenced using primers 
PGK-NheI-For, SV40-Tag-F, SV40 Primer1, SV40 Primer2, SV40 Primer3, 
SV40-TAg-2A-R and CER-R (listed in Table 2.1-1). 
 
Table 2.1-1. Primers used to generate and sequence pB-PGK-TAG-CER 
construct. Primers for PGK-NheI-For and Rev were used to generate 
PGK fragment for pB-PGK vector. pB-PGK-A and B were used to modify 
pB-PGK vector. SV40-SacII-F and SV40-T2A-Tail-R were used to 
generate SV40T Fragment. 2A-F, 2A-R, 2CER-F, CER-R were sued to 
generate 2A-CER fragment by overlapping PCR. SV40 primer 1 through 
4R were used to sequence SV40T region. All primers were synthesized 
at Integrated DNA Technologies, Inc. 
DNA from clones with correct TAG-2A-CER cassette was maxipreped, 
electroporated into OP9 or 293T cells. Expression of Cerulean fluorescence protein 
was confirmed using flow cytometry, confocal microscopy and immuno-histological 
staining. Expression of SV40T antigen was also confirmed using 
immuno-histological staining. After pB-PGK-TAG-CER transfected cells recovered 
from electroporation, they were seeded onto gelatin coated wells with autoclaved 
cover slips and used next day. On the next day, 10X TBS stock solution was 
prepared by adding 14.8g of Na2HPO4•2H2O, 4.3g of KH2PO4, 70g NaCl, 50g Tris 
and 2g NaN3 into 1L ddH2O and mixed well. Then 4% paraformaldehyde (PFA) 
solution was made from PFA powder. To help PFA dissolve, 18MΩ water was 
heated and some NaOH were added. Cell culture medium was aspirated and cells 
were washed twice with TBS, then they were fixed in 4% PFA solution for 10 
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minute at room temperature. Fixed cells were treated with TBST (1X TBS solution 
with 3% Triton X-100) for two washes of 5 minute each. After TBST wash, cells 
were blocked by blocking solution made by adding 1% BSA and 3% goat serum to 
TBST solution, incubated for 15 minute at room temperature. Then cells were 
incubated with SV40T primary antibody (BD Pharmingen, catalogue 
number:554149, isotype: mouse IgG2a) at 1:200 concentration and Alexa 
488-conjugated GFP antibody at 1:200, which also recognize Cerulean (Voges, 
Bachmann et al. 2010) (Life Technologies, catalogue number: A21311) at 4°C 
overnight. Next day, the cells were washed three times with TBST for 10min at 
room temperature. Then they were incubated with Alexa 568 goat-anti-mice 
secondary antibody (Life Technologies catalogue number: A11004) at 1:750 for 1 
hour. After that cells were stained with DAPI for 5min and washed three times for 
10min in 1X TBS. At last, the cover slip was coated with ProLong antifade reagent 
(Life Technologies, catalogue number: 36930) and placed on a slide. Pictures were 
taken with an Olympus IX50 inverted microscope and a QImaging Retiga 2000 
camera. 
Functionality of SV40T large T antigen was confirmed by growth curves. Growth 
curves were established by transfecting pB-PGK-TAG-CER vector and 
pB-PGK-CER control vector into separate but identical AGM primary cell sample 
and counting both samples during each passage. Functionality of CER was 
confirmed by confocal microscopy. Transfected cells were seeded in sterile 
coverslips placed in 6 well-plate wells and cultured as normal. Untransfected cells 
derived from head tissues of E11.5 BL6 were used as negative control. On the day 
of analysis, coverslips with cell were picked up from well using forceps, briefly 
stained with propidium iodide (PI, provided by SCRM flow cytometry core) and 
carefully dried, then mounted to slides and observed under a Leica SP5C confocal 
microscope at Confocal and Advanced Light Microscopy Facility (CALM) in QMRI, 
UoE. Following parameters were used: excitation: 458nm, laser power 27%; 
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collection filter: 465-600nm, PMT amplification voltage: 1081V scan speed is 
400Hz, 2,5ms. Pictures were taken with 40X projective lens.   
A pB-PGK-CER control vector was also constructed that lacks SV40T. Primers used 
to make this construct were listed in table 2.1-2. Both primers were designed based 
on CER sequence from pCR-Blunt-CER1 vector. SacII-Ko-ATG-F primer had 
protective bases, SacII site, Kozak sequence and ATG added before CER sequence, 
SalI-R primer had SalI site and protective bases added after CER sequences. Briefly, 
Ko-ATG-CER cassette was generated by PCR and inserted into pCR-BluntII vector. 
After sequencing, correct clone was cut by SacII and SalI to release the 
Ko-ATG-CER cassette. Digested Ko-ATG-CER fragment was ligated with digested 
pB-PGK-M vector. Resulting clones were screened using enzymatic digestion and 
sequencing. The pB-PGK-CER control vector was electroporated into destination 
primary cells alongside with pCyL043 helper plasmid. Expression of Cerulean was 
confirmed by flow cytometry. 
 
Table 2.1-2. Primers used to generate and sequence pB-PGK-CER 
control vector.  
2.2. Establishing electroporation parameters for AGM primary 
cells 
To establish the optimal parameters for primary AGM cell transfection, a set of pilot 
experiments were carried out. All experiments were conducted with identical 
experimental templates to allow comparison between them. AGM dissection 
methods were described in Medvinsky, Taoudi et al. (2008). Electroporation was 
carried out using Neon™ Transfection System and its proprietary buffer R (Life 
Technologies, catalogue number: MPK5000)  
Experiments were aimed to find an optimal electroporation parameters combination. 
Parameter being optimized were: pulse voltage (V), pulse width (ms), pulse number 
(n). An initial survey of different parameter combinations with E11.5 AGM cells 
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was conducted. Then an envelope expansion experiment near rich spots discovered 
previously was done. Later, transfected cells were analysed with a refined set of 
marker to detect potential bias in electroporation efficiency.  
2.2.1. Electroporation of murine AGM cells 
In a typical experiment, mice were mated at 16:00 afternoon. In the next morning, 
females with detectable vaginal plug were pooled together and designated as 
embryonic day 0.5 (E0.5). At pre-determined time of dissection, pregnant mice were 
culled by cervical dislocation and had their uterus taken out with scissors. These 
uterus were kept in dissection buffer (7% FCS in PBS with Ca2+ Mg2+ from Gibco, 
catalogue number: 14040-083). Each uterus was carefully opened with a pair of 
forceps and had its embryos collected in a new petri dish soaked in dissection buffer. 
After all embryos were collected, they were dissected using a pair of Tungsten 
needles under dissection scope, detailed dissection technique was explained in 
(Medvinsky, Taoudi et al. 2008). Harvested tissues were collected in a FACS tube 
(5mL polystyrene round bottom tube, BD Biosciences catalogue number 352054) 
with about 900µL dissection buffer. After dissection, 10X concentrated 
collagenase/dispase (made from powder, Roche Applied Science, catalogue number: 
11097113001, stock solution concentration: 10mg/mL) were added to the tube to a 
final concentration of 1X and cells were incubated on 37°C rotating water bath for 
35-40 minutes. To stop reaction, about 4mL FACS buffer (PBS without Ca2+ and 
Mg2+ from Sigma, catalogue number: D8537 with 7% FCS) were added. Cells were 
centrifuged at 1350 rpm for 5 minutes and resuspended in 1mL FACS buffer. Then 
cells were counted with Fast-Read 102 dispensable hemocytometer (Immune 
System Ltd). Then cell suspension was transfer to a 1.5mL screw cap tube (Sarstedt, 
catalogue number 72.692.005) that was electrical neutral. Cells were centrifuged at 
1350 rpm for 5 minutes and resuspended in electroporation solution (containing 
DNA and Buffer R). Every optimization sample contained 10e5 or 30e5 cells, 500ng 
of maxipreped pEGFP-N1 DNA. They were resuspended in 12µL Buffer R and was 
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electroporated with respected parameters. Real samples were transfected with 
pB-PGK-TAG-CER and pCyL043 vectors with the following parameters: 1350V, 
20ms, single pulse. After electroporation, each sample was placed separately in 96 
well plates, each well contained 200µL electroporation medium (50mL IMDM 
medium from Life Technologies, catalogue number: 21980-065 with 600µL 
Glutamine from SCRM tissue culture core lab). Tips were changed every two 
electroporations. Pen/Strep solution (Penicillin-Streptomycin, Life Technologies, 
catalogue number: 15140-122, final concentration: 100U/mL made by SCRM tissue 
culture core lab) was added 24 hours after electroporation. 
2.2.2. Flow cytometry analysis of transfected cells.  
48 hours post transfection, cells were harvested by 4X TVP treatment. Medium in 
the wells were aspirated and 200µL of PBS without Ca2+ and Mg2+ (Sigma, 
catalogue number: D8537) was added to each 96 well-plate well to wash cells. After 
aspirating PBS, 200µL 4X TVP (made by SCRM TC, PBS solution with 0.1% TVP, 
1% Chicken Serum, 0.04% EDTA. Used 2.5% Trypsin from Life Technologies, 
catalogue number: 15090046; Chicken serum from Sigma-Aldrich, catalogue 
number C5405; EDTA from BDH, catalogue number: 104245-S; PBS from 
Sigma-Aldrich, catalogue number: D8537) was added to each well. After 5 minute 
incubation at room temperature, reaction was quenched using 50µL Foetal Calf 
Serum (FCS, from Life Technologies, catalogue number: 10270106). 5µL well 
shaken Microbeads solution from Cytognos (catalogue number: CYT-PCM-100) 
was added to each well to accurately count cells using flow cytometry. Later cells 
were centrifuged at 1350 rpm for 5 minute, resuspended in 50µL FACS buffer 
containing antibodies listed in table 2.2.2-1. Note each transfection condition had 
two samples, one was stained with “endothelial” set of staining solution while the 
other one was stained with “mesenchymal” set of staining solutions. These two 
samples were used to detect transfected (GFP+) cells in different sub-populations. 
All samples were stained in dark on ice for 30 minute. At same time, isotype 
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controls were made from spare untransfected primary cells that were kindly 
provided by colleagues. Beads control for V450, FITC, PE and APC were also made. 
After first staining, reaction was stopped by adding 200µL FACS buffer. Cells were 
pelleted by centrifuging at 1400rpm (357g on Beckman GS-6R centrifuge with 
GH3.8 rotor) for 5 minutes. Then they were resuspended in 50µL FACS buffer 
containing Streptavidin-PE for 30 minute. During both incubations, samples were 
kept on ice in the dark. After second staining, cells were washed with 200µL FACS 
buffer, and were resuspended in 50µL 7AAD viability staining solution 
(concentration 1:40, eBioscience catalogue No 00-6993-50) and analysed using 
LSRFortessa™ (BD bioscience) flow cytometer. Data were analysed using FlowJo7 
(FlowJo, LLC).  
 
Table 2.2.2-1. Antibodies used to analyse pEGFP-N1 transfected cells. 
Antibodies labelled as “both” were used in both mesenchymal staining 
and endothelial staining. Antibodies labelled as “Endothelial” or 
“Mesenchymal” were used to make respective solutions. Concentration 
column states final concentration of antibodies in staining solution.   
2.3. Establishing feeder cell lines from mouse embryos 
To derive cell lines from murine embryos, pregnant females were generated in same 
the way as described in section 2.2.1. Dissection protocol was similar to section 
2.2.1. All embryos were screened visually to make sure they were at correct 
developmental stage before dissection. To generate cell lines from E8 pre-somatic 
embryos, one E8 embryo was dissected. To generate cell lines from E9 embryos, 
caudal half of embryos were harvested by cutting between heart and forelimbs. For 
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E10 embryos, AGMs were dissected out. Then cells were dissociated and 
electroporated as described in section 2.2.1.  
In different experiments, either AGM, aorta or dorsal part of aorta of E11.5 embryos 
were dissected and collected. Cell suspensions were passed through a cell strainer to 
remove clumps (BD Biosciences, catalogue number 352235). Then E11.5 samples 
were stained with marker of interest (table 2.3-1) as described earlier in section 2.2.2. 
Staining volume was 100µL. In different experiments, different surface marker 
combinations were experimented, they were listed in table 2.3-2. After staining, 
primary cells were sorted on BD FACSAria™ II flow cytometry sorter. Large 
populations (e.g. CD123-CD106-) were collected in FACS tube with 1mL 
electroporation medium (the one with IMDM, not electroporation solution), while 
smaller population (e.g. CD123+CD106+) were collected in 1.5mL tubes with screw 
cap (Sarstedt, catalogue number 72.692.005). After sorting, cells were collected and 
electroporated. Master-mixes of buffer R and two plasmids were made for all 
samples. For samples with more than 10,000 cells, each sample received 0.5µg of 
pB-PGK-TAG-CER immortalization vector and 0.5µg of pCyL043 helper plasmid. 
Samples with less than 10,000 cells received 0.25µg immortalization vector and 
0.25µg helper plasmid. Then each sample was resuspended in 10µL corresponding 
master-mix and electroporated with a single 1350V 20ms pulse.  
 
Table 2.3-1. Antibodies used to stain primary AGM cells to derive cell 
lines from different sub-populations. Note unconjugated antibodies 
against SCF was from R&D system and biotinlayted by our lab 
members using biotinylation kit from Life Technologies. Clones used 
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were CD123: 5B11; CD106: 429 MVCAM.A; SCF: 40215; VE-Cadherin: 
BV13; Flt3: A2F10.   
 
Table 2.3-2. List of cell line derivation experiments with E11.5 AGM cells. 
All experiments were conducted using BL6 embryos. 
After electroporation, cells from each population were distributed to 24 wells. Four 
of them each had roughly one fourth of total population, they were denoted as “bulk 
culture” wells. 20 wells each had 2-50 cells seeded (assuming 90% electroporation 
efficiency and 10% cell survival), they were denoted as “low density” wells. 48 
hours post electroporation, Pen/Strep was added to each well. Cells were fed with 50% 
fresh OP9 medium and 50% AGM-line-conditioned OP9 medium every week. OP9 
medium was made by adding 50mL of FCS, 2.4mL Glutamine, 2.4mL Pen/Strep, 
200µL 2-Mercaptoethanol (2ME, diluted in UHP water, final concentration 0.1M) to 
200mL IMDM medium. Conditioning time was usually 2-3 days. Wells were 
observed for up to three months, those with cell outgrowth were harvested using 4X 
TVP treatment described earlier. Cultures were gradually expanded and frozen down 
to two tubes in liquid nitrogen at passage 4 (cultured in T75 flasks).   
To sub-clone bulk cultured populations, transfected primary cells were harvested 
when they reach confluence in 96 wells, cells were lifted using 4X TVP treatment 
and counted with haemocytometer, then samples were diluted and were deposited to 
gelatine coated 96 well plate wells in a concentration of 1 or 2 cells per well. 
Sub-clones were passaged once they reached confluence and treated the same way 
as other lines.                          
2.4. Characterization of Derived Cell lines 
Several assays were used to characterize the cell lines. First, the cell lines were 
aggregated with E11.5 AGM primary cells and cultured at the air liquid interface for 
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4 days. And the haematopoietic colony formation potential of cells in aggregates 
was determined by methylcellulose CFU-C assay using MethoCult GF M3434 
(Stem Cell Technology). After 7 days, haematopoietic colonies in methylcellulose 
dishes were categorised and counted. Selected cell lines were aggregated with E9.5 
caudal part cells and tested for their ability to mature E9.5 pro-HSC into definitive 
HSCs by a combination of CFC, flow cytometry and transplantation assays.  . 
2.4.1. E11.5 haematopoietic progenitor assay 
Immortalized cell lines were passaged every 3-5 days. Before aggregation, they 
were maintained in T75 flasks (Corning) until confluent. To maximize cell recovery, 
in the first experiment of given batch, cultures were generally given more cells to 
allow them stay in over confluence before experiment. On the day of aggregation, 
immortalized cells were harvested using 4X TVP treatment described before and 
counted. Primary cells from E11.5 BL6 mouse embryo were harvested using method 
described earlier. Harvested cells were stored in FACS buffer and kept on ice. After 
harvest, primary and immortalized cells were mixed and made into aggregates using 
methods described in Medvinsky, Taoudi et al. (2008) and section 2.4.1.1. Four days 
after culture, aggregates were harvested and subjected to CFU-C assay as described 
in section 2.4.1.2.  
2.4.1.1. Setting up 3D aggregation culture 
The protocol used in this experiment was similar to one described in (Medvinsky, 
Taoudi et al. 2008). For aggregation experiments in E11.5 haematopoietic 
progenitor assay, each cell line was tested in three conditions: one with AGM 
primary cells and growth factors (Flt3l, SCF, Il3, referred as “+GF” conditions); one 
with AGM primary cells but without growth factors (“-GF” conditions) and one 
without AGM cells (immortalized cells only) but with growth factor (referred as 
“blank” conditions). Before harvesting cells, media for aggregation culture were 
prepared. Volume of basal media (without growth factor) and with growth factor 
(+GF) media were calculated. To make 10mL basal media, 7.8mL IMDM medium, 
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2mL aggregation “gold” serum (Foetal Bovine Serum “Gold”, EU approved, PAA, 
catalogue number: A15-151), 100µL freshly defrosted glutamine, 100µL Pen/Strep 
were added together and mixed well. +GF media were made by adding 100µL of 
Flt3L, SCF and Il3 IMDM solution to 10mL basal media. These stock cytokine 
solutions had a concentration of 10µg/mL (Flt3l, PeproTech, catalogue number: 
250-31L; SCF PeproTech, catalogue number: 250-03; Il3 PeproTech, catalogue 
number: 213-13). This made the final concentration of each cytokine in “+GF” 
media was 100ng/mL. After preparation, medium were kept on ice. Once defrozen 
aggregations serum could be kept in 4°C for up to 3 days. 
At same time membranes used to hold aggregates on air-medium interface were also 
prepared. In every experiment, each condition used one membrane, so each cell line 
used 3 membranes. A few spare membranes were prepared. 0.8µm nitrocellulose 
filter membranes from Millipore (catalogue number: AAWP02500) were washed 
four times in sterilized 10MΩ Millipore water. Each wash was 15 minute long. After 
wash membranes were dried on top of yellow tips in an open tip box in sterile hood. 
A visual examination of membranes was conducted to make sure no greyish humid 
spot existed on them. Membranes must be completely white or they will sunk into 
liquid surface once deployed. Washed membranes could be stored for several 
months. 
Aggregation tips were also made before experiment. One square “section” of 
parafilm M (Bemis Company Inc., catalogue number: P7668-1EA) was cut into four 
equal smaller square pieces. Then each piece was folded twice along centreline, 
forming a small square that was one sixteenth of original “section” size. To make 
aggregation tip, an autoclaved 200µL yellow tip was used to half penetrate the 
parafilm right in the centre. After that the rest of small “square” was squeezed 
around the tip to form a tight seal. 
On the day of aggregation, primary E11.5 AGMs were dissected and dissociated into 
single cells as described earlier. Clumps in primary cells were removed using 
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strainer. Next immortalized cells were harvested using 4X TVP treatment. 
Appropriate number of both primary and immortalized stromal cells were mixed 
together in a clean FACS tube prepared for every condition tested. After 
centrifugation, they were resuspended in basal medium. 20µL of basal medium were 
used for one aggregate. Each membrane had 5 aggregates, each aggregate contained 
10e5 stromal cells and 0.2ee (embryo equivalent) primary AGM cells. Each 
aggregation tip loaded with solutions contained cells was transferred to a sterile 
FACS tube and all tubes were centrifuged at 4°C at 350g for 12 minute. At the same 
time, 5mL of aggregation medium was put into each well of 6-well plate. All 
bubbles on surface of medium were pierced using a yellow tip. Then dried 
membranes were carefully floated on top of the medium, a visual examination was 
conducted to make sure edge of membranes was not below the media surface, which 
would cause the membranes to sink to bottom of wells during culture. 
After centrifugation, parafilm seal tied to the tip of yellow tube was carefully 
removed without disrupting aggregates inside. Then aggregate was carefully 
expelled from tip onto filter membrane floating on medium by squeezing from the 
open end of tip with thumb. Each condition had 3-5 aggregates on one membrane 
with 5mL aggregation medium, all aggregates shared same cell sources. After all 
aggregates were placed onto membrane, the plate was incubated at 37°C 5% CO2. 
Special care was exercised to prevent membrane held aggregates to sink into 
medium due to shaking. 
At end of culture, aggregates were harvested. In E11.5 haematopoietic progenitor 
assay, aggregation culture was 4 days long and in E9.5 pro-HSC maturation assay 
aggregation culture time was 7 days. For each condition, one FACS tube with 1.2mL 
dissection buffer was prepared. Membranes with aggregates were picked up with 
forceps, the edge of the membrane without cells was cut away and the remaining 
part was quickly submerged in dissection medium. After all membranes were picked 
up, they were treated with 1.5mL of 1x collagenase/dispase solution in 37°C rotating 
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water bath for 35-40 minutes. Reaction was stopped by topping up the tube to 4.5mL 
with FACS buffer and centrifuging for 5 minutes. Then supernatant was removed 
without exposing the membrane to air. Afterwards, membranes were washed again 
with FACS buffer to remove residue collagenase/dispase. Next cells attached to 
membrane were washed away by pipetting. To pick up and check membrane at 
bottom of FACS tube, a yellow tip was inserted on top of a blue tip and bended. 
Such assembly was used as a hook. Once all cells were washed away from 
membranes, waste membranes were removed from FACS tube and cells were 
collected by brief centrifugation and resuspended in 1mL FACS buffer. For 
conditions with growth factors (+GF conditions), 0.01ee cells were taken for CFC 
assays. For conditions without growth factors (-GF conditions), 0.1ee cells were 
taken. For blank aggregate without primary cells, half of all cells (equivalent to 
250K input cells) were taken.   
2.4.1.2. Colony Forming Unit assay 
Colony Forming Unit-Culture (CFU-C) assays were aimed to detect haematopoietic 
progenitor cells presented in samples. For all sample dishes observed, clusters of 
feeder cells were excluded based on their tight sphere shaped morphology. 
Granulocytes and Macrophages were distinguished by size of cell and compactness 
of the colonies. Granulocyte-Macrophage colonies were identified by presence of 
two cell size in one colony. Mast colonies were identified by their ultra-small size 
and “radiating” feature. Erythrocyte colonies were identified by their red colour. 
GEMM colonies were identified by the presence of both red and white cells and at 
least two different cell sizes should be observed in same colony. For examples of 
colonies observed, see figure 6.1-1.   
After harvest, cells from each condition were placed in respective tubes containing 
2mL mouse methylcellulose (MethoCult GF M3434, Stem Cell Technology, 
catalogue number: 03434). The contents inside the tubes were briefly mixed on 
vortex shaker and distributed to two different uncoated 30mm plastic dishes. Dishes 
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contained methylcellulose were incubated in 37°C incubator with a dish of sterile 
water to keep the area humid. After 7-8 days, dishes were observed under 
microscope (Motic AE2000) with 100X magnification. Colonies were classified and 
counted. Dishes contained blank aggregates were also observed to train to 
distinguish clumps of stromal cells with real haematopoietic colonies. All readings 
were inputted into Microsoft® Excel and processed.  
2.4.2. E9.5 pro-HSC maturation assay 
Each cell line was tested with +GF (supplemented with growth factors Flt3l, SCF, 
Il3, final concentration 100ng/mL, Peprotech) and –GF (without growth factors) 
conditions. Membranes and medium were prepared in the same way as described in 
section 2.4.1.1. Feeder cells were harvested as described in section 2.4.1.1. Special 
care was taken to identify developmental stage of E9.5 embryos, only embryos 
within 24-28 somatic pair stage were used. They were staged by counting somite 
pairs, staging was confirmed Dr Stanislav Rybtsov. Caudal part of corrected staged 
E9.5 embryos were processed with method described in section 2.3. 
Each condition had three aggregates shared the same membrane and medium. Each 
aggregate had 105 immortalized cells and about 1 embryo-equivalent primary cells. 
For E9.5 HSC maturation assays, only 2mL medium were added into each well in 
the first day. After 1 day of incubation, medium in wells were carefully removed and 
5mL of fresh aggregation medium were carefully added back into each well. It was 
very important to avoid membranes broke the surface of the medium, to sink or 
rotate during this process. Six days later, membranes were harvested as described in 
section 2.4.1.1. This made total culture length 7 days. 0.01ee (+GF conditions) or 
0.2ee (-GF conditions) aggregates cells were used in CFU-C assay as described in 
section 2.4.1.2; about 0.1 to 0.3ee cells were used for flow cytometry analysis with 




Table 2.4.2-1. Antibodies used to analyse harvested aggregates with 
flow cytometry. Clones of antibody used were: CD45: 30-F11; CD41: 
MWReg30; CD144: BV13; CD16/32: 93. 
2.4.2.1. Transplantation of aggregated cells into irradiated 
recipients 
The remaining cells, about 3ee, were used for transplantation into irradiated mouse 
recipients. Each condition had three recipient mice, each of them received cells from 
1 aggregate contains CD45.2 homozygous primary cells and 10e5 carrier cells from 
bone marrow of CD45.1 homozygous mice. Cells were resuspended in 300µL 
transplantation buffer (PBS without Ca2+ and Mg2+ with 3% FCS) and kept on ice. 
BL6-ly5.1/ly5.2 heterozygous recipient mice were gamma irradiated for two doses 
of 10 minute and 7 minute 48 seconds (9.5Gy) with at least 3 hours in between. 
Then mice were left to recover for 4-5 hours before transplantation. Next cell 
suspensions were injected into tail vein of irradiated mouse using 30G needle (BD 
Microlance™ 3, catalogue number 30400). After injection, mice were kept on sterile 
water with antibiotics for a month. 
Peripheral blood samples were taken from recipients 6 weeks after transplantation. 
Approximately 50µL of tail blood was taken from the tail vein by venesection and 
collected into 500µL bleeding buffer (FACS buffer with 10µM EDTA). Two spare 
blood samples were taken for single staining controls. After bleeding, all cells were 
centrifuged briefly and resuspended in 1x BD Pharm Lyse RBC lysis solution (BD 
Bioscience, catalogue number 555899). Lysis was completed with 5-7 minutes 
incubation at room temperature. After lysis, white cells were collected by 
centrifugation and stained with CD45.1-APC (eBioscience, catalogue number: 
17-0453-82, clone A20) and CD45.2-PE (eBioscience, catalogue number: 
12-0454-83 clone 104) antibodies. Donor (CD45.2 homozygous) engraftment was 
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determined by flow cytometry using BD FACSCalibur™ flow cytometer. Gating 
was set based on CD45.1 APC and CD45.2 PE single stain sample.  
6 months post transplantation, mice with significant (>10%) engraftment in 
peripheral blood were subjected to multilineage analysis. Blood samples were taken 
and lysed as described above. They were analysed with LSRFortessa™ flow 
cytometer with antibodies listed in table 2.4.2.1-1.   
 
Table 2.4.2.1-1. Antibodies used for flow cytometry analysis of blood/ 
spleen/bone marrow samples to detect multilineage engraftment. 
CD45.1 antibody was used to exclude carrier and recipient originated 
cells. Ter119 antibody was used to exclude erythrocytes. Gr-1 antibody 
was used to label granulocytes. Mac-1 antibody was used to label 
Macrophage. B220 antibody was used to label B cells, CD3e was used 
to label T cells. Fc block was used to prevent unspecific staining.   
After multilineage analysis of blood sample, select mice were culled. Blood sample 
of these mice were taken as described before. Thymus and spleen were dissected, 
and placed in dissection buffer. Spleens were further cut into pieces with a pair of 
scissors. Bone marrow cells were flushed from both femurs of mice using FACS 
buffer and a 25G needle. Then thymus and spleen were crushed using piston from 
1mL syringes against cell strainer. Cells were collected by washing crushed tissues 
using FACS buffer. Blood, bone marrow and filtered spleen cells were stained in 
100µL staining solution (table 2.4.2.1-1) with the method described in section 2.2.2. 
Antibodies used was listed in table 2.4.2-1. Thymus samples were stained using 
antibodies listed in table 2.4.2.1-2. Fluorescence minus one (FMO) controls were 
made from spare bone marrow cells. FMO controls were set against following 
channels V450, V500, APC, FITC, PE and PE-Cy7. Beads staining controls were 
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also made. Extra buffer was added to the spleen samples because they could be very 
sticky. Then samples were analysed on LSRFortessa™. Data were processed with 
FlowJo™. Because some samples were very sticky, and might affect florescence 
readings as cytometer running time accumulate, a time gating was applied to gate 
out events with altered florescence strength signals. 
 
Table 2.4.2.1-2. Antibodies used for flow cytometry analysis of thymus 
samples to detect multilineage engraftment in thymus samples. CD45.1 
antibody was used to exclude carrier and recipient originated cells. 
Ter119 antibody was used to exclude erythrocytes. CD4 and CD8 
antibodies were used collectively to determine stage of thymocyte 
development. TCR beta and CD127 were also used to label stage 
specific development of T cells. 
Later, one highly engrafted mouse was culled, and its bone marrow cells are 
harvested from its femur and i.v. transplanted into two secondary recipients. Each 
recipient receives cell amount that equivalent of one third of a femur. 7 weeks post 
transplantation, peripheral blood of secondary recipients was analysed for CD45.2+/+ 
secondary engraftment as described before. 
At last, a preliminary experiment to detect transfected cells in engraftment recipient 
was carried out. One mouse from experiment SRYZH6 and two mice from SRYZH9 
were tail bled 6 months after transplantation. Genomic DNA was isolated using 
Puregene Blood core Kit C (Qiagen, catalogue number: 158389). Isolated gDNA 
was amplified using Taq DNA polymerase kit (Qiagen, catalogue number 201205). 
PCR parameters were listed in appendix table 8.3-1 a. Primer 2A-F and CER-R were 
used to detect gDNA from transfected cells (table 2.1-1), while primer Myo-1 and 
Myo-2 were used as internal control. Sequence for primer Myo1 was: TTA CTG 
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CCA TCG TGG ACA GC, sequence for primer Myo2 was: TGG GCT GGG TGT 
TAG TCT TA. Reaction system was listed in appendix table 8.3-1 b. PCR product 
was ran on agarose gel and visualized with UV illuminator.  
2.5. Reverse transcription quantitative-PCR  
All RT-qPCR experiments were performed using LightCycler® 480 II instrument 
(384 wells version. Roche, product no: 05015243001, serial no: 5335). UPL probes 
and LightCycler® 480 probe master (Roche, product No 04887301001) were used. 
All reactions used UPL probe had 10µL volume. Each sample well contained 4µL of 
cDNA (1ng/µL assuming 100% RT efficiency), 1µL of primer-probe mix (table 
2.5-1), and 5µL of LightCycler® 480 probe master (Roche, product No 
04887301001).  
 
Table 2.5-1. Composition of Primer-Probe Mix (PPM) for qPCR reactions 
used UPL technology. To ensure reproducibility, PPMs were made as 
100µL master mixes. They could stay in freezer for about a month. 
A candidate pool of 64 genes was selected based on educated guess. All genes were 
checked against mouse reference genomic assembly version GRCm38 C57/Bl6J 
hosted on NCBI (http://www.ncbi.nlm.nih.gov/assembly/GCF_000001635.20/). For 
loci with only one transcript, the transcript was designates as the target transcript of 
that locus. For loci with multiple transcripts, its locus structure was studied and a 
literature survey was conducted to determine the transcript with desired biological 
function. If no previous literature available, I tried my best to pick a most 
representative transcript as target transcript. Loci without a clear representative 
transcript were excluded from study. All target transcripts were loaded into UPL 
assay design centre with Organism set to Mus musculus and feature “automatically 
select an intron spanning assay” set to on (Roche, qpcr.probefinder.com). For every 
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target transcript, the best scoring pair of primers was selected. If no intron spanning 
assay was available, the best pair of intra exon primers was selected. If the primary 
pair failed in verification experiment, I tried my best to design the second pair of 
primers so they spanned another intron or at least had different primer binding sites 
spanning the same intron.  
As a result, target transcripts for 46 genes are identified by a combination of 
bioinformatical analysis and literature search. A total of 96 pairs of primers 
(appendix table 8.4-2) were designed against those 46 target transcripts. 15 out of 96 
pairs were kindly designed by Ms. Alison McGarvey. For gene Igfbp2 and Fgf9, 
Roche’s database did not contain newest transcript listed in GRCm38 
(NM_013518.4 and NM_008342.3), thus the newest version in Roche database 
(NM_013518.3 and NM_008342.2) were designated as target transcript 
Primer pairs were named by their MGI symbol followed by exons they bind with. 
For example, “Angpt2 E5/6” was the name of a pair of primers targeting Angpt2 
gene spanning exon 5 and 6. If multiple primer pairs were designed spanning same 
exon junctions, a suffix was added, like “Bmp4 E3/4b” indicated the second pair of 
primers designed targeting exon junction 3/4 of Bmp4 gene. Primers within a pair 
were distinguished by suffix, e. g. “Bmp4 E3/4b 5’ ” and “Bmp4 E3/4b 3’ ”. They 
were all synthesized by Integrated DNA Technologies, Inc.  
Total RNA from cell lines were harvested using RNeasy Plus Mini Kit (Qiagen, 
catalogue number: 74134) in according to manufacturer’s instructions. Isolated RNA 
was reverse transcribed using M-MLV Reverse Transcription system (Life 
Technologies, Catalogue No: 20825-013) with Random hexamer (Thermo Scientific, 
Catalogue No: AB-1297/B). RNaseOUT™ Recombinant Ribonuclease Inhibitor 
(Life Technologies, Catalogue No 10777-019) was used in reverse transcription to 
prevent RNA degradation. Every pair of primers and its corresponding probe was 
tested with different cDNA sample. In every run, a standard curve with 4 data points 
was included. Their cDNA concentration were: 20ng/rxn, 2ng/rxn, 0.2ng/rxn and 
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0.02ng/rxn. Three identical wells with 4ng cDNA pre reaction were also included 
for every primer pair. qPCR program was listed in table 2.5-2. 
Table 2.5-2. qPCR program used to evaluate primers. Amplification time 
was slightly increased to 17 sec to maximize template extension. 
A pair of primer was considered good when in two consecutive runs, amplification 
efficiency calculated from standard curve was between 1.75 and 2.1 and 
amplification error of both standard curve and repetitive wells was smaller than 0.2. 
If one of two repeats had results that were slightly out of boundary, verification of 
the cDNA-primer/probe pair was repeated until two consecutive good runs were 
achieved.     
The primers passed first round of evaluation was subjected to a SYBR green melting 
curve screen to detect unspecific product. qPCR experiments with SYBR Green was 
carried out using LightCycler® 480 SYBR I green master (Roche, product No 
04707516001). In SYBR Green experiments, total volume was 10µL. Concentration 
of cDNA and primers was the same as UPL experiments. In SYBR green 
experiments, SYBR I green master (Roche, product No 04707516001) was used and 
no UPL probe was added to reaction. Parameters for SYBR green qPCR and melting 
curve experiment were listed in table 2.5-3. I used E11.5 caudal parts cDNA 
generated by Alison McGarvey and Dr. Stanislav Rybtsov from our group. cDNA 
concentration was 125ng/µL. Concentration for standard curve wells were 40ng/rxn, 
4ng/rxn, 0.4ng/rxn, and 0.04ng/rxn. And all of the three sample wells had a 
concentration of 4ng/rxn. A primer was considered good if at least two of three 
replicates showed single peak in melting curve analysis (appendix figure 8.4-1). All 





Table 2.5-2. qPCR program used to determine melting curve of selected 
primers. Amplification time was slightly increased to 18 sec to 
maximize possibility to detect unspecific products. 
15 pairs of primers passed the primer verification test. Two redundant sets of 
primers that preformed less well were removed. Their sequence was listed in table 
6.1-1. RT-qPCR was carried out with 9 stromal lines plus the OP9 positive control. 
RNA extraction and reverse transcription were done as described previously. qPCR 
program was listed in table 2.5-4. Crossing points for each well was determined 
automatically by LightCycler® 480 Software release 1.5.1.62 (Roche, product No 
04994884001) using secondary derivate max method in high confidence mode. Then 
data were extracted to Excel 2010 and all graphs are drawn using it. 
 
Table 2.5-4. qPCR program used to get expression data for 
haematopoietic genes. Note the format of holding time was mm:ss, thus 




3. Chapter 3: Generation of a piggyBac transposon based 
immortalization vector system           
In this study, a novel immortalization system was established. It surpassed previous 
systems because it can immortalize primary cells based on their surface marker 
expression, and immortalized cells did not went through crisis. In order to meet such 
requirements, immortalization vector was designed and constructed with following 
properties: 
 The vector should contain the piggyback Inverted Terminal Repeat (ITR) to 
facilitate translocation of immortalization cassette to genomic DNA 
 The vector should have a normal SV40T gene, stronger than previously used 
tsA58 factor. It should allow direct immortalization of transfected cells without 
going through crisis. 
 The vector should have a fluorescent protein tag to label immortalized cells. its 
expression level correlates with SV40T expression 
A vector contained SV40T and Cerulean protein linked together by T2A 
self-cleaving polypeptide was constructed (Kim, Lee et al. 2011). It was named as 
pB-PGK-TAG-CER. To determine its functionality, a pB-PGK-CER vector lacked 
SV40T immortalization factor was made as a control. The pB-PGK-TAG-CER 
vector went through following tests: 
 Enzymatic test and sequencing to confirm vector’s structure and sequence of 
SV40T-2A-CER cassette.  
 Immunohistochemistry staining of transfected cells to detect expression of both 
SV40T and CER. 
 Flow cytometry and confocal microscopy assay to prove the functionality of 
Cerulean fragment. 
 Side-by-side comparison of immortalization vector transfected culture and 
control vector transfected culture, to establish a growth curve that demonstrated 
functionality of SV40T immortalization factor.   
In this chapter, I discussed results related to generation and verification of 
pB-PGK-TAG-CER vector. These results indicated that clone M20 of 
pB-PGK-TAG-CER vector could express functional SV40T and CER protein. The 
expression level of SV40T was strongly enough to immortalize primary cells. 
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However, fluorescence generated by Cerulean protein was not strong enough to 
label all transfected cells. 
3.1. Construction of pB-PGK-TAG-CER and pB-PGK-CER vectors 
The piggyBac based immortalization system used in this project utilised two vectors. 
One was the pCyL043 helper plasmid described in Wang, Lin et al. (2008). The 
pCyL043 vector encoded a piggyBac transposase (IFP2) driven by CAG promoter 
and a PGK driven puromycin selection gene (Wang, Lin et al. 2008). The other was 
the pB-PGK-TAG-CER immortalization vector, which was constructed in this 
project.  
A pB-PGK-CER control vector was constructed to demonstrate that unrestricted 
growth of transfected primary cells was promoted by SV40 large T antigen, not due 
to genomic integrations disrupting tumour-suppressor genes, or some other elements 
on the piggyBac backbone. The control vector was based on pB-PGK-M9 backbone 
same as immortalization vector, but Cerulean protein expression was initiated 
directly from its start codon in a strong Kozak context (Kozak 1987). This vector 




a)            b) 
   
Figure 3.1-1. Maps of pB-PGK-TAG-CER vector (a) and pB-PGK-CER 
control vector (b). (a) The pB-PGK-TAG-CER vector clone M20 had 
SV40T and Cerulean fused with T2A polypeptide. The SV40T-2A-CER 
fusion was driven by PGK promoter. Note the XhoI site was destroyed 
after triple ligation. (b) pB-PGK-CER control vector had a Cerulean 
fragment downstream of PGK with Kozak sequence. The polyA 
sequence of both vectors was obtained from rabbit beta-globin gene.  
The CAG promoter of pB-CAG vector was replaced with PGK promoter, and 
additional enzymatic sites were introduced to pB-PGK backbone. DNA fragments 
encoding SV40 T antigen and Cerulean were cloned into pCR-BluntII intermediate 
vector respectively. A triple ligation of the three was conducted taking advantage of 
the fact that SalI and XhoI were isocaudomers (Figure 3.1.2a). Two clones, M20 and 




a)                          b) 
 
c)                                         d) 
        
Figure 3.1-2. pB-PGK-TAG-CER vector was generated by a triple ligation 
reaction. a) Schematic representation of triple ligation reaction. b) 
Digested and recovered piggyback backbone (5108bp), T antigen 
(2470bp) and 2A-CER (783bp) DNA fragments. Upper band of Tag8 in 1st 
recovery was re-purified and shown in right panel. c) Screening of 
pB-PGK-TAG8-CER1 clone 1 to 30 used PCR targeted to T antigen. 
Clone number 20 was marked with a *.  Lane A was negative control 
reaction with pB-PGK M9 backbone only, Lane C was negative control 
reaction with pB-PGK M9 and pCR-BluntII-CER1 plasmid. (See table 
8.1.1-1 in appendix) Lane “+” were positive control with TAG8 plasmid, 
and lane “–” were no template control. Lane M was 1kb+ ladder from 
Life Technologies d) HindIII digestion of selected clones. Clone 1, 20, 24, 
28 and 29 shown here were from T antigen PCR screen, D5 was from Dr 
David Hills. Lane TAG was a positive control digestion contained 526bp 
target band. (This experiment was conducted once, n=1) 
To construct pB-PGK-CER control vector without T antigen, a pair of primers that 
introduced the Kozak translational initiation sequence at the start codon of CER was 
designed (Table 2.1-3). The SacII-Ko-ATG-CER-SalI fragment was generated by 
PCR and recovered. Both vector and insert were sequentially digested with SalI and 
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SacII (figure 3.1.3a). Digestion products were recovered and ligated together using 
T4 DNA ligase. DNA from transformed clones was prepared and digested with NheI 
and PstI. Correct clones should have bands of 3875bp and 1974bp. Clone number 2 
had expected bands (figure 3.1.3b) and was confirmed by sequencing. Original 
chromatograms, sequence and annotation of pCR-BluntII-CER1 plasmid could be 
accessed in electronic supplementary files. 
a)  b) 
             
Figure 3.1.3. pB-PGK-CER control vector was generated with ligation of 
pB-PGK M9 backbone and SacII-Ko-ATG-CER-SalI PCR product. a) 
Digestion of pB-PGK-M9 and SacII-Ko-ATG-CER-SalI PCR product. 
Lane M was 1kb+ DNA ladder from Life Technologies. Lane M9 was 
circular M9 plasmid, Lane M9d was pB-PGK-M9 after SalI and SacII 
digestion (5099bp). Lane P was PCR product digested with SalI and 
SacII (750bp). b) NheI/PstI digestion of transformed clones. Lane M was 
1kb+ DNA ladder. Expected products sizes are 3875bp and 1974bp. 
(This experiment was conducted once, n=1)   
 
3.2. Verification of vector function 
The PGK-TAG-2A-CER region of pB-PGK-TAG-CER clone M20 and D5 were 
sequenced. Chromatograms of both clones did not show mutations that caused 
amino acid substitution or early termination. Once sequences were confirmed, 
clones were purified using EndoFree Plasmid Maxi Kit (Qiagen, catalogue number: 
12362) and verified by HindIII digestion to avoid cross-contamination (appendix 
figure 8.1.1-1).  
To detect translation products of SV40T and CER, DNA of pB-PGK-CER clone 
M20 was electroporated into OP9 cells using Neon™ electroporation machine (Life 
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Technologies, catalogue number: MPK5000). Optimization condition 14 (1200V 
20ms, two pulses) from Neon™’s manual was used, because it was one of the best 
performing conditions in early pilot studies done by Dr. Jordi Senserrich (personal 
communication). 1-2x106 cells were electroporated using a 100µL electroporation 
tip. These cells were cultured for 4 days to allow them time to recover from 
electroporation and express both proteins. Subsequently cells were seeded (1:6) to 
gelatin coated coverslips and stained with antibodies against SV40T (BD 
Pharmingen, catalogue number: 554149, clone PAb 101) and Cerulean (Life 
Technologies, catalogue number: A21311). An anti-GFP antibody was used because 
it cross-react with Cerulean. Immunohistochemistry (IHC) staining showed strong 
expression of SV40T and CER in OP9 cells transfected with pB-PGK-TAG-CER 
clone M20 and pCyL043 (figure 3.2-1).  Expression of neither protein was detected 




Figure 3.2-1. pB-PGK-TAG-CER clone M20 transfected OP9 cells 
expressed SV40T and CER proteins. Green channel was used to detect 
Cerulean expression with Alexa-488 conjugated anti GFP antibody 
recognizing Cerulean. Red channel was used to detect SV40T protein 
with Alexa-568 goat anti mouse antibody (Life Technologies, catalogue 
number A11004) recognizing SV40T positive cells labelled by mouse 
anti SV40T antibody.  Bottom right picture was green channel and red 
channel merged with DAPI (Blue). Negative control pictures were 
shown in appendix figure 8.1.1-2. (This experiment is conducted once, 
n=1) 
3.3. Functional test of the immortalization system 
After successful confirmation of Cerulean protein expression by 
immune-histo-chemistry (IHC) staining, functionality of CER protein was tested. 
Olympus IX51 and Motic AE31 microscope failed to detect above background 
signal of Cerulean florescence in both FITC and CFP channels (data not shown).  
Therefore, CER fluorescence was analysed using flow cytometry and confocal 
microscopy. Flow cytometry data showed a significant shift in V_525/50 channel 
(CER) in 293T cells transfected with pB-PGK-TAG-CER clone M20, but no shift in 
untransfected 293T cells (figure 3.3-1). This shift was continuous, without forming 
two separate cell populations. No shift in B_530/30 channel was observed which 
was used to detect FITC or GFP. On the other hand, pB-PGK-TAG-CER clone D5 
showed a considerably smaller shift in CER channel, suggesting mutations might 
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exist outside sequenced regions that affect fluorescence generation. Thus, clone D5 
was excluded in further experiments. 
 
Figure 3.3-1. pB-PGK-TAG-CER transfected 293T cells showed 
continuous shift in V_525/50 channel but not B_530/30 channel. Left 
column was flow cytometry plots of untransfected 293T cells control. 
Gatings used in this experiment were based on them. Middle column 
was plots of 293T cells transfected with pB-PGK-TAG-CER clone D5, 
only a weak shift in V_525/50 (Cerulean) channel was detected. Right 
column was plots of 293T cells transfected with pB-PGK-TAG-CER 
clone M20. A strong shift in CER channel is detected and such shift was 
continuous. In cells transfected with both clones, no shift in B_530/30 
channel used by FITC and GFP is detected. (This experiment is 
conducted once, n=1) 
Next, E11.5 ventral aorta (AoV) cells were transfected with pB-PGK-TAG-CER 
clone M20 and pCyL043 plasmid and analysed by confocal microscopy. 
Untransfected AoV cells were used as negative control. Propidium Iodide (PI) 
staining was used to label dead cell. Merged picture of bright field, CER 
(465nm-550nm) and PI (560nm-760nm) showed that M20 transfected cells had 
strong fluorescence with emission spectra similar to CER, and such fluorescence did 
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not co-localize with PI staining (figure 3.3-2, a), indicated it was specific for live 
cells. Fluorescence intensity of pB-PGK-TAG-CER clone M20 transfected cells and 
untransfected control cells were compared at CER peak emission range (465-495nm) 
or outside CER emission range (555-585nm). Images taken at peak emission 
wavelength of transfected sample showed strong emission while images taken 
outside emission range showed no emission, such observation suggested transfected 
cells express fluorescence similar to CER (figure 3.3-2, a, b). As a comparison, 
untransfected control had almost no emission in and out Cerulean wavelength range 
(figure 3.3-2, a, b). Combined results from IHC, FACS and confocal microscopy 
firmly indicate cells transfected with pB-PGK-TAG-CER clone M20 express 





Figure 3.3-2. pB-PGK-TAG-CER transfected cells had similar 
fluorescence property as Cerulean. Right side pictures were primary 
cells transfected with pB-PGK-TAG-CER clone M20. These cells were 
isolated from ventral aorta of E11.5 embryos. Left side pictures were 
untransfected control from same source. a) Merged picture of bright 
field, PI staining (red) and CER (blue). These pictures indicated blue 
emission is not from dead (PI positive) cells.  b) Fluorescence signal 
near peak CER emission (465-495nm). Image of cells outside of CER 
emission spectrum could be seen at figure 8.1.1-3. All pictures were 
taken with 40x oil objective. (This experiment was conducted once, n=1) 
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After testing Cerulean activity, SV40T antigen activity was functionally tested. Cells 
were harvested from AGM region of E11.5 BL6XBL6 embryos. 106 primary cells 
were electroporated with pB-PGK-TAG-CER vector and pB-PGK-CER control 
vector respectively. Equal amount of pCyL043 helper plasmid was added to 
electroporation mixture. Flow cytometry analysis at four days post electroporation 
showed that the transfection efficiency of pB-PGK-CER was not lower compared to 
efficiency of the pB-PGK-TAG-CER vector (figure 3.3-3, b). Transfected cells were 
seeded in 6 well plate wells, and then passaged side by side when 
pB-PGK-TAG-CER transfected cells reach full confluence. During every passage, 
cell numbers in both cultures were counted. Based on cell counting, growth curves 
of cells transfected with respective vectors was established (figure 3.3-3, a). Growth 
curve clearly shown that pB-PGK-TAG-CER transfected primary cells maintained 
exponential growth while pB-PGK-CER transfected control cells had a slight 
expansion at passage 1, then stopped growing. Because pB-PGK-CER vector shared 
the same pB-PGK-M9 backbone but did not induce exponential expansion of 
transfected cells, such exponential growth observed in pB-PGK-TAG-CER 
transfected cells must be result of SV40 T antigen. Taken together, the data clearly 
confirmed immortalization activity of pB-PGK-TAG-CER vector was dependent 
upon the expression of the SV40T antigen.  
In summary, a functional piggyBac based immortalization vector was constructed. 
Its SV40T and CER components were verified at DNA sequence level and 
functionally tested. During vector validation process, basic protocols for cell culture, 
transfection and detection of Cerulean fluorescence were established. The work 








Figure 3.3-3. pB-PGK-TAG-CER vector transfected primary cells 
maintained exponential growth for five passages. a) pB-PGK-TAG-CER 
(TAG-CER) transfected cells maintained exponential growth while 
pB-PGK-CER (CER only) transfected primary cells ceased growth 
shortly after culture. b) Flow cytometry analysis of transfected primary 
cells 4 days after transfection. Note CER positivity rate was higher in 
pB-PGK-CER transfect cells compared to pB-PGK-TAG-CER 
transfected cells. This observation suggested observed growth 
difference was nod due to favourable transfection efficiency of 























4. Chapter 4: Derivation of cell lines from haematopoietic sites 
of mouse embryos 
In this chapter, I described experiments aimed at deriving immortalized cell lines 
from diverse backgrounds. Such as primary cells bear different surface marker 
combinations of E11.5 AGM regions or primary cells from early embryos. To 
achieve this aim, experiments were conducted in the following ways:  
 Optimizations of transfection protocol. That included finding an optimal 
parameter combination for E11.5 AGM derived primary cells and developed 
procedure to electroporate small amount of cells.    
 Derived cell lines from sub-dissect AGM, included from dorsal wall of ventral 
aorta, where HSCs were thought to first emerge. 
 Immortalized cells with different surface marker expression, including CD123, 
CD106, Flt3, membrane bound-SCF, VE-Cadherin.  
 Derived cell lines from haematopoietic sites of a range of developmental stages 
(E8, E11.5)  
 Established cell freezing and thawing protocol and monitored marker expression 
of derived lines 
All in all, a method to derive cell line from small population was derived. 33 cell 
lines were derived from E11.5 AGM and 15 cell lines were derived from earlier 
embryos. Preliminary experiments showed that CD106 expression was maintained 
in lines tested while CD123 positive and negative cells tended to express CD123 at 
similar levels, caused expression level to be “blurred”.    
4.1. Optimization of transfection protocols  
To derive cell lines from primary AGM cell, an effective transfection protocol was 
required. First, parameter of electroporating primary AGM cells was established. 
The Neon™ electroporation system used in this study was the second generation, it 
used capillary electroporation chamber. Such capillary chamber generated smoother 
electric field and required less cell number. Manual of Amaxa Nucleofector™ did 
not suggest sample contains less than 2X105 cells. On the other hand, manual of 
Neon™ machine stated minimum cell number was as low as 1X104 cells. However, 
preliminary experiments showed that some populations of interests in pooled 
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primary AGM samples had few thousands (103) cells, that translated to less than 100 
target cells per AGM, thus transfection protocol was optimized to suite small cell 
numbers well below manufacture’s recommendation. In optimization experiments, 
rare GFP positive cells were detected 24 hours post transfection in culture of 200 
primary cells transfected with the pEGFP-N1 plasmid (figure 4.1-1). However, these 
rare GFP+ cells disappeared when viewed a week post transfection. Such 
observation indicated that the Neon™ System could transfect as few as 200 cells, 
but those transfected cells failed to grow in vitro. More experiments were needed to 
enhance survival of transfected cell.  
a)                                 b) 
  
Figure 4.1-1. Single GFP+ cells generated from 200 input cells 
electroporated with pEGFP-N1 plasmid with 1350V 20ms 1pulse, 24 
hours after transfection. Both images were taken in GFP channel of 
IX51 inverted microscope a) GFP+ cell transfected without 
centrifugation after transfection. b) GFP+ cell transfected with 
centrifuged for 5 minutes at 1420rpm. 
To find the optimal parameter combinations for transfecting embryonic primary 
cells, an approach based on linear programming (optimization) was adopted (Murty 
1983). In all optimization experiment, primary cells were harvested from AGM 
region of BL6XBL6 embryo. Two initial survey experiments were conducted to 
explore cell survival rate of different parameter combinations, these combinations 
that generate viable cells collectively formed feasible combination set. This set of 
parameter combinations generally defined the scope of operation of electroporation 
system that could yield surviving cells, thus was also called “operational envelope” 
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in engineering. In these survey experiments, it was determined that pEGFP-N1 
plasmid could be utilized to label transfected cells. Such labelling did not selectively 
expansion of transfected population, thus was better compared to 
pB-PGK-TAG-CER for optimization experiments. 
Initial survey experiments discovered some rich “spots”, they were combinations of 
parameters that displayed favourable transfection efficiency or cell survival rate. In 
next phase of experiments parameter combinations near those favourable spots were 
examined. I hoped to find local optimal parameter combinations. Based on linear 
programming theory, optimal parameter combinations often appear at edge of 
operational envelope, hence favourable spots near edge of envelope were tested with 
special attention. All in all, this study covered electroporation conditions ranging 
from 0V (negative control) to 1700V, pulse width from 10ms to 40ms, pulse number 
from 0 to 3. Parameter combinations explored in this study is shown in figure 4.1-2. 
Figure 4.1-2. Electroporation conditions covered in this study. Each 
point on the polygon shown above represent a specific parameter 
combination for electroporation. Vertexes of the polygon were tested, 
some points on surface of polygon or inside polygon were also tested.   
To improve accuracy of measurement, cell counting beads were used to measure 
number of survived cells. Protocol was adjusted to prevent sparks during 






































































































increased to improve reproducibility of experiment. Mature blood cells were gated 
out in flow cytometry analysis with mix of lineage markers (CD45, Ter119, CD11b, 
Ly6G) while pro-HSCs were gated out with CD41 antibody. Remaining population 
of non-haematopoietic cells were analysed for transfection efficiency in either 
mesenchymal related population (CD105 and CD51) or endothelial related 
population (CD123 and VE-Cadherin). Such analysis was aimed at to discover any 
potential transfection bias toward specific cellular populations. 
Data points of optimization were grouped based on length of electroporation (in 
millisecond) and number of pulses applied to primary cells. For each pulse 
length/pulse number pair, cell survival or transfection efficiency was plotted against 
voltage. It was observable that percentages of transfected cells were more consistent 
between replications while cell yields measured in absolute number were more 
variable (appendix figure 8.2.1-1 and 8.2.1-2). This kind of variation was considered 
to be introduced during electroporation.   
Resulting graphs show several clear trends: firstly, as voltage increases, cell survival 
rate held steady until a certain drop-off voltage. After that voltage, cell survival 
(measured by percentage of 7AAD- live cell) decreased linearly as voltage increases. 
Drop-off point for single 20ms pulse was near 1350V, for single 30ms pulse was 
near 1250V; for 20ms two pulses was near 1100V; for 30ms two pulses was near 
900V. Drop-off voltage for 20ms 2 pulses was 200V lower compared to 20ms single 
pulse. Drop-off voltage for 30ms 2 pulses was 250V lower compared to 30ms single 
pulses. Thus wider and repeated pulses generally pushed the drop off voltage lower. 
On the other hand, as voltage increases, transfection efficiency tended to increase 
until a peak point. After that point, transfection efficiency dropped down, usually 
accompanied by a decrease in cell survival. Taking together cell survival and 
transfection efficiency, conditions with a single 20ms pulse generated high 
transfection efficiency while retained good cell survival.  
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Thus, conditions of 20ms single pulse group and adjacent conditions were analysed 
in more detail. No observable efficiency bias was observed (appendix figure 8.2.1-3). 
Based on aggregated data, conditions with 20ms 1 pulse appeared to be the best for 
the purposes of this project. In different voltage conditions, 1350V was the best. 
Comparison was also made of all conditions with 1350V voltage (figure 4.1-4). 
Although 1350V 30ms 1 pulse had slightly higher transfection efficiency, cell yield 
was lower compared to 1350V 20ms 1 pulse condition (figure 4.1-4, b).  
Thus, 1350V 20ms single pulse was chosen as the electroporation condition for 
future experiments. For this conditions, overall cell survival and transfection 
efficiency were satisfactory (figure 4.1-3 and 4.1-4a and appendix figure 8.2.1-4). 
Moreover, E11.5 AGM primary cells bear all marker combinations tested could be 
effectively transfected using this condition (figure 4.1-4, c).  
 
Figure 4.1-3. Flow cytometry plots showed 1350V 20ms 1 pulse 
condition (lower panel) retained enough survival cells (left) and a good 




Figure 4.1-4. 1350V 20ms 1 pulse was the best condition examined. 
Performance of the optimal series of electroporation conditions with 
1350V voltage. 20ms 1 pulse condition gave best cells yield in the 
series and good transfection efficiency. a) Cell survival and transfection 
efficiency of different conditions. Percentage of viable cell was 
calculated by dividing number of 7AAD- cell by number of all cellular 
events. b) Over all cell yield of different conditions. c) Breakdown of 
transfection efficiency in different subpopulations. Error bars indicated 
standard derivation, calculated using STDEV.S formula in Microsoft™ 
Office 2010. 
4.2. Cell lines established from E11.5 embryos 
A total of 33 cell lines were generated from 6 experiments with primary E11.5 aortic 
cells. Each experiment focused on a different set of ancestral cell surface marker 
combinations. Experiment flow was illustrated in figure 4.2-1. In six experiments 
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carried out, one was done with primary cells harvested from whole aorta while other 
experiments were done with sub-dissected ventral half of aorta. Selection of surface 
marker was based on combination of unpublished data and educated guess. Surface 
marker used in this study include CD123. CD106, membrane bound SCF, 
VE-Cadherin, and Flt3. Their functions in HSC maturation were discussed in section 
7.2 
 
Figure 4.2-1. Experimental scheme to derive cell lines from E11.5 
embryos. Either ventral aortas or whole aortas were dissected from 
E11.5 embryos. Dissociated cells were sorted using FACSAria II sorter. 
Each sorted populations was electroporated independently, and plated 
into different wells to establish cell lines. Established lines were tested 
using aggregation culture assays. Detail of cell line characterization 
was described in chapter 5 and 6. The picture of E11.5 embryo was 
reproduced with permission from Dzierzak and Speck (2008) 
8 of cell lines derived were from bulk culture (each well contained one fourth of 
original population) and 25 of them were from low density cultures (each well 
received up to 50 cells, assumed cell survival rate of 10% and transfection 
successful rate of 90% (table 4.2-1).   
 
Table 4.2-1. Multiple cell lines were generated from experiments with 
E11.5 Aortic primary cells. In each experiment, four different 
populations are sorted and electroporated separately. Selection criteria 
of each population and number of cell lines derived from them were 
listed in the table. Meaning of “Bulk lines” and “Low Density” (LD) lines 
were described above. VE-Cad was short for VE-Cadherin and mSCF 
mean membrane-bound SCF.  
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During cell sorting, cellular events were selected based on FSC-A and SSC-A 
signals, then duplets were excluded based on FSC-A and FSC-H signals. Then cells 
positive for 7AAD, lineage, CD45 and CD41 were gated out using corresponding 
FMO (Fluorescence minus one) controls (appendix figure 8.2.2-1). Then gates to 
separate positive and negative cells were set using corresponding FMO controls 
(appendix figure 8.2.2-1). FACS plots for sorting samples from each experiment 
were shown in figure 4.2-2.  
 
Figure 4.2-2 FACS plot of Lineage-CD45-CD41- population of AoV/AGM 
samples. Gating of different populations shown here was based on 
FMO controls (figure 9.7.2-2). In actual sorting experiments, some 
space was left between gates to enhance purity. (n=6 independent 
experiments performed) 
It was observed that the expression level of CD123 was very low in this study 
(figure 4.2-2). This made separation of CD123+ cells from CD123- background 
population difficult. A retrospective literature search showed that that murine 
embryonic AGM cells and cells from AGM explant contains CD123 positive cells 
(figure 4.2-3)(Robin, Ottersbach et al. 2006, Robin and Durand 2010), and a small 
population of rare CD123high cells was detectable by flow cytometry. This was not 
observed in our study. I thought such difference could be explained by difference of 
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cell harvesting protocol. The Trypsin used in my study might be harmful for the 
CD123 molecule. Such explanation suggested that collagenase used by Robin et al. 
should be used to dissociate primary tissues in future studies to better distinguish 
CD123high cells. 
 
Figure 4.2-3. CD123high could be detected form 3 days explant culture of 
E11.5 AGM. The AGM explant was dissociated using Collagenase. Note 
the CD123 (Il3Ra) high population. Reproduced with permission from 
Robin, Ottersbach et al. (2006). 
It was also noticed that membrane bound SCF (mSCF) expression was very weak, 
except in sorting experiments with SCF and VE-Cadherin. In that experiment, a 
population (about 8%) of SCF high cells were observed in 
CD45-CD41-Lineage- ventral aorta (AoV) cells. This was not due to unspecific 
binding of streptavidin-PE because the FMO control without biotin-SCF did not 
contain similar populations (appendix figure 8.2.2-3). Such above background signal 
of mSCF expression was not detected in another experiment with 
bio-SCF/strep-APC and Flt3-PE; although latterly more CD45-CD41-Lineage- AoV 
cells (670,782 cells) were detected compared to that observed in SCF/VE-Cadherin 
experiment (494,142 cells). The fact that membrane bound form of SCF was only 
detected once during experiments might be explained by trypsin used to make single 
cell suspension. Retrospective literature search indicates that SCF protein was 
susceptible to tryptic digestion (Lu, Clogston et al. 1991, Fan, Ding et al. 2012). It 
was very lucky that in one experiment involved mSCF, the trypsin did not fully 
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work and retained the SCFhigh population. In further studies, the cell harvesting 
procedure to detect mSCF could be optimized. And/or the antibody used in Lodish’s 
study could be used to better detect mSCF expression (Chou and Lodish 2010). 
Above examples highlighted the challenge of sorting out rare cells. Constant 
experimentation of different cell harvesting procedures and different antibodies was 
needed. Standard Operating Procedures (SOP) were needed to make result of 
different experiments comparable. On the other hand, collecting more cell was 
another way to increase chance of deriving cell lines from rare primary cells. This 
was done in the second experiment with CD123 and CD106 staining (Experiment 2). 
It was aimed to generate cell lines from CD123+ populations. With more embryos 
dissected and improved cell handling, one line (ID: P12-027 G7) was successfully 
generated from CD123+CD106+ primary cells. That line was tested in more detail in 
next chapter. This highlighted that deriving cell lines from small population could be 
a probabilistic event; repeat experiment multiple times might improve the chances of 
deriving additional cell lines from rare populations. 
Next, bulk cultures from experiment 4 (marker tested: VE-Cadherin and Flt3) were 
sub-cloned at passage 1, each cell were seeded at 1-2 cells/well density. Out of four 
marker combinations tested, only population bearing marker VE-Cadherin+Flt3+ did 
not generate viable lines, suggested such culture contained multiple interdependent 
cell types. Thus it might be better to keep using bulk culture to keep the 
interdependent populations alive.   
4.3. Cell lines established from earlier embryos (E8.5-E10.5) 
Experiments were also conducted to derive cell lines from embryos of earlier 
developmental time points. Beside E10.5 embryos at different stage, E8.5 embryo 
was also used as source for cell line derivation. One aim was to explore whether E8 
embryos harbored the ability to mature pro-HSC into definitive HSCs. Another aim 
was to test the immortalization system of primary cells on early embryos. 
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Cell lines from E8.5 pre-somatic stage embryo, and E10.5 30sp 32sp 34sp embryos 
were established. One embryos of each stage was used. AGM of E10.5 embryo of 
different stages were dissected separately using similar method as E11.5 embryos. 
The whole E8.5 embryo was dissociated. Harvested primary cells were 
electroporated directly without sorting. Subsequently, cells were cultured in the 
same way as cell lines generated from E11.5 embryos. In total, 15 cell lines were 
generated (table 4.3-1). 14 were from bulk culture and only one low density line was 
generated. This could be due to early primary cells being more fragile and having 
lower survival rate compared to E11.5 cells.   
 
Table 4.3-1. Number of cell lines generated from early developmental 
points. One embryo from each stage was used to generate cell lines. 
During culture, pictures of AGM and earlier-embryo derived cell lines were taken. 
Those cell lines displayed distinct morphologies (see figure 4.3-1). No correlation 
between cell morphology and cell function was observed. And all cell lines were 






Figure 4.3-1. Cell morphologies of different AGM derived cell lines, 
images were taken with 10x objective in bright field.  a) Cell line Q32, 
CD123-CD106+ low density (LD) culture, passage2. b) Cell line Q41, 
CD123-CD106- LD culture, Passage 12. c) Cell line P12-004 B4, 
CD123-SCF- LD culture, passage 2. d) Cell line P12-004 D5 CD123+SCF- 
LD culture, passage 1. e) Cell line P12-006 A5, VE-Cadherin-SCF- LD 
culture, passage 1. f) Cell line P12-006 F11, VE-Cadherin+SCF- low 
density culture, passage 2.   
To investigate whether cell lines maintained surface marker profile of their ancestral 
population, cell lines generated in a CD123/CD106 preliminary experiment were 
passaged for two months and stained using same antibody as initial sorting and 
analysed with flow cytometry (figure 4.3-2). Compared with their primary cell 
ancestors, CD106 expression was maintained, while CD123 experiment was 
somehow blurred. Part of culture derived from CD123+CD106+ population became 
CD123- and CD123-CD106+ primary cells had given progenies that were CD123+. 
This suggested cell lines might adapt to culture conditions in plastics and change 
their surface marker expression. How such adaption affects cell line’s ability to 
mature HSC specification was one interesting direction for further studies.       
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Figure 4.3-2. Comparison of marker expression level of primary cells 
during sorting and cell lines established thereafter. Plots showed here 
were 7AAD-Lin-CD45-CD41-VE-Cadherin- population gated using similar 
strategy shown in 9.7.2-1. Upper panel showed primary AoD (dorsal 
aorta) and AoV (ventral aorta) from E11.5 BL6 embryos. Gates for 
CD123 and CD106 were set against FMO controls. After electroporation, 
cell lines were derived from CD123+CD106+ and CD123-CD106+ bulk 
culture well of AoD samples. Two months after electroporation, two 
daughter lines were analysed using same staining and gating strategy 




5. Chapter 5: Characterization of cell lines derived from AGM 
or early embryos 
Previous studies involved stromal cell lines mostly focused on testing derived lines’ 
capacity to support the HSC or HPC (Xu, Tsuji et al. 1998, Oostendorp, Harvey et al. 
2002). Most studies did not test derived cell lines in aggregation culture system. 
Such system was critical for maturation of pre-HSC or even pro-HSC (Rybtsov, 
Batsivari et al. 2014). To fill such obvious gap of knowledge, cell lines derived in 
this study were characterized using the robust aggregation system developed by 
Medvinsky, Taoudi et al. (2008). This rigorous assay tested one cell line’s capacity 
to mature pro-HSCs into dHSCs. Cell lines derived from E8 embryo and E11.5 
AGM region had been tested. Those lines from E11.5 AGM were derived from cells 
expressed CD123, CD106, Flt3 and VE-Cadherin. Derived cell lines were tested in 
the following ways:  
 Cell lines were aggregated with E11.5 AGM cells for 4 days and were subjected 
to CFC-U assay. This assay estimated cell line’s ability to induce 
Haematopoietic Progenitor Cells (HPCs). 
 Selected cell lines were subjected to the more rigorous test of the E9.5 pro-HSC 
maturation assay. Such assay focused on the capacity of cell lines to mature 
pro-HSCs. In that assay, primary cells from the caudal part of E9.5 embryos 
were dissected and aggregated with cell lines subjected to test and cultured for 7 
days. Resultant cultures were subjected to transplantation assay, CFU-C assay 
and flow cytometry analysis. 
 At last, gene expression of supportive and non-supportive lines was compared by 
qPCR in order to elucidate the molecular signature of pro-HSC maturation niche. 
Details about qPCR were discussed in chapter 7.  
Data described in this chapter showed that stromal line I derived could promote 
generation of various types of haematopoietic colonies. Some cell lines could 
promote the maturation of pro-HSC even without help of growth factors. This was 
superior comparted to OP9 cells. Donor derived cells could give rise to both myeloid 
and lymphoid cells six months past transplantation. Secondary engraftment from 
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aggregate culture was detected, suggesting stromal line promoted maturation of 
bona fide HSCs. 
5.1. Cell lines were able to maintain and expand E11.5 AGM-derived 
haematopoietic progenitors 
The cell lines derived in chapter 4 were tested for their ability to induce 
haematopoietic progenitor cells (HPC) from primary E11.5 AGM cells. HPCs 
presented in end of E11.5 4 day culture comes from three different sources: 1. 
progenitors presented in E11.5 AGM and maintained/expanded during culture. 2. 
Progenitors differentiated from HSCs presented in E11.5 AGM. 3. Progenitors 
differentiated from de novo matured HSC from pre-HSCs in E11.5 AGM. Previous 
data generated in our lab indicated that the OP9 cell line derived from mouse bone 
marrow (Nakano, Kodama et al. 1994) could potently maintain and expand those 
haematopoietic progenitors during 4 days of culture in this aggregation system 
(Taoudi, Gonneau et al. 2008) (Dr Stanislav Rybtsov, personal communication). By 
comparing cell lines derived in this study and OP9 in similar settings, the capacity of 
supporting HPC by these newly derived cell lines could be evaluate. Special 
attention was paid to cell lines that were either highly effective in expanding 
haematopoietic progenitors, or could not support haematopoietic progenitors at all.  
A total of 8 CFU-C experiments were carried out to test 14 newly derived cell lines. 
Each cell line was tested in up to three biological replicates in different experiments. 
Experiments were carried out in 4 batches, each batch contained two experiments. 





Figure 5.1-1. Procedure of E11.5 4 day culture assay. AGM of E11.5 
embryos were dissociated and mixed with stromal cells. Next they were 
aggregated and deployed onto membranes. Each membrane had 3-5 
aggregates. In each experiment, each stromal line had three 
membranes, one floated on medium with external growth factor 
supplement, one floated on medium without growth factor added, the 
third membrane floated on medium with growth factor but the 
membrane held blank aggregate with stromal cells only.  
Cultures contained primary E11.5 AGM cells aggregated with OP9 were included as 
positive control in each experiment. An analysis of experimental consistency 
showed that readings from OP9 controls was quite consistent between experiments 
of the same batch (appendix figure 8.3-1). But some differences between batches 
were observed. This might be caused by the switching of animal unit during 
experiments. Mouse from different providers might behave differently between 
experiments. 
Stromal cells aggregated with themselves only were named as blank culture. They 
were the negative controls in this study. They were used to estimate rate of 
spontaneously haematopoietic colonies generation. In this study, rate of 
spontaneously generation of haematopoietic colonies was extremely low, less than 1 
per 100 cultures. Blank cultures were also observed to learn the size of shape of 
stromal cell clusters that grown in methylcellulose culture. That information was 
used to distinguish between outgrowth of stromal cells and real haematopoietic 
colonies. 
CFU-C reading from replicates of aggregates with cell lines derived in this study 
displayed considerable variation similar to OP9 controls (figure 5.1-2). However, 
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CFU-C assay proved these cell lines could support generation of multiple types of 
haematopoietic colonies, included granulocyte colonies, macrophage colonies, 
erythrocyte colonies, mast cells, granulocyte-macrophage colonies, GEMM mixed 
colonies, megakaryocyte colonies. Representative pictures were shown in figure 
5.1-3. Generally, more colonies were generated when growth factor is added to 
culture medium. 
Moreover, cell lines derived in this study generated CFU-C readings in a wide range, 
from only very few colonies (line P12-009 E10 and P12-009 F10) to had 
comparable number of colonies with OP9 positive controls (line P12-015 B4). 
Surprisingly, later experiments showed that both CFU-non-supportive line P12-009 
E10 and CFU rich line P12-015 B4 could mature E9.5 pro-HSC, suggesting CFU 
assay with 4 day aggregation assay of E11.5 primary AGM cells might not serve as 
a good indicator for pro-HSC maturation capacity. 
 
Figure 5.1-2. CFU-C colonies generated for 14 cell lines in 4 day 
aggregation assays. Each cell line was labelled by its name. CFU-C 
readouts already converted into CFU-C per embryo equivalent. Cell line 
P12-021 C2 and P12-026 E1 had infections and only have one viable 
readout, other samples had at 2-3 biological replicates. Error bars 
showed range of reading. 
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Figure 5.1-3. Haematopoietic colonies generated in CFU-C assays. a) 
Granulocyte colony generated by aggregating primary cells with line 
P12-026 E1 with growth factors. b) Macrophage colony generated by 
aggregating primary cells with line P12-026 A8 with growth factors. c) 
Erythrocyte colony (BFU-E) generated by aggregating primary cells 
with line P12-026 C2 cells with growth factors. d) Mast colony generated 
by aggregating primary cells with line P12-026 E1 with growth factors. e) 
GM colony generated by aggregating primary cells with line P12-026 E1 
with growth factors. f) GEMM colony generated by aggregating primary 
cells with line P12-026 E1 with growth factors.  
5.2. Cell lines were able to support maturation of pro-HSC from E9.5 
embryos 
Previously Dr Stanislav Rybtsov modified our E11.5 AGM region aggregation 
system so that OP9 cells could mature E9.5 haematopoietic precursors (pro-HSCs) 
into transplantable definitive HSCs (dHSCs) with the help of growth factors SCF, 
IL3 and Flt3l (Rybtsov, Batsivari et al. 2014). In that system no transplantable HSC 
could be generated without help of these growth factors. Therefore it was of interest 
to test cell lines derived in this study in a similar setting. Could they promote 
development of dHSCs from pro-HSC cells, both in the presence or absence of 
growth factors? (The lines tested in this study were listed in table 5.2-1).  
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Table 5.2-1. List of 11 cell lines tested in E9.5 HSC maturation assay.  
Every line listed was tested both with and without growth factors. In 
“source” column AoV stand for Ventral Aorta. “Marker/stage” denoted 
source of stromal cell used in aggregation. “Cell line name” column 
listed name of cell lines used. Cell line names were combination of plate 
and well number of original well the line was derived. For example, line 
P12-015 B4 come from plate P12-015, well B4. In “Cell line type” column, 
BK stand for Bulk culture, LD stand for low density culture. 
“Engrafted/total” column indicated number of mice engrafted (>5% 
donor contribution) and total number of mice survived for at least 6 
weeks.  Note cell line P12-034 H12 was derived by sub-clone line 
P12-026 E1 (bulk, source population: VE-Cad+Flt3-). (In total, 108 mice 
injected with aggregate contained experimental cell lines survived until 
6 weeks. 22 of them were engrafted. 6 out of 24 of recipients received 
positive control aggregate were engrafted) 
In the E9.5 pro-HSC maturation assay, caudal halves of E9.5 embryos (25-29 somite 
pairs, CD45.2 homozygous) were dissected and dissociated to single cells, which 
were aggregated with stromal cell lines or OP9 with the method used in section 5.1. 
Experimental flow was described in figure 5.2-1. In brief, each aggregate contained 
1ee of E9.5 primary cells and 105 stromal cells. Two kinds of culture were set up, 
one with Flt3l, SCF and Il3 growth factors supplement (“+GF conditions”) and one 
without growth factor supplement (“-GF conditions”). The next day, all cultures 
were carefully fed with fresh medium. Six days later, the cultures were harvested, 
making total culture time seven days. After harvest, the majority of cells were 
transplanted via tail vein. Each condition had three irradiated recipients (CD45.1 
homozygous). Each irradiated recipient received harvest from about 1 aggregate 
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alongside with 105 carrier cells (CD45.1/CD45.2 heterozygous). Remaining cells 
were subjected to CFU-C assay and flow cytometry analysis like in section 5.1.  
 
Figure 5.2-1. Procedure of E9.5 pro-HSC maturation assays. Caudal 
parts of E9.5 embryo were cut out between and forelimbs, they were 
dissociated and aggregated with stromal cells and cultured on floating 
membranes for 7 days. Then aggregates were harvested. Harvested 
cells were subjected to CFC-U, flow cytometry and transplantation 
assay. In one experiment, each cell line had two membranes, one with 
growth factor supplement and one without growth factor supplement. 
Contribution of E9.5 cells to irradiated recipients was analyzed as shown in figure 
5.2-2. In brief, all mice survived were analysed for donor chimerism of peripheral 
blood six weeks post transplantation. Donor, stromal, carrier and recipient derived 
cells were distinguished by their CD45 expression profile (figure 5.2-2). Recipients 
with more than 5% donor derived cells were considered as engrafted. Selected 
engrafted recipients were examined for multilineage engraftment in peripheral blood 
six months post transplantation. Next, one mouse form each transplantation 
experiment was selected and culled. Peripheral blood, bone marrow, spleen and 
thymus from these culled mice were dissected and dissociated. Processed samples 
were stained and analysed on flow cytometer. B cell, T cell and myeloid were 




Figure 5.2-2. Experimental flow to characterize donor engraftment in 
recipient mice. Source of cells were distinguished by their CD45 
surface marker subtype during flow cytometry analysis. Donor cells 
were CD45.2 homozygous. Stromal cells were derived from sorted 
CD45- ancestral population. Recipients were CD45.1 homozygous. 
Carrier cells used to radio protect recipients were harvested from bone 
marrow of CD45.1/CD45.2 heterozygous mice.      
Experiments were performed in batches of two using the same material. Experiment 
with more than one mice engrafted was considered as successfully transplanted. 
However, it was found that the first experiment performed in a batch usually was not 
successful. That was, all recipients in experiments 1, 3, 5, 8 did not contain donor 
derived cells; even OP9 positive controls failed to engraft. On the other hand 
experiments 2,4,7,9 were successful, indicated by multiple engrafted mice. Only 
batch 4 was an exception, as mice from both experiments 6 and 7 were successful.  
It was a very puzzling observation considering the fact that both experiments in one 
batch were conducted using same feeder cells and shared same reagent. Moreover, 
CFU-C assay and flow cytometry analysis at the end of aggregation culture did not 
show significant differences between pair of experiments in the same batch 
(appendix figure 8.3-2). Additionally, in experiment 6 and 7, feeder cells that were 
in over-confluent and culture that just reached confluence were compared. No 
difference was observed between experiments that generated engraftment and 
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experiments that did not. A detailed examination of experimental procedures 
revealed the length of time spend during super confluence was critical to successful 
engraftment of donor derived cells. In experiment 1, 3, 5 and 8 cultures stated in 
over confluent condition for 2-3 days. On the other hand, most culture in experiment 
2,4,6,7 and 9 did not reach or just reached over confluent condition. The over 
confluent culture in experiment 6 and 7 stayed in confluence less than 1 day long. It 
seemed that cultures stayed in over-confluent condition for more than 1 days lost 
their ability to mature pro-HSCs. Further research was needed to determine the 
mechanism behind it. 
Out of 11 cell lines tested, 7 were able to support maturation of E9.5 pro-HSCs to 
HSC (figure 5.2-3). The percentage of donor engraftment generated differed 
between experiments. The forth experiment, named as SRYZH4, was the best 
performing. Transplantation results were shown with experiment numbers in figure 
5.2-3 a) and b), aggregated transplantation results were shown in figure 5.2-3 c). The 
average engraftment for all recipients (excluding positive and negative controls) in 
“–GF” conditions was 8.04% while average engraftment for all recipients excluding 
controls in “+GF” condition was 11.34%. Even in experiments that were successful, 
some lines that performed good in previous experiments failed to engraft completely. 
Such observation highly suggest the probabilistic nature of E9.5 pro-HSC 
maturation aggregation system. Average donor contribution of engrafted mice of 
each line was listed in table 5.2-1.    
Representative flow cytometry plots of engrafted mice were shown in figure 5.2-4 
with single stain controls. In each sample, contribution of donor, recipient and 
carrier cell in recipient peripheral blood was varied (appendix figure 8.3-3). Results 
showed that engraftment from cultures with growth factors supplement yielded more 
engraftment compared to cultures without growth factors. OP9 cells were found to 
be the most stable cell line supporting generation of engraftable HSC. I found that 5 
cell lines supported generation of engraftable HSCs when aggregated with E9.5 
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pro-HSCs in the absence of growth factors (“-GF” conditions). In particular, 
embryonic cells aggregated with lines P12-002 A6, P12-009 E10 and P12-021 C1 
generated more than 20% donor engraftment in “–GF” conditions (appendix figure 
8.3-3). This was better than E9.5 caudal part/OP9 aggregates which did not give 
engraftment when cultured with growth factors. As seen in table 5.2-1, cell lines that 
were able to mature E9.5 pro-HSCs came from diverse background. They also came 
from different embryonic stages, including E8, E10.5 and E11.5 embryos. E11.5 cell 
lines derived from various surface marker combinations were able to mature 
precursors of HSCs, including CD123-CD106-, CD123+CD106+, Flt3+SCF-, 
VE-Cad+Flt3- and VE-Cad-Flt3+. These observations suggested that niche cells 
which could mature E9.5 pro-HSCs into definitive HSCs might existed at multiple 










Figure 5.2-3. Peripheral blood of transplanted recipients contained 
donor derived cells, six weeks after transplantation. Eleven cell lines 
were tested alongside with OP9 positive control. Seven of these lines 
promoted donor engraftment, four did not. a) Performance of cell lines 
with growth factors, each experiment was labelled with their names. 
Each dot represented one mouse. b) Performance of cell lines without 
growth factors. The labels were in the same layout as panel a. c) 
Combined results of all experiment, grouped by cell line name. 22 mice 




Figure 5.2-4. Peripheral blood sample of engrafted recipients contained 
CD45.2 homozygous cells of donor origin. This sample was taken 9 
months post transplantation. a) Gating strategy to select blood cells 
(left) and to gate out dead cells (right). b) Left, flow plot of peripheral 
blood of engrafted recipient. This mouse was injected with E9.5 primary 
cells aggregated with cell line P12-009 E10, +GF condition. Centre, 
CD45.1-APC single stain control sample. Right, CD45.2-PE single stain 
control sample. To view all 108 flow plots for 5 different experiments, 
please see appendix figure 8.3-3. 
To characterize donor engraftment obtained, selected engrafted recipients were 
further analysed. According to lab protocol, peripheral blood samples were taken 
from recipient mice again 6 months after transplantation. Compared engraftment 
rates at 6 weeks and 6 months, engraftments in some recipients did increase (Figure 





Figure 5.2-5. Percentage of CD45.2 donor chimerism changed after 
transplantation. Donor cell percentages were measured as percentage 
of CD45.2 homozygous cells in all 7AAD- cellular events.  
After confirming that donor derived cells was retained after 6 months, blood 
samples of these mice were analysed for multilineage engraftment. The gating 
strategy and flow cytometry plot for FMO controls were shown in appendix figure 
8.3-4. After excluded recipient and carrier cells, donor derived cells were analysed 
for B220 and CD3e expression to detect B cell and T cells respectively. Myeloid 
cells were characterized by Mac-1 (macrophage) and Gr-1 (granulocyte) expression. 
It was noticed that some cell lines supported generation of HSCs that could achieve 
multilineage repopulation (B cell, T cell and myeloid cells) while other cell lines 
tested did not (figure 5.2-6). No correlation between ancestral markers or 
development stage and multi-lineage engraftment was observed. The cellular 
identity of donor derived haematopoietic-maker-negative engraftment of P12-021 
C1-GF aggregated culture showed in figure 5.2-6 had not yet been determined. 
Further experiments were needed to establish their identity. More efforts were 





Figure 5.2-6. Multilineage flow cytometry analysis of selected mice after 
6 months.  “A6 +GF” plots were from aggregates contained the 
P12-002 A6 low density line (passage 30) with growth factors 
supplement. Engraftment at 6 weeks was 54.3% and at 6 months was 
38.1%. “E10 –GF” plots were from aggregates contained the P12-009 
E10 low density line (passage 32) without growth factors supplement. 
Engraftment at 6 weeks was 40.8% and at 6 months was 33.5%. “C1 -GF” 
plots were from aggregates contained the P12-021 C1 bulk line 
(passage 23) without growth factors supplement. Engraftment at 6 
weeks was 59.8% and at 6 months was 59.3%. “OP9 +GF” plots were 
from aggregates contained OP9 positive control cell (passage 30) with 
growth factors supplement. Engraftment at 6 weeks was 38% and at 6 
months was 19.6%. All mice were from experiment SRYZH4. Gating 
strategy and FMO controls were listed in appendix figure 8.3-4. All plots 
for multilineage engraftment were included in supplementary files. In 
total, 24 mice were analysed. 
Finally, four mice were culled to check multilineage engraftment in blood, bone 
marrow, spleen and thymus. One mouse was selected from each of those four 
experiments that yielded engraftment (table 5.2-2). The mouse from experiment 2 
(mouse ID: SRYZH 216) was negative control. That mouse was engrafted at 6 
weeks post transplantation but engraftment dropped below 5% 6 months after 
transplantation. The other three mice had engraftments either very high (70.7%), 
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high (52.4%) or modest (24.3%) 6 months after transplantation. Gating strategy and 
FMO controls were shown in appendix figure 8.3-5. Profiles of donor derived cells 
differed between different recipients and organs. The mouse that received primary 
cells aggregated with cell line P12-002 A6 was the best performing with both 
lymphoid and myeloid donor contribution detected in multiple tissues (figure 5.2-7, 
brown bar, appendix figure 8.3-6). Significant numbers of CD4+CD8+ and CD4 
single positive cells were present in thymus, although number of CD4 single 
positive cells was low. The mouse received 026-C6 aggregate also contained both 
lymphoid and myeloid donor contribution in multiple tissues. However, less cells 
were detected compared to A6 recipient, this observation was in line with the fact 
that C2 engraftment level at 6 months was 46.4% lower compared to A6 recipient. 
The mouse received P12-021 C1 aggregate performed worst; this recipient had very 
few donor derived cells in bone marrow, spleen and thymus. There was significant 
donor contribution in blood, but the majority of CD45.1- donor derived cells did not 
have B cell, T cell, macrophages and granulocytes markers. The identity of these 
blood circulating non-haematopoietic cells required further study. Moreover, 
mechanism behind such cell line specific contribution observed in this experiment 
was worth further investigation.  
Table 5.2-2. List of mice tested for multilineage engraftment in multiple 
organs. Engraftments are measured by percentage of CD45.2 homo 
cells in all live cells of blood sample. P12-027 G7 mouse is used as a 
negative control.  
Contributions of donor derived cells to B cell, T cell and myeloid cell lineages were 
shown in figure 5.2-7, with original flow cytometry plot shown in appendix figure 
8.3-6. Above background (mouse 2 1 6 was negative control) contribution to most 
lineages was detected. Original flow cytometry plots were shown in appendix figure 
8.3-6. Donor contribution to specific lineages of specific recipient was positively 
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correlated with overall contribution of that recipient, as shown in table 5.2-2 and 
figure 5.2-7. No obvious bias of contribution toward certain lineages was detected.  
 
Figure 5.2-7. Donor derived cells contributed to B, T and myeloid cell 
lineages. Such multilineage contribution was detectable in multiple 
organs. Donor contribution was measured as percentage of 
CD45.1-Ter119- cells to total Ter119- live cells in that specific cell 
compartment. Sample were taken at least six months after 
transplantation. Mouse 2 1 6 received cells aggregated with line 
P12-027 G7, +GF condition, it was the negative control. Mouse 4 1 6 
received aggregate of P12-002 A6, -GF condition. Mouse 6 2 7 received 
aggregate of P12-021 C1, +GF condition. Mouse 9 3 1 received 
aggregate P12-026 C2, +GF condition Gating strategy was shown in 
appendix 8.3-5. Original flow plots were included in supplementary files. 
(n=4)  
Secondary transplantation experiments were carried out. A mouse which received 
E9.5 caudal parts aggregated with cell line P12-021 C1 with growth factors 
supplement was used. Its donor chimerism at 6 weeks was 25.9% and donor 
chimerism at 6 months was 52.4%. 7 weeks after secondary transplantation, two 
secondary recipients had 3.28% and 1.11% of donor derived cells in circulating 
blood (figure 5.2-8) respectively. Secondary engraftment data confirmed the fact 
that E9.5 primary caudal part cells could produce bona fide HSC after aggregation 
with newly derived cell lines. However, the majority of blood cells in the secondary 
recipient came from carrier cells in first transplantation (105 bone marrow cells per 
recipient), although in the primary recipient used for secondary transplantation, their 
contribution in peripheral blood were roughly the same. This observation also 
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suggested E9.5 that derived cells were being out competed by carrier cells. How to 
increase its competitiveness remained an interesting direction for further studies.  
 
Figure 5.2-8. Secondary recipients contained low level donor 
contribution 7 weeks after transplantation. Left plot was the peripheral 
blood sample of primary recipient used for secondary transplantation. 
Middle and right picture were secondary recipient. Each secondary 
recipient received cell amount equivalent to one third of one femurs 
bone. Note that donor derived cells were CD45.2 homozygous, carrier 
cells were CD45.1 homozygous and recipient cells were CD45.1/CD45.2 
heterozygous. (n=2).  
To detect whether immortalized stromal cells were able to engraft in primary 
recipients, blood samples were taken from three mice six months after 
transplantation and had their genomic DNA were isolated. CER fragments were 
amplified alongside with Myo. It was used as an internal control, reaction 
parameters were listed in appendix table 8.2-1. PCR result suggested no CER DNA 
was detectable in recipients’ peripheral blood (figure 5.2-9). Such data suggested 





Figure 5.2-9. No genomic DNA containing CER sequence could be 
detected from blood sample by PCR. Two lane M were 1Kb+ ladder. Left 
panel was Myo internal control sample, right was CER sample. Lane 1 
of both panels were gDNA isolated from blood of mouse SRYZH 6 3 8. 
Lane 2 of both panels were gDNA from mouse SRYZH 9 2 9. Lane 3 of 
both panels were gDNA from mouse SRYZH 9 2 10. Lane 4 of both 
panels were positive control, verified gDNA isolation from mouse ear 
sample was used as a positive control template for Myo. CER plasmid 
was used as a positive control template for CER. Lane 5 of both panels 
were no template negative control.  
Taken together, data presented in this chapter demonstrated that cell lines derived in 
this study could support production of HPCs as well as HSCs. HSCs produced could 
achieve long term multilineage haematopoietic engraftment in multiple organs of 
primary recipients. Such haematopoietic maturation capacity could be observed with 
cell lines derived from populations expressing several different combinations of 
markers and from haematopoietic related sites of different developmental stages. 
Donor derived cells from engrafted primary recipient could engraft secondary 
recipients, although at low levels. More interestingly, cell line P12-002 A6, P12-027 
G7, P12-015 B4, P12-009 E10 and P12-021 C1 could mature HSCs without the help 
of externally added growth factors; this was superior compared to OP9 cells. All 
these data demonstrated that immortalized cell lines derived from haematopoietic 
sites could promote maturation of pro-HSCs into definitive HSC. The environment 
that support haematopoietic maturation existed in multiple time points and was not 
confined to specific surface marker profile.   
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6. Chapter 6: Gene expression in AoV cells (RT-qPCR) 
A set of reverse transcription quantitative PCR (RT-qPCR) experiments was carried 
out to compare the transcriptional profiles of cell lines that could mature pro-HSCs 
into dHSC and those that could not. A set of preliminary experiments was conducted 
to determine reliability and reproducibility of qPCR platform used by characterizing 
its systematic errors and random errors. To better control the quality of experiment, 
MIQE standard was adhered (Bustin, Benes et al. 2009).    
Later, 9 cell lines derived in this project and OP9 control were tested for expression 
of haematopoietic genes. Expression information was extracted and compared with 
data generated in Nagao, Ohta et al. (2008). 
In summary, in this chapter, the following was achieved: 
 Establishment of a reliable qPCR experimental platform that compatible with 
MIQE standard 
 Used such platform to determine expression level of key haematopoietic genes 
in 9 cell lines. 
 Analysis of expression data and comparison of results with Nagao et al.’s result.  
6.1. QPCR primer design 
64 haematopoietic related genes were selected based on the literature, microarray 
data generated in our laboratory and on advice from various members of our group 
(appendix table 8.4-1). Primer pairs against 13 of these genes passed validation, 
their sequence were listed in table 6.1-1. Most remaining primer pairs failed to 
amplify when tested with cDNA from OP9 and cell line P12-009 E10, P12-021 C1, 
P12-015 B4. It was not clear if such failure can be attributed to these primer pairs 
tested or tested cell lines just didn’t express corresponding transcripts at all.   
Primer pair Tbp E6/7 was used as reference gene. Primers were designed for 
Ubiquitin C (Ubc), which was used as reference in Prof Berthold Göttgens’s recent 
publication (Moignard, Macaulay et al. 2013). 
It was discovered in primer verification experiments that amplification efficiency 
will fluctuate more than 0.1 between runs, even when the same preparation of cDNA 
and primer-probe mix were used (appendix table 8.4-5). It was more related to the 
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ratio of mixing of primer-probe-mix and cDNA solution. So a standard curve was 
set up for each primer pair used in every run to compensate for such fluctuations. 
 
Table 6.1-1. Sequence of 13 primer pairs used. Melting temperature data 
were calculated using Roche’s UPL assay design centre. 
6.2. qPCR Characterization of cell lines 
cDNA isolated from 9 cell lines derived in this project plus OP9 positive control 
were tested (table 6.2-1). OP9 was chosen because it was the best haematopoietic 
promoting cell line I have on hand. Out of those 10 lines, 7 could mature E9.5 
pro-HSCs into definitive HSC while 3 lines could not. Sample information was 
listed in table below.    
 
Table 6.2-1.  List of cell lines subjected to RT-qPCR experiment. Note 
“Yes” in Engraftment column indicated that E9.5 caudal parts cells 
co-aggregated with that cell line generated more that 5% donor 
chimerism at 6 weeks. Engraftment data was taken from experiments 
SRYZH 2, 4, 6, 7 and 9.  
Expression levels normalized to Tbp were shown in table 6.2-2. Raw Crossing 
points reading for all transcripts were in appendix table 8.4-3. Amplification 
efficiencies were in acceptable range and compensated using standard curve. No 




Table 6.2-2. Relative expression level of 13 transcripts used in 10 cell 
lines. Expression level was normalized to Tbp, the housekeeping gene. 
ND was not determined. (n=3)  
The box and whisker plot below (figure 6.2-3) showed a varied expression profile 
across different primer pairs. Detailed examination of data from cell line E10 
showed Cp readings of most transcripts were higher compared to other lines, 
suggested cell line P12-009 E10 had less mRNA in total RNA content. One 
explanation could be that E10 cell line had more ribosomal RNA, which was 
consistent with its faster replication speed.  
 
Figure 6.2-3. Box and whisker plot showed distributions of Cp in all 10 
cell lines. Upper and lower whiskers indicated maximum and minimum 
Cp respectively. Beside Tbp E6/7, primer pairs were sorted according to 
their max Cp value. 
Reference primer pair Tbp E6/7 gave relatively stable readings in most cell lines. 











Mean Cp distribution, 10 cell lines
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percentage in total RNA content. Further experiments were needed to monitor the 
stability of Tbp expression in various cell lines of different passages. It was 
important to determine the frequency that outliers appear, if Tbp expression was not 
as stable as it seemed to be, alternative reference genes like Ubc could be used 
(Moignard, Macaulay et al. 2013).   
To better compare expression values across different cell lines, Crossing points (Cp) 
were converted to relative expression values and were normalized against Tbp 
expression value (Table 6-2.2). A two tailed student t-test was applied to all 
normalized expression values. Result (data not shown) showed no different could be 
detected between average expression of cell lines that could mature pro-HSCs and 
those that could not. There were no difference between supportive and 
non-supportive clones at individual transcript level neither. Thus I focused on 
expression variability between different cell lines. Based on coefficient of variation 
of normalized expression of 10 cell lines (appendix figure 8.4-2), 6 out of 13 
transcripts had a coefficient of variation bigger than 100%, suggesting these 
transcripts were differently regulated between cell lines. The high variable group 
included Itgav, Vcam1, Tgfb1, Bmp4, Nes, Kitl. On the other hand, expression of 
Inhba, Cdh2, Jag1, Il3ra. Flt3l and Wnt4 was less variable.  
In 2008, Kenji Nagao et al. (Nagao, Ohta et al. 2008) analysed sub-clones of cell 
lines derived from E10.5 mouse AGM by Nakahata’s group (Xu, Tsuji et al. 1998). 
Nagao and colleagues performed sub-cloning of those AGM derived lines. One of 
the sub-clones analysed, AGM-S3-A9, could support haematopoietic progenitor 
expansion during co-culture, and could maintain HSC activity in murine BM LSK 
cells. Another sub-clone, AGM-S3-A7, of same origin failed to do so. They 
compared expression profiles of those two sub-clones and OP9 positive control cell 
line generated using the Affymetrix® MG-U74 microarray platform. I extracted 
their microarray data from NCBI’s GEO resource (dataset: GSE11891, GEO 
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Accession: GPL81) and compared its expression value with qPCR data collected in 
this project.  
Reference gene used in this study was used to normalize expression level extracted 
from Nagao’s experiment. In my data, average Tbp expression of supportive cell 
lines in qPCR experiment were 1.47 fold higher compared to expression of Tbp in 
OP9, and average Tbp expression in non-supportive cell lines was 2.88 times higher 
than Tbp expression in OP9. That was comparable with Nagao et al.’s result (1.35 
fold higher for supportive cell line and 0.98 fold for non-supportive cell line). 
However, expression differences of many genes between feeder lines derived in this 
project and OP9 control were significantly higher. In the most extreme case, in OP9 
cells, Nes expression level was barely detectable, with only 1 out of 6 replicates 
have a Cp of 38.54, but Nes Cp in stromal lines derived in this project are generally 
around 28, indicating at least 1024 (210) fold expression difference. After exclusion 
of Nes, on average transcripts of interest in haematopoietic-supportive lines had 
normalized expression 8.63 fold higher compared to OP9. Non-supportive lines had 
normalized expression 3.42 times higher. Such large differences were not observed 
in Nagao et al.’s microarray experiments. In their data, after excluding Nes, 
normalized fold change of average expression level between supportive clone and 
OP9 was 1.40, between non-supportive clone and OP9 was 1.39. I checked all 
expression values in their assay (figure 6.2-5). In their data, overall distribution of 
expression values was similar between two sub-clones and OP9, indicating the lack 
of expression difference in 13 genes selected was not biased, but a representation of 
overall trend.  
It was unclear which distribution their data had, but it was unlikely this data was 
normally distributed since frequency of expression values was not symmetrical. 
Such difference could be explained by qPCR platforms had larger liner detection 
range. Microarrays had very high throughput compared to qPCR method, but their 
probe sets sometimes could be over saturated by excessive transcript binding and 
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underestimate transcript content. That oversaturation might cause the chip reader fail 
to recognize higher expression values. 
 
Figure 6.2-5. Overall distribution of expression values of two 
sub-clones and OP9 extracted from Nagao et al.’s data. Distribution 
figures shown here were based on raw readings directly exported from 
GEO2R “value distribution” page.  
Correlation analysis was conducted between each pair of transcripts. Five transcripts 
showed highly correlated expression patterns, with correlation higher than 0.93. 
They were Itgav, Vcam1, Tgfb1, Bmp4, Nes and Kitl. Their normalized expression 
levels in cell lines derived in this study were higher compared to expression level in 
OP9 positive control. On average, supportive cell lines expressed Itgav 6.67 fold 
higher than OP9; expressed Vcam1 46.65 fold higher; expressed Tgfb1 12.55 fold 
higher; expressed Bmp4 5.85 fold higher; expressed Nes 2188.6 fold higher and 
expressed Kitl 5.76 fold higher. On average, non-supportive lines expressed Itgav 
3.31 fold higher than OP9; expressed Vcam1 9.64 fold higher; expressed Tgfb1 4.12 
fold higher, expressed Bmp4 2.72 fold higher, expressed Nes 544.35 fold higher and 
expressed Kitl 4.07 fold higher. 
In Nagao et al.’s experiment, expression level of these transcripts were more varied. 
Itgav expression level was 28% less than OP9 in supportive clone and was 17% less 
in non-supportive clone. Vcam1 expression level was 31% more than OP9 in 
supportive clone and was 23% less in non-supportive clone. Tgfb1 expression level 
was 112% more than OP9 in supportive clone and was 14% more in non-supportive 
clone. Bmp4 expression level was 75% more than OP9 in supportive clone and was 
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5% less in non-supportive clone. Nes expression level was 143% more than OP9 in 
supportive clone and was 117% more in non-supportive clone. Kitl expression level 
was 12% more than OP9 in supportive clone and was 66% less in non-supportive 
clone (see figure 6.2-6). The fact that these genes with diverse 
haematopoietic-related function highly correlated expression profile suggested that 
they were tightly regulated by the same set of “core” transcriptional regulators 
which might define the identity of HSC maturation niche. 
 
Table 6.2-3. Correlation matrix of normalized expression value of 
different transcripts in 10 cell lines. Highlighted primer pairs had 
correlation higher than 0.9. Correlation matrix was generated using 
Excel 2013’s data analysis tool.  
Itgav (CD51, Integrin alpha V) was a cell adhesion molecule involved in HSC niche 
interaction. It was showed that most human Nestin+ cells were also positive for 
PDGFα and Itgav. Those PDGFα+CD51+ cells could support haematopoietic 
progenitor cell expansion (Pinho, Lacombe et al. 2013). Plus Itgav (CD51) 
expression was observed in intra-aortic haematopoietic clusters in E10.5 AGM 
(Boisset, Clapes et al. 2013). It was also reported that Itgav induced Tgfb1 activation 
was critical for the normal development of retinal vascular endothelial cells (Arnold, 
Ferrero et al. 2012).  
Vcam1 was a cell adhesion molecule that bind to Integrin α4β1 complex. It was 
involved in HSC-niche interaction by modulating HSC homing and mobilization 
(Simmons, Masinovsky et al. 1992) (Papayannopoulou, Craddock et al. 1995). 
Literature search did not reveal anything meaningful discussing co-regulation 
mechanism between Vcam1 and its co-regulated peers.  
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Bmp4 was another critical secreted factor showed pattern of co-regulation. It was a 
potent mesodermal inducer and promotes haematopoietic specification (Sadlon, 
Lewis et al. 2004). Furthermore, literature indicated Bmp4 was selectively expressed 
in the stroma cells below intra-aortic haematopoietic clusters, polarized to the 
ventral wall of dorsal aorta (Marshall, Kinnon et al. 2000), suggested Bmp4 might 
had indispensable roles in HSC maturation after mesodermal stage (Durand, Robin 
et al. 2007). It was observed that some Nestin positive MSCs isolated from bone 
marrow could secret Bmp4 when co-cultured with neurospheres derived cells 
(Wislet-Gendebien, Bruyere et al. 2004). It would be interesting to see if Nestin 
positive cells in AGM expressed Bmp4. They might be a critical part of 
haematopoietic maturation niche. 
Tgfb1 was a powerful regulator of cell cycle (for review, see Hu and Zuckerman 
(2001)). Bai et al. showed that in pluripotent stem cell differentiation models, TGF 
beta signalling could promote mesodermal formation at early stage but was 
inhibitory to formation of CD34+CD31+VE-Cad+ progenitors. This finding 
suggested a stage specific role of TGF beta signalling in early haematopoietic 
development (Bai, Xie et al. 2013). Data from co-culture assays suggested Tgfb1 
was beneficial to haematopoietic maturation while data from pluripotent cell 
differentiation assay did not support such idea. However, Bai et al. did not conduct 
any transplantation experiment, only tested haematopoietic progenitor content with 
CFU assays. As a result, differentiated cells they produced might not represent real 
haematopoietic stem cells.  
Another very interesting molecule of the co-regulated group was Nes. Nes (Nestin) 
was a cell cycle related protein. Beside its co-regulation events with Itgav and Bmp4 
described above, Nestin positive cells had other important haematopoietic functions. 
Mirko et al. showed that the Nestin+ perivascular cells support human HSPCs 
(Corselli, Chin et al. 2013). Simon et al. showed Nestin+ cells were a critical 
107 
 
component of mouse bone marrow niche for haematopoietic stem cells 
(Mendez-Ferrer, Michurina et al. 2010).  
The last member of co-regulation group was Kitl, its common name was SCF (stem 
cell factor). Since primer pair used in this study could not distinguish solvable form 
and membrane bound form of SCF, SCF was considered as a secreted molecule. 
SCF was a critical regulator that controls haematopoietic cell survival. Kitl locus 
was also known as steel locus (SI). Complete knocking-out of SCF production 
leaded to anaemia and embryonic lethality (Ding, Saunders et al. 2012). SCF was 
also a critical cytokine for the aggregation system used in this study. The fact that 
cell lines derived in this project expressed SCF at a higher concentration might 
imply that the SCF was widely expressed at haematopoiesis locations during 
embryonic development. This was confirmed by Nagao’s supportive clone. Their 
non-supportive clone expressed less SCF compared to OP9. Culture adoption and 
sub-cloning might contributed to the loss of SCF expression and ability to support 
haematopoietic expansion of that specific clone. 
 
Figure 6.2-6. Expression of six co-regulated transcripts in stromal lines. 
All expression values were normalized to Tbp expression first, then 
normalized to expression in OP9 cell lines. Readings from Nagao’s 
microarray were directly taken from GEO2R without further 
normalization or quality control measures. Probeset ID for Itgav was 
98366_at; for Vcam1 was 92559_at; for Tgfb1 was 101918_at; for Bmp4 
was 93455_s_at; for Nes was 103549_at; for Kitl was 99577_at. Note y 
axis was log scale. 
108 
 
In this study, expression level of five haematopoietic related cytokines and receptors 
were investigated, they were: Cdh2, Jag1, Il3ra, Flt3l, Wnt4 (figure 6.2-7). In this 
study, Cdh2 expression level in supportive lines was 6.25 fold higher than OP9 and 
in non-supportive clones was 6.09 fold higher. Jag1 expression was 25% less than 
OP9 in supportive lines and was 77% less in non-supportive lines. Il3ra expression 
was 38% higher than OP9 in supportive lines and 11% less in non-supportive lines. 
Flt3l expression was 5% lower than OP9 in supportive lines and 45% lower in 
non-supportive lines. Wnt4 expression was 14% lower than OP9 in supportive lines 
and 39% lower in non-supportive lines. 
In Nagao et al.’s experiment, Cdh2 expression level in supportive lines was 16% 
lower than OP9 and in non-supportive clones was 37% lower. Jag1 expression was 
74% less than OP9 in supportive lines and was 76% less in non-supportive lines. 
Il3ra expression was 47% higher than OP9 in supportive lines and 12% higher in 
non-supportive lines. Flt3l expression was 149% higher than OP9 in supportive lines 
and 97% higher in non-supportive lines. Wnt4 expression was 2% lower than OP9 in 
supportive lines and 5.43 fold higher in non-supportive lines. 
Cdh2 (N-Cadherin) was an adhesion molecule that was involved in stem cell niche 
interaction (Arai, Hosokawa et al. 2012). Recent research measured the force 
generated by N-Cadherin based stem cell-niche interaction model (Burk, Monzel et 
al. 2015).   
Jag1 was the ligand of Notch1. Notch was critical to normal embryonic 
haematopoietic development (Bigas, D'Altri et al. 2012). Both qPCR data and 
Nagao et al.’s microarray data showed stromal cell lines had less Jag1 compared to 
OP9 controls. One explanation could be OP9 was very good at inducing Notch 
signalling, and lines derived in this study could be enhanced by overexpressing Jag1. 
The other explanation could be cell lines promote maturation of pro-HSCs without 
strong activation of Notch signalling. If the later explanation was true, it would be 
interesting to study the Notch independent interaction of pro-HSC and surrounding 
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niche. Jag1 expression was also positively correlated with Flt3l expression, literature 
search revealed nothing discussing such co-regulation event.  
Il3ra (Interleukin 3 receptor alpha) was the specific subunit of interleukin 3 receptor. 
It was known that IL3 signalling was critical in aggregation system used in this 
project, and IL3 did not directly function at pro-HSC but works through surrounding 
niche. So it was speculated that at least some compartment of HSC maturation niche 
expresses Il3ra.  
Another factor investigated was Flt3l. It was ligand for Flt3, a tyrosine kinase. Flt3 
was expressed at human LT-HSC (Kikushige, Yoshimoto et al. 2008) and mouse 
ST-HSCs (Christensen and Weissman 2001). Previous work conducted in our lab 
indicated Flt3l was a powerful haematopoiesis promoting cytokine in aggregation 
system. It would be very interesting to continue screening all the cell lines derived in 
this project and compare haematopoietic stem cell maturation ability between Flt3l 
high lines and lines that expressed less Flt3l.  
Wnt4 was another secreted factor investigated in this study. Wnt4 was picked up by 
educated guess. Wnt signalling was required for haematopoietic specification of 
endothelial cells (Ruiz-Herguido, Guiu et al. 2012).  
 
Figure 6.2-7. Expression of Cdh2, Jag1, Il3ra, Flt3l and Jag1 in stromal 
lines. Readings from Nagao’s microarray were directly taken from 
GEO2R without further normalization or quality control measures. 
Probeset ID for Cdh2 was 102852_at; for Jag1 was 116304_at; for Il3ra 
was 92955_at; for Flt3l was 102929_s_at; for Wnt4 was 103238_at. All 
expression values were normalized to Tbp expression first, then 
normalized to expression in OP9 cell lines.  
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At last, Inhba was investigated in this study. In this study, normalized expression of 
Inhba in supportive lines were 7.22 fold higher than OP9, in non-supportive lines it 
was 5.45 fold higher. In Nagao’s experiment, normalized expression of Inhba in 
supportive clone was 2.35 fold higher than OP9 and 83% higher in non-supportive 
clone. Inhba (Inhibin beta-a) was the homolog of human INHBA gene. The human 
INHBA gene was a subunit of inhibin complex which antagonize Activin activity. 
Cerdan et al. showed that Activin A promoted expansion of mesodermal fate in 
human embryonic stem cells and stimulate early haematopoietic development 
(Cerdan, McIntyre et al. 2012). How Inhba involved in pro-HSC maturation was 
open to further studies. 
After analysing each transcript, normalized expression of each transcript in different 
cell lines and percentage of engraftment from E9.5 pro-HSC maturation assay were 
compared. Only expression of Jag1 shows weak correlation (0.84) with engraftment 
level in with growth factors conditions and overall engraftment (0.85) (appendix 
table 8.4-7). Further investigation was needed to find a marker of haematopoietic 
maturation ability. 
At last, a correlation analysis between each stromal cell lines and OP9 were 
conducted (table 6.2-4). It was observed that cell lines P12-009 E10, P12-027-G7, 
P12-015 B4, P12-004 D5, P12-015 H5 were highly correlated (correlation bigger 
than 0.95). These cell lines came from different developmental stages, some could 
support pro-HSC maturation and some could not. A follow up RNA-seq study 
would better determine the significance of such correlation.  
 
Table 6.2-4. Correlation coefficient of normalized expression in 10 cell 
lines. Highlighted cell lines have correlation higher than 0.95. 
Correlation matrix was generated using Excel 2013’s data analysis tool.  
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7. Chapter 7: Discussion 
In this chapter, different aspects of this study were discussed. Section 7.1 discussed 
about the construction of immortalization vector and directions of further 
improvements. Section 7.2 discussed about designing immortalization protocol, cell 
line derivation and generation of new cell lines. Section 7.3 discussed 
characterization of cell lines. Section 7.4 was focused at qPCR assay. At last in 
section 7.5, I gave a new model of haematopoietic specification using multi-ordered 
stochastic Markov model.    
In section 1.3.2, some previous works were reviewed. This project was aimed at to 
address some caveats of previous studies. For example, cell lines from wild type 
AGM tissue were derived using a stronger immortalization factor to avoid going 
through crisis. A piggyBac based immortalization system replaced viral 
immortalization system used in some previous studies (Seandel, Butler et al. 2008). 
Fluorescence marker was introduced into immortalization vector to mark transfected 
cells. Plus, newly derived cell lines were compared with OP9 cells (Nakano, 
Kodama et al. 1994)to determine if they better capture the maturation capacity of 
maturing pro-HSCs.  
In summary, in this study the concept of deriving stage or marker specific cell lines 
with haematopoietic maturation capacity was verified. Cell lines derived in this 
study had better haematopoietic maturation capacity compares with OP9. To further 
fulfil the potential of this immortalization system, more improvements could be 
made to accommodate derivation of cell lines from populations of extremely low 
cell number. The immortalization vector could be improved to better label 
transfected cells. Also transfection parameters could be explored further to improve 
efficiency and survival. Experimental protocols to derive cell lines could also be 
optimized to promote survival of very low cell numbers. Sorting protocol and 
antibodies used could be optimized to better separate positive and negative cell 
populations. Moreover, the E9.5 aggregation culture system should also be 
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stabilized. To discover mechanism of stem cell niche interaction, high throughput 
systems like Fluidigm and RNAseq systems were needed. It would allow high 
throughput screening of additional haematopoietic genes. 
7.1. Discussion about vector establishment 
The vector constructed in this study was aimed at improve some caveats of previous 
studies. Previous work done by Oostendorp, Medvinsky et al. (2002) were forced to 
employ constitutive expressed immortalization factor and didn’t achieve direct 
immortalization without going through crisis. I wanted to improve that by achieving 
direct immortalization. In this study, I used the SV40T immortalization factor that 
was stronger compared to tsA58. SV40T was chosen as the immortalization factor 
because it was used to directly immortalize murine cells in previous studies (Pipas 
2009). To fine adjust expression of SV40T and prevent over-alteration of the 
transcriptome by SV40T during immortalization, the powerful CAG promoter 
originally on piggyBac backbone was replaced with weaker PGK promoter. This 
change was aimed at lower SV40T expression to prevent possible over-alteration of 
haematopoietic related transcription program. The DNA sequence corresponding to 
SV40T intron was retained to stabilize its RNA expression.  
The tsA58 immortalization system used in Oostendorp’s study was easy to use and 
expression of immortalization vector was reversible, this was advantageous 
compared to some of the later works with viral delivery systems (Seandel, Butler et 
al. 2008). My immortalization system was also designed to be easy to use. The 
piggyBac system I employed avoided the tedious work of viral particle generation 
and did not contain infectious material. Others also shown that piggyBac 
transposons could be excised from genome (Wang, Lin et al. 2008) (Woltjen, 
Michael et al. 2009). This property should allow the immortalization factor to be 
turned off. It would be very interesting to test this capacity in future experiments.    
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Pervious study conducted by Oostendorp and Rafii did not label immortalized cells. 
This made distinguish feeder cell and primary cell in co-culture very difficult, 
especially when primary cells and immortalized cells were from the same origin. To 
separate them, I introduced a Cerulean fluorescent label into the immortalization 
vector (Sarkar, Koushik et al. 2009). Cerulean had an excitation/emission profile 
that did not interfere with detection of FITC and PE and had the brightest 
fluorescence in this range, made it an excellent candidate marker to use in 
experiment involved multicolour flow cytometry analysis. T2A, one member of 2A 
self-cleaving peptide family (Kim, Lee et al. 2011), was used to fuse SV40T and 
CER together. Using the 2A polypeptide to drive expression of multiple proteins had 
two advantages. First, it was shorter compared to IRES, thus was easier to 
manipulate and reduced overall plasmid size. Second, because CER and SV40T 
were fused together in the same open reading frame, expression of CER confirmed 
that SV40T coding region was successfully translated. However, later experiments 
confirmed that expression of CER was not strong enough to label all transfected 
cells. The silencing of CER could be caused by positional effect. Or T2A might 
reduce CER protein production level. To counter this problem, a stronger and more 
silencing-resistant marker might be required.  
During this study, it was noticed that in culture, sometimes stromal cells grow 
drastically and consumed a lot media. It would be much better if growth of stromal 
cells in culture could be inhibited. One way to achieve it was to introduce a 
chemically inducible suicidal gene into the immortalization vector, like iCasp9 
system (Ramos, Asgari et al. 2010).   
It would be easy to replace components of the PGK-SV40T-2A-CER cassette. The 
immortalization vector constructed in this study was designed with a modular 
concept, with accurate maps of all molecules generated during vector construction at 
single nucleotide resolution. With all mapped intermediate vector on hand, it would 
be very easy to replace CER with more efficient labels. A panel of piggyBac based 
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vector each had different immortalization factor/label combination could be 
established since the pB-PGK backbone was modified to contain SalI and NcoI 
restriction sites. Another possible modification was to move Cerulean fluorescence 
marker forward of SV40T antigen and use a stronger promoter. In this setting, 
expression of CER would be significantly increased, and SV40T expression might 
also increase. To go one step further, the SV40T and Cerulean could be controlled 
under independent promoters, enabling fine adjustment of their expression. 
Finally, because electroporation did not involve receptor-envelope recognition, the 
vector I used was organism neutral. It could be applied towards cells from any 
species that could be immortalized with SV40T. One only needed to adjust 
electroporation parameter to apply the system to new species. 
7.2. Discussion about cell line generation 
Previous works by Xu, Tsuji et al. (1998) and Oostendorp, Medvinsky et al. (2002) 
established cell lines from AGM region of E11.5 and E10.5 embryos. They 
demonstrated cell lines derived from AGM region could support HSC and/or 
progenitors. In this study, I pushed a little further to investigate if cell lines derived 
from earlier developmental time points could mature pro-HSC. I tried to sub-dissect 
E11.5 AGM region and establish cell lines from primary cells having different 
surface marker combinations. Such study would reveal dynamic of interactions 
between different populations in AGM region. 
To achieve this goal, I developed a protocol to sub-dissect AGM region into 
HSC-rich ventral aorta (AoV) and HSC-depleted dorsal aorta (AoD) and establish 
cell lines separately. After successfully derived cell lines from dorsal and ventral 
aorta, I tried to sort sub-dissected cells and establish lines from sorted populations. 
Preliminary experiments carried out using primary cells from E11.5 ventral aorta 
showed some cell populations of interest contain only about 1000 cells.  
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Primary cell loss during transfection was minimized to increase cell recovery. I used 
1.5mL electrically neutral tube instead of 5mL polystyrene tubes. Such electrical 
neutral tubes greatly reduced number of cells lost due to them stuck to the tube wall. 
By adjust tube holder and parameter of sorter, I achieved better aiming of drop 
stream and greatly reduced number of centrifuging and liquid transfer steps. These 
improvements yielded some success; I generated cell lines from populations with 
only a few thousand cells. 
The bottleneck of transfecting cell populations with even smaller number was cell 
survival. I successfully transfected a population of only 200 cells with pEGFP-N1 
plasmid, judged by observing GFP+ cells next day. But the lone survivors failed to 
grow. Further improvements were need to focus on reduce cell loss and enhance cell 
survival. One potential way of improving cell survival was to shorten length of pulse. 
Experiments done in this study did not fully explored the survivability of all 
experimental conditions. Based on trends with 30ms and 20ms conditions, 
conditions with 10ms length and slightly higher voltages (higher than 1350V) could 
have better survivability without compromising transfection efficiency.  
Plus, samples with low cell number might require lower voltages compared to 
samples with plenty of cells, so a special experiment could be conducted to find 
optimal electroporation parameter for populations with less than 105 cells. Amount 
of plasmid applied to sample with small numbers could also be reduced. A quick 
chart of electroporation parameters and plasmid amount suitable for different sample 
size could help researchers determine optimal condition to transfect different 
samples. 
Fluorochromes and antibodies used for flow cytometry could be adjusted to enhance 
separation of positive and negative populations, this would enhance recovery rate of 
cell populations with weak expression of surface markers.  
To enhance cell survival after transfection, several methods could be used. First, 
Matrigel® could be used to coat wells of 96 well plate to better facilitate cell 
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attachment. It might provide extra cellular matrix that was needed for cell survival. 
Also, untransfected primary cells from stage-matched EGFP embryos could be used 
as a source of feeder cell. These cells can provide the much needed niche for 
transfected cells to grow. After a few passages, primary cells will reach crisis and 
cease to growth, leaving only immortalized cells in culture.  
In this study, cell lines bear different markers were derived. The markers used to sort 
primary cells were: Il3ra (CD123), Vcam1 (CD106), membrane bound SCF, 
VE-Cadherin and Flt3. They were chosen based on educated guess. Il3ra 
(Interleukin 3 receptor alpha) was the specific subunit of interleukin 3 receptor. It 
was known that IL3 signalling was critical in aggregation system used in this project, 
and IL3 had positive effect on HSC emergence in AGM region (Robin, Ottersbach 
et al. 2006). So it was speculated that at least some compartment of HSC maturation 
niche expresses Il3ra. However, in this study, the expression level of Il3ra detected 
in ventral aorta cells was very weak. One possible explanation was that the 
collagenase/dispase solution used in this study was too strong and digested CD123 
molecule on cell surface. Gentler dissociation methods like Accutase or just 
collagenase itself might be beneficial for detecting Il3ra positive cells.   
Vcam1 was a cell adhesion molecule that binds to Integrin α4β1 complex. It was 
involved in HSC-niche interaction by modulating HSC homing and mobilization 
(Simmons, Masinovsky et al. 1992) (Papayannopoulou, Craddock et al. 1995). 
During my study, Vcam1+ populations was detected in AoV cells and quite a few 
cell lines were generated from Vcam1+ primary cells.  
SCF was a critical regulator that control haematopoietic cell survival. Kitl locus was 
also known as steel locus (SI). It produced cytokine that bind to c-kit receptor. 
Complete knocking out SCF productions lead to anaemia and embryonic lethality 
(Alexander 2000-). Membrane bound SCF was critical for normal haematopoiesis. 
SCF was also a critical cytokine within aggregation system used in this study. In this 
study, membrane-bound SCF expression was also very weak, expect in the 
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experiment involved VE-Cadherin and membrane-bound SCF. Because the FMO  
“–SCF” control behaved normally in that experiment, the most likely reason of 
detecting SCF expression in the VE-Cadherin/SCF experiment was the signal was 
real. It could be that in other experiments, the membrane-bound SCF proteins were 
destroyed, caused a loss of SCF signal. In the VE-Cadherin/SCF experiment, the 
dissociation solution somehow worked less effectively, leaving some 
membrane-bounded protein intact. In the future, weaker dissociation solutions could 
be used to retain the membrane-bound SCF proteins. Less secondary antibodies 
could also be used to prevent over amplification of fluorescence signals.  
The fourth marker tested was VE-Cadherin. It was demonstrated that HSCs emerged 
from VE-Cadherin positive pre-HSC stages (Rybtsov, Sobiesiak et al. 2011). Thus 
the VE-Cadherin positive endothelial lining in dorsal aorta must contained some 
permissive niche to allow maturation of pro-HSCs into pre-HSCs and definitive 
HSCs. In this study, successful separation of VE-Cadherin positive and negative 
primary cells was achieved. Cell lines were derived from both populations.  
The last marker tested was Flt3. It was expressed at human LT-HSC (Kikushige, 
Yoshimoto et al. 2008) and mouse ST-HSCs (Christensen and Weissman 2001). 
And my data indicated Flt3l was a powerful haematopoiesis promoting cytokine in 
aggregation system used in this project. It was hoped that Flt3 might be used as a 
marker to enrich niche related cells. In this study, cell lines were derived from both 
Flt3 positive and Flt3 negative cells. However, no enrichment of pro-HSC 
maturation capacity was detected yet. More experiments were needed to determine 
whether Flt3 could be used as a marker of pro-HSC maturation capacity.     
Data gathered in this study indicated that the idea of establishing cell lines from 
sorted primary cells was achievable. This achievement was of better than previous 
studies. However, I screened markers mentioned above. They did not enrich 
pro-HSC maturation capacity. This finding suggested additional markers and more 
cell lines were needed to be screened.  
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7.3. Discussion about cell line characterization 
One of the disadvantages of previous studies was that most studies only 
characterized cell lines using flat co-culture method. In this study, I decided to use 
the more robust 3D liquid gas interface aggregation system (Taoudi, Gonneau et al. 
2008). The aggregation system we used not only could support growth and 
expansion of HPCs and HSCs in vitro, it also can mature pro-HSCs into definitive 
HSCs. That was seldom achieved previously. Two assays were uses in this study 
based on the aggregation system. (1) A four days E11.5 aggregation assay was used 
to demonstrate cell lines can produce haematopoietic progenitor cells from E11.5 
embryos. (2) Cells from caudal half of E9.5 embryos were aggregated to stromal 
cells in E9.5 pro-HSC maturation assay to demonstrate that these lines  could 
mature pro-HSCs from of E9.5 mouse embryos.  
The four days E11.5 aggregation system was known to support maintenance of 
haematopoietic progenitors ex vivo. In this system, OP9 cell line could potently 
expand progenitors in aggregation culture, thus was used as positive control. The 
results gathered in this study indicated that some cell lines derived in this project 
could support production of haematopoietic progenitors from primary cells of E11.5 
embryos. All kinds of colonies were generated, including GEMM (Granulocyte, 
Erythrocyte, Monocyte, Megakaryocyte) colonies. And the number of colonies 
varies between different lines, ranged from very low to comparable to OP9 positive 
controls. However, it was discovered that results of four days E11.5 aggregation 
assays were not correlated with E9.5 pro-HSC maturation assay. This suggested 
improvement of E11.5 assay was needed. Experimental protocol needed to be 
streamlined, animal source and husbandry procedure should be stable. Change of 
animal housing like happened during this study should be avoided at all cost. 
Dissection and sample handling could be improved to minimize contamination and 
sunk of membranes that caused data loss. To prevent stromal cells interfere 
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colony-counting in CFU-C assays, stromal cells could be killed by suicidal gene 
introduced within an improved immortalization vector.        
The other assay employed, the E9.5 pro-HSC maturation assay, was aimed at to 
determine if cell lines derived in this study could mature pro-HSCs presented in 
caudal half of E9.5 embryos. Dr Stanislav Rybtsov made necessary improvement to 
culture system. He demonstrated that by extending culture time to seven days and 
adding SCF, Flt3L and Il3, such culture system could mature pro-HSCs into 
definitive HSC (Rybtsov, Batsivari et al. 2014). However, no engraftment was 
observed when aggregating E9.5 primary cells with OP9 without presence of growth 
factors. The results gathered in this study indicated that some cell lines derived in 
this study could mature pro-HSCs into definitive HSCs. The functions of HSCs 
derived were verified via multilineage assay and secondary transplantation. A few of 
the lines could achieve primary engraftment without help of growth factors. This 
was an advance compared to previous studies. 
It was noticed that cell lines that were capable of maturing pro-HSCs were derived 
from diverse developmental stage and populations each carried different marker 
combinations. This finding suggested cells capable of functioning as developing 
haematopoietic niche existed at multiple time points and bear different markers. 
Another interesting observation made with the E9.5 pro-HSC maturation assay was 
stromal cells stayed in over-confluence culture for more than one day failed to 
promote pro-HSC maturation. Such maturation capacity could only be regained by a 
period of free growth. During culture, the capacity of mature pro-HSC seemed to be 
periodically lost and regained, thus “oscillating”. 
Such finding challenged the notion that HSC were matured by some rare niche cells 
with in. If such rare cell existed, transplantation result should be “all or nothing”. 
That was cell lines with haematopoietic maturation potential should mature HSC 
every time while lines without such potential should never matured pro-HSC to 
definitive HSC. That was not true. The high failure rate of experiments of 
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maturation of E9.5 pro-HSC suggested pro-HSC maturation niche was not “all or 
nothing”, or put it in a more scientific way, the pro-HSC maturation niche was not 
“deterministic”. One interesting question arise from this observation, that if 
haematopoietic maturation niche was not deterministic, how was such potential 
regulated?  
To investigate these derived cell lines further, several improvements were needed. 
Beside improvements to aggregation system mentioned two paragraphs above, 
several improvements were needed for E9.5 pro-HSC assay. The pro-HSCs and 
definitive HSCs were more fragile compared to progenitors, thus E9.5 pro-HSC 
assay was more time sensitive compared to E11.5 four day aggregation assay. 
Dissection, sample processing, culture harvesting and transplantation all needed to 
be sped up. Because the pro-HSC maturation niche was dynamic, time of cells spend 
in free growth needed to be carefully monitored, especially when cell lines grew at 
different speed. Another way to better capture the dynamic pro-HSC niche was to 
use primary cells from Runx1 +23 enhancer reporter transgenic mice (23GFP mice), 
the Runx1 +23 enhancer could label cells going through EHT (Swiers, Baumann et 
al. 2013). With 23GFP cells, one could detect maturing pro-HSC in. In this way, 
capacity of pro-HSC maturation could be visualized by GFP activity. Stromal cells 
near GFP+ cells should have pro-HSC maturation capacity, they could be easily 
sampled. With such improvements, cell lines derived in this study could be better 
studied. The mechanism behind their pro-HSC maturation capacity could be 
revealed. 
7.4. Discussion about qPCR 
A RT-qPCR assay was carried out to probe haematopoietic related gene expression. 
In this study, qPCR was used to determine expression level of key haematopoietic 
genes in derived cell lines. List of haematopoietic related transcripts were 
determined by educated guess. Then a RT-qPCR system was established to 
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determine expression level of transcript of interest. MIQE standard was used to help 
design RT-qPCR experiment. Current qPCR experimental platform was robust. In 
follow up research, RNA-Seq might replace qPCR. It could increase the throughput 
of gene expression study. With more genes and cell lines tested, additional 
co-regulation events could be revealed and novel regulatory mechanisms could be 
estimated. 
Current RT-qPCR results showed some interesting correlation of haematopoietic 
genes. Data discussed in section 6.2 shown a cluster of co-regulation. Its members 
included Itgav, Vcam1, Tgfb1, Bmp4, Nes and Kitl. Such co-regulation was 
interesting, suggested they were regulated by same set of regulators during 
haematopoietic development. However, with only limited data on hand, it was hard 
to accurately determine possible master regulators just based on promoter sequences 
alone. More events of co-regulation were needed to enhance accuracy of regulatory 
mechanism prediction. However no correlation between expressions of 
haematopoietic genes with phenotype was detected (percentage of engraftment). To 
further investigate expression profile of haematopoietic related genes, current 
RT-qPCR protocol should be improved. 
7.5. Interpretation of results using multi-ordered stochastic 
Markov model  
In this project, several cell lines with haematopoietic maturation capacity were 
established from mouse embryos of different developmental stage and had ancestors 
bearing different surface markers. The unique “first time failure” phenomena 
suggesting pro-HSC maturation capacity was oscillating and was related to free 
growth of stromal cells. How I could fit such findings into the wider picture of 
definitive HSC maturation was worth discussing.  
HSCs were no strangers to oscillation. For example, Gata2, one critical 
haematopoietic transcription factors was oscillating in adult haematopoietic cells 
(Koga, Yamaguchi et al. 2007) and in developing aorta (Prof. Elaine Dzierzak’s 
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personal communication). To model the developing aorta, Variable-ordered Markov 
Random Field model could be applied. It abstracted every cell in developing aorta as 
a node in field. Each cell interacted with other cells nearby through cell to cell 
interactions. They also secreted signaling molecules to ECM, created a 
disseminating wave of signal that gradually spread from one cell to another. Such 
signaling wave could be reinforced or antagonized by neighboring cells. Thus, 
diffusion of signaling molecules could be treated as a gradual process that advances 
from one cell to next. Systems with properties were named as cellular automaton. 
Initially, every cell had similar transcriptional state (starting state). At the next time 
point, every cell updated its cell state based on previous state and the signals it 
received from its neighbors. After they updated their cell states, each cell sent out 
signals to their neighbors according to transcriptional program of the new state. This 
goes on and on, gradually, different cells started to acquire drastically different 
identity and behave differently. 
Russian mathematician Andrey Markov and others developed mathematical tool to 
describe such systems. To honor his contribution, it was named as Markov Random 
Field (Kindermann, Snell et al. 1980). In such field, the conditional probability 
distribution of future state of every node only depended upon its present state. In 
1983, scientist introduced memory of past events into Markov Random field to 
makes it Variable-order Markov models (Rissanen 1983). Theoretical biologist 
already used it to describe firing and interactions of complex neuronal systems 
(ZIPPO 2010). I though similar model could also be applied to simulate of 
embryonic development events like ones occurred in the developing haematopoietic 
niche. 
In stochastic model like Variable-ordered Markov Random Field, outcome of 
development was naturally variable because the stochastic nature of both external 
signaling and its internal procession. It was hard to determine developmental path of 
individual cells, but a probability distribution of different cell types ensured in most 
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of times, enough cells of each type were produced to meet the embryo’s demand. Or 
in a mathematical word, an expectation of number of specific cell lineage at certain 
developmental time point could be established, like in E11.5 mouse embryos, only 
one definitive HSC was expected to exist per AGM (Kumaravelu, Hook et al. 2002, 
Taoudi, Gonneau et al. 2008). 
One property of stochastic model was that some embryos at left most part of 
distribution would not have enough cells to survive. That means the naturally, some 
embryos would not generate enough haematopoietic cell and/or HSCs during 
embryonic development. That might contribute to natural abortion observed in 
embryonic development. On the other hand, if one embryo developed too many 
definitive HSCs in AGM region, there were simply not enough niches in fetal liver 
for all of them to colonize it. Without fetal liver niche, excessive HSC would 
differentiate or die and ultimately disappear. To assure robustness of developmental 
program, powerful attractor states existed so cells divide and acquire new identity 
(cell states) of desired types. These attractor states had high frequency in entire 
distribution and could ensure enough cells for most lineages needed.  
Under stochastic paradigm, cell state was more important than ontogeny. This view 
was reinforced by successful reprogramming of various cell lineages using 
Yamanaka strategy (Takahashi, Tanabe et al. 2007). Reprogramming of 
differentiated cells to vastly different identity suggested that memory of past 
differentiation steps could be overcame if correct transcriptional program was 
established. To prohibit trans-differentiation or reverse-differentiation in normal 
embryonic development, cell memory served as a ratchet to restrict cell state change 
toward undesired directions. In vivo, lineage selection of a cell was strongly 
influenced by its neighbors. But after in vitro isolation, cellular memory and fate 
selection could be changed by expression of transcriptional program from other 
lineages (Kim, Flaßkamp et al. 2014) or remodeling of DNA methylation and 
histone modification patterns (Hou, Li et al. 2013).   
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Such property was of great use to study specification of HSC during embryonic 
development. One possible way to establish HSC cell identity with aggregation 
culture was to erase cell memory of endothelial cells. If that worked, they should be 
more responsive to cues produced by haematopoietic promoting cell lines. This 
could be achieved by adding epigenetic remodeler like 5-Azacytidine or 
3-deazaneplanocin A to aggregation culture medium. In normal in vivo development, 
most endothelial cells in aortic linings were committed to endothelial fate. This was 
critical for normal function of the aortic wall. However in aggregation culture those 
non-haematopoietic endothelial fated cells were wasted. “Unlocking” these cells 
should enhance production of transplantable HSCs. 
In stochastic model, at beginning all cells in p-SP region were similar. Purely by 
chance, some cells turned on haematopoietic related program and started to secret 
haematopoietic promoting morphogens. Such secretion was regulated by positive 
feedback loops, thus such haematopoietic maturation signaling was amplified from 
cell to cell and formed a traveling wave that reflected in p-SP and AGM region. 
After a while, these travelling waves slowed down and became stationary. 
Haematopoietic clusters were formed at peak of such stationary waves. Frequency of 
haematopoietic cluster and spacing between each cluster was determined by rate of 
diffusion of participating morphogens through tissue (transformation matrix) and 
shape of aortic wall. Because stem cell precursors were developing simultaneously 
alongside surrounding endothelial cells, synchronization was critical to successful 
wave formation. Similarly, in in vitro culture feeder (stromal) lines must be able to 
grow alongside with precursors of HSC and transduce haematopoietic signaling 
in-between in order to maintain and expand such haematopoietic waves. 
To maintain haematopoietic waves in aggregation culture, the phase of development 
between feeder cells and stem cell precursors needed to be matched. It was observed 
that embryonic HSCs had different cell cycle rates compared to their mature 
counterparts (Pietras, Warr et al. 2011). Embryonic HSCs cycled faster, matching 
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cycling time of their neighbors. It might be postulated the haemogenic endothelial 
cells that were in the same phase as surrounding cells had better chance of 
developing into definitive HSCs. Cells out of synchrony might be just naturally 
eliminated. 
The unique “first time failure” phenomena observed in this study might of extra 
importance. In two back to back experiments, most first experiment failed to 
generate engraftable HSCs, while latter experiment is usually good. Such difference 
was not related to over-confluence. But it was likely relates to time spent after 
reaching confluence. I postulated that cells might turn off embryonic development 
related genes induced by rapid growth after reaching confluence; these embryonic 
related gene regulatory networks might only be switched back on after sustained 
growth. Thus cells that had been expanding were more responsive to haematopoietic 
signal. They were more “primed” to interact with pro-HSCs in aggregation culture. 
After a while in confluence, inhibition of growth turned off some embryonic 
haematopoietic development related transcriptional programs. In such condition, 
cells lost their capacity to promote maturation of pro-HSCs.  
To investigate effect of cell cycle in aggregation culture, cell’s growth rate could be 
studied with Fucci reporter mice. Fucci reporter mice by Abe et al. (Abe, 
Sakaue-Sawano et al. 2013) contained two fluorescence labeled cell cycle proteins 
that could label cells at different stage of cell cycle with different colors. To advance 
a step further, one could use single cell digital qPCR assay to detect genes that were 
cycling in stromal cells. Digital qPCR had the advantage of absolute quantification, 
thus avoided problem of determining amplification efficiency of individual template 
(White, VanInsberghe et al. 2011). Understanding of such oscillating gene 
regulatory network was especially important for describing phases of stromal cell. 
By matching stromal cell’s cycle with primary cells in aggregates, probability of 
successful HSC maturation might be greatly increased.      
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Polarization of HSC specification to the ventral wall of the dorsal aorta also 
suggested that signals to promote HSC maturation did not just come from inside 
aorta. External signaling also plays a role in HSC specification. To enhance HSC 
specification in our aggregation system, stromal cell lines used in aggregation assay 
could be transfected to express such signals. One possible way was to express 
ventralizing signal of E10.5 to E11.5 embryo in stromal cells. This might enhance 
definitive HSC generation in aggregate system.       
The most important feature of the stochastic model was that it enables direct study 
of formation of haematopoietic wave in aorta explant or aggregation culture. Before 
generation of stationary haematopoietic wave and formation of haematopoietic 
cluster, there should be local random drift in signaling. Then traveling waves inside 
aorta should form. With fluorescence reporter and time lapse imaging device, local 
drift and traveling waves could be visualized. One way to visualize waves in HSC 
specification was to take advantage of inherent property of cellular automaton- 
every cell was equal; they received signals and passed it on to generate a wave of 
haematopoietic morphogens. So stromal lines could be transfected with fluorescence 
reporter knocked into promoter of various morphogens. Or they could be transfected 
with reporter driven by promoters that could be activated by specific morphogens. 
Such compound reporter cell lines could be aggregated with untransfected primary 
cell to detect morphogen waves in aggregates. Fluorescence intensity of each cell 
could be determined using fluorescence microscopy. With time lapse imaging, a 
time series of images can be generated. Then various cells inside aggregates could 
be sampled to generate a time series of light intensity (correlate to intensity of cell 
signaling). A filter, either by wavelet analysis or Fourier transform, could be applied 
to filter out local noises that did not grow to larger coherent structure. Background 
removed time series could be subjected to Fourier transform to distinguish major 
components in frequency spectrum. Components that appear multiple times in 
multiple locations could be considered as main components of haematopoietic 
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maturation wave. By doing this, morphogens that affected haematopoietic clusters 
formation in aggregates could be identified; they were likely to be responsible for 
haematopoietic cluster formation. And parameters of morphogen gradient generation 
and wave formation could also be determined.     
Besides determining parameters of individual morphogen wave, haematopoietic 
specification wave could also be determined by fluorescence reporter driven by 
haematopoietic promoters, like Runx1, Kit, or Sca-1. Pattern generated by 
haematopoietic wave should match pattern observed in aorta wall (figure 7.5-1, a). 
After filtering out local fluctuations, haematopoietic wave function could be derived. 
It could determine the probability of a specific cell in AGM region to become a 
haematopoietic cell.  
Wave function was the mathematical language to describe the haematopoietic 
specification wave. With wave function, computer simulation of haematopoietic 
cluster formation could be achieved. Haematopoietic wave could be decomposed as 
a combination of effect of single haematopoietic factor/signaling (figure 7.5-1, b). 
This could be done with Fourier Transform using wave function of individual 
haematopoietic signaling as “base” frequency in frequency domain (figure 7.5-1, c). 
Fourier transform could help quantify contribution of each haematopoietic signaling 




Figure 7.5-1. A hypothetical case of Fourier transform of 
haematopoietic waves. a) Haematopoietic wave was devised based on 
oscillating expression of key haematopoietic transcriptional factor and 
location of haematopoietic clusters in tissue wall. b) Haematopoietic 
wave was combined effect of many individual signaling. c) Fourier 
transform of haematopoietic wave in frequency domain detect its main 
frequency components. d) Based on frequency, main signaling in 
haematopoietic wave was determined. Note signaling molecules 
mentioned here was just to explain the case. They did not correspond 
to real events in haematopoietic field. Image modified from 
http://en.wikipedia.org/wiki/Fourier_transform#mediaviewer/File:Fourier_transform
_time_and_frequency_domains_%28small%29.gif under creative common 
license, original author: Lucas V. Barbosa.   
More interestingly, haematopoietic wave function also enabled manipulation of the 
shape and size of haematopoietic wave in tissue of given shape and size, thus 
manipulate the shape and size of haematopoietic clusters that contained definitive 
HSC. Manipulation could be achieved by changing shape or size of aggregates, or 
by careful modifying feeder cell’s ability to produce certain haematopoietic 
molecule and how they respond to them. With such a capacity, it may be possible to 
massively generate HSC from 3D aggregate or even 2D flat culture.    
To summarize, it had long been observed that during embryonic development, 
complex patterns arose from almost homogenous tissue via collective behavior of 
many cells. Behavior of such a collection of cells could be described using 
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Variable-order Markov Random Fields. Data gathered in this project suggested 
haematopoietic specification was not restrained by limited availability of niche. And 
the “first time failure” phenomena observed in E9.5 aggregation experiment 
suggested that haematopoietic specification was a stochastic process. Alan Turing 
proved that complex mosaic pattern could arise from 3D tubular Markov field with 
even just 2 to 3 signaling molecules (Turing 1952). Such mosaic patterns were 
formed by waves of signaling that travel inside the developing niche that gradually 
become stationary. Thus I postulated that the complex pattern of haematopoietic 
cluster arose in developing dorsal aorta by waves of few simple haematopoietic 
signaling molecules that become stationary.  
In summary, a novel immortalization system was established in this study. With it, 
cell lines were derived from multiple embryonic stages or bear different cell surface 
marker combinations. Derived cell lines displayed haematopoietic promotion 
capacity that enables maturation of dHSCs from pro-HSCs. Such capacity was not 
restrained to specific marker combination or time point tested, suggested HSC 
maturation was not restrained by availability of niche. The “first time failure” 
phenomena observed in experiment suggested HSC maturation process was 
stochastic and depending of cooperation of both pro-HSC and surrounding cells. It 
was proposed that such cooperation depended on synchronization of phase between 
precursor of stem cell and their neighbor. They formed wave of haematopoietic 
signaling and induced haematopoietic cluster formation. Immortalization system 
developed and cell lines derived in this study could help detecting such 




8.1. Establishment of immortalization system 
8.1.1. Generation of vectors 
  Tube (unit: µL) 
Item A B C D E 
pB-PGK-M9 digested by NcoI/SalI 4 4 4 4 4 
pCR-BluntII-TAG8 digested by 
NcoI/XmaI 
0 4 0 4 8 
pCR-BluntII-CER1 digested by 
XmaI/XhoI 
0 0 2 1 1 
18MΩ water 9 5 7 4 0 
10X T4 DNA ligase buffer 1.5 1.5 1.5 1.5 1.5 
NEB T4 DNA ligase 0.5 0.5 0.5 0.5 0.5 
Total 15 15 15 15 15 
Table 8.1.1-1. Triple ligation of pB-PGK backbone, TAG and CER 
fragments. Tube A, B,C were negative controls. Tube E had higher TAG 
concentrations. For plate D,E a total of 80 clones were screened (40 
each).  





           
Figure 8.1.1-1. Digestion of pB-PGK-TAG-CER and pCyL043 plasmid 
after maxiprep. a) HindIII digestion of three maxiprep products. Note 
clone D5 and M20 had correct bands. Lane p43 was HindIII digested 
pCyL043 plasmid, it had distinct digestion products. This ruled out 
possibility of cross contamination. b) BamHI/NotI digestion of pCyL043 
plasmid (Lane p43), released the 1791bp DNA encoding piggyBac 
transposase. Lane M in both figures were 1kb plus DNA ladder. 
 
Figure 8.1.1-2. Immunostaining of untransfected OP9 negative controls, 
showed Cerulean staining (Green) SV40T (Red) and DAPI (Blue). Green 
channel was Alexa-488 conjugated anti GFP antibody recognizing 
Cerulean, Red channel was Alexa-568 goat anti mouse antibody 
recognizing SV40T positive cells labelled by mouse anti SV40T 
antibody. Pictures here were taken with similar parameters as 




Figure 8.1.1-3. Spectrum property of transfected cells. These negative 
control pictures were taken with same parameter of those in figure 3.3-2. 
They showed fluorescence signal outside peak CER emission 
(555-585nm) of untransfected control (left) and M20 transfected cells 




8.2. Establishment of cell lines  
8.2.1. Establishing transfection parameters 
 
Figure 8.2.1-1. Cell survival and transfection efficiency measured as 
percentage of parent population in optimization experiments. Primary 
AGM cells from E11.5 BL6XBL6 embryos were used. “7AAD- %” was 
percentage of 7AAD negative cells in all cellular events. “GFP% in 
Lineage- CD45- CD41- 7AAD- ” was percentage of GFP positive cells in 
all Lineage-CD45-CD41-7AAD- cells Figures labelled with “E” displayed 
data gathered from samples stained with antibodies against endothelial 
markers, and figures labelled with “M” displayed data gathered from 
samples stained with antibodies against mesenchymal markers. Error 
bars showed standard derivation calculated by STDEV.S formula in 
Excel 2010. (Different conditions were experimented from one to three 




Figure 8.2.1-2. Cell survival and transfection efficiency measured as cell 
yield in optimization experiments. Primary AGM cells from E11.5 
BL6XBL6 embryos were used.  “7AAD- cells” was total number of 
7AAD negative cells calculated using counting beads and normalized to 
100000 input cells. “Lineage-CD45-CD41-7AAD- GFP+ cells” was total 
number of Lineage-CD45-CD41-7AAD-GFP+ cells calculated using 
similar methods. Figures labelled with “E” displayed data gathered 
from samples stained with antibodies against endothelial markers, and 
figures labelled with “M” displayed data gathered from samples stained 
with  antibodies against mesenchymal markers. Error bars showed 
standard derivation calculated by STDEV.S formula in Excel 2010. 










Figure 8.2.1-3 Marker specific transfection yield of optimization 
experiments. Primary AGM cells from E11.5 BL6XBL6 embryos were 
used. Figures labelled with “E” displayed data gathered from samples 
stained with antibodies against endothelial markers, and figures 
labelled with “M” displayed data gathered from samples stained with 
antibodies against mesenchymal markers. a) Cell survival and 
transfection efficiency measured as percentage of parental populations. 
b) Cell survival and transfection efficiency measured as cell yield. 
Number of GFP+ cells was calculated using counting beads and 
normalized to 100000 input cells. Note for endothelial staining, most 
cells were VE-Cad-CD123-, so these double negative populations were 
plotted on secondary Y axis. Error bars showed standard derivation 
calculated by STDEV.S formula in Excel 2010. Each condition was 





Figure 8.2.1-4 Transfection efficiency was not biased to specific cell 
compartment. Left plot was CD105 and CD51 expression of 
Lineage-CD51- population, right four plots were GFP expression of each 




8.2.2. Establishing feeder cell lines from mouse Embryos 
 
 
Figure 8.2.2-1. Gating strategy used to sort E11.5 primary cells. 
Experiment showed here was ventral aorta samples stained with CD123 
and mSCF. Lineage, CD45, CD41 were stained by biotinylated antibody 
and labelled with streptavidin-FITC antibody.  a) All events were 
displayed on SSC-FSC plot and only events with size and shape similar 
to a cell were selected. b) Single cells were selected based on FSC-H 
and FSC-A signal. c) FACS plot showed ventral aorta sample with 7AAD 
and FITC channel, only 7AAD- (live) and FITC- (CD45-,CD41-, 
Ter119-,Mac-1-, Gr1- cells were selected for further studies. d) Similar 
FACS plot showed FMO –FITC control made AGM derived primary cells 
from same litter. In this controls, all other antibodies were same with 









Figure 8.2.2-2. FACS plot of FMO –PE and FMO –APC controls used to 
set gates for marker of interest.  a) P12-001/002 experiment with CD123 
and CD106. b) P12-027 experiment with CD123 and CD106. c) 
P12-003/004 experiment with CD123 and SCF. d) P12-006/007 
experiment with VE-Cadherin and SCF. Note the FMO –SCF control had 
2.83% of SCF positive cells, higher than FMO-SCF control in  panel e). 
e) P12-008/009 experiment with Flt3 and SCF. f) P12-016 experiment 
with VE-Cadherin and Flt3.  
 




8.3. Characterization of AoV Cell lines  
   
 
Figure 8.3-1. Colonies generated from OP9 positive controls in 8 
different experiments. In each experiment, 300-500K feeder cells were 
aggregated with 0.6-1 embryo equivalent (ee) E11.5 AGM derived 
primary cells and cultured for 4 days without feeding. Then for “with 
growth factor” conditions, 0.01ee of cultured cells were distributed to 
two dishes, for “without growth factor” conditions, 0.1ee of cultured 
cells were distributed to two dishes. 7 days later, colonies in both 






















Figure 8.3-2. Flow cytometry and CFU-C analysis results of aggregates 
after 7 days of culture. a) CFU-C readings from culture after 7 days of 
culture. For +GF conditions, 0.01ee of cells were used in CFU assays, 
for –GF conditions, 0.1ee of cells were used. b). Results of flow analysis 
of aggregates after 7 days of culture. Note SRYZH was the surfix of 
name ofmy experiments. Note following membranes were sunk or 
infected during culture. E3+GF in SRYZH1; E3+GF, 






























Figure 8.3-3. Flow cytometry plots of all recipients survived until 6 
weeks post transplantation. That included 108 recipients received 
experimental aggregates and 24 recipients received positive control 
aggregates. Those aggregates were transplanted in 5 different 
experiments belonged to 4 batches (SRYZH6 and SRYZH7 belonged to 
the same batch). Each experiment had its own OP9 control mice. For 
every bleeding, three separate blood samples were prepared for two 
single stain controls and unstained negative control. Each plot in this 
figure was labelled with original earmark number, they were explained 




Figure 8.3-4. Gating and FMO controls of multilineage FACS analysis. 
Panel a) showed gating to remove debris, dead cell, Ter110+ cells, 
CD45.1+ recipient and carrier cells in a stepwise manner (left to right). 
Panel b) showed FMO controls to set gate for B220 and CD3e in 
Ter119-CD45- population from panel a. Panel c) showed FMO controls to 












Figure 8.3-5. Gating and FMO for multi-organ multilineage analysis. a) 
Gating strategy for multilineage analysis. All sample groups shared 
similar gating strategy. The sample shown was from bone marrow. b) 
FMO control sets for bone marrow/blood/spleen. c) FMO control sets 
for thymus. Note bone marrow, blood and spleen samples shared same 
set of antibodies, while thymus used another set of antibodies, so two 









Figure 8.3-6. Flow cytometry plots of engraftments in multiple organs. 
Four mice were analysed for multilineage engraftments. A P12-027 G7 + 
GF mouse from SRYZH2 experiment was negative control. Blood, Bone 
marrow and spleen samples were stained with antibodies against Gr-1 
PE, Mac-1 FITC, CD3e APC and B220 PE-Cy7. On the other hand, 
thymus samples were analysed with TCR-b PE, CD127 PE-Cy7, CD8 
FITC and CD4 APC antibodies. All plots were representing 




a) Reaction system 
Item Concentration Volume (µL) 
18MΩ water n/a 9.4 
10X Cl buffer  10X  2 
Solution Q 10X  4 
dNTP 10mM each 0.4 
Forward Primer 100nM 0.5 
Reverse Primer 100nM 0.5 
Taq DNA polymerase 5u/µL 0.2 
Blood gDNA Individual labelled 5 
Total   22 
b) PCR parameter 
Cycle Step Temperature(°C) Time 
1 Pre-Denature 95 5min 
35 Denature 94 30s 
 
Annealing 58 30s 
  Extension 72 60s 
1 Final extension 72 10min 
  Cool off 4 Hold 
 
Table 8.3-1. PCR system used to detect CER fragment in gDNA isolated 
from recipient mice. a) Components of reaction system used, b) 
parameter of PCR used. gDNA concentration for mouse SRYZH6-3-8 
was 23.6ng/µL, for SRYZH9-2-9 is 203.7 ng/µL and for SRYZH9-2-10 was 
342.3ng/µL. 
8.4. qPCR  
The quality of qPCR reaction were reported here. In both plates, PPM Flt3l E6/7 did 
not generate good standard curves. The abundance of Flt3l transcript in total cDNA 
was low, that caused wells with low cDNA concentration had different amplification 
efficiency or failed to amplify all together. Besides that, each plate had two PPMs 
yielded slightly higher amplification efficiency between 2.1 and 2.15. The quality of 
cDNA slightly varied between different cell lines. Most cell lines had around 2 
PPMs yielded standard error higher than 0.2. However, cDNA from 002 A6, 009 
E10 and 015 B4 showed less consistency between replicates. Some even happens in 
low Cp wells, indicated problem more than just low cDNA concentration. Based on 
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previous experience, such inconsistencies were probably caused by trace 
contamination introduced during RNA extraction and reverse transcription. 
 
Table 8.4-1. All genes selected for qPCR primer design and their target 
transcripts.  
 
Table 8.4-2. All qPCR primer pair designed in this study. These primer 
pairs were only compatible with Roche’s UPL technology with 





Table 8.4-1. Mean crossing points of each transcript in cell lines tested. 






Figure 8.4-1. Melting curves generated from primer pair Flt3l E6/7. Panel 
a showed melting curve from 4ng replicate well 1. This well contained 
non-specific product. Panel b showed melting curve from 4ng replicate 






Figure 8.4-2. Coefficient of variation of normalized expression for each 
transcript in 10 cell lines. Standard derivations were calculated using 
STDEV.P function in Excel 2013, averages were calculated using 
Average function in Excel 2013, coefficient of variations were calculated 
using formula CV=Stdev/average. 
 
Figure 8.4-3. Native agarose electrophoresis of extracted RNA sample.  
Left lane was 50ng 1KB+ DNA ladder to determine the amount of RNA 
isolated. Middle lane was RNA isolated from 106 cells of line P11-100 
Q31 passage 22. Right lane was Positive control isolated from several 
E11.5 embryos. Note the 28S and 18S RNA were the most abundant 





Table 8.4-4. Correlation between expression level of single transcript in 
feeder cells and cell lines ability to promote maturation of E9.5 
precursor measured by average engraftment after 6 weeks. Note “all” 
was weighted average of +GF and –GF conditions. 
8.5. Discussion 
8.5.1. Chaos and stochastic progress related background information  
HSC specification was a complex dynamic process involves multiple cell 
populations. Most dynamic processes fitted into two categories: chaos or stochastic 
(Smith 2007). Both systems could contain complex regulatory networks where a 
slight perturbation of input could lead to drastically altered outcomes. However, 
there was one important distinction: chaos was deterministic while stochastic system 
was random. That was, if input A was feed into a chaotic system, it would always 
generate result B, while slightly modified input A’ would generate a drastically 
different result Z. Repetition of putting input A into such system always got result B, 
while A’ always got result Z. Early development of C. elegans was perhaps one of 
the most recognized chaotic systems in biology. A map could be drawn to show the 
fate of every cell generated from zygotes to adulthood (Sulston, Schierenberg et al. 
1983). The sequence of events happen in embryonic development was determined. 
However, a slight perturbation, like disruption of a gene or killing a specific cell in 
early development could cause drastic and yet reproducible changes. On the other 
hand, a stochastic system was random; repeating the same experiment would 
generate different results each time. After many repetitions, a distribution appeared 
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indicating how likely each outcome was going to happen in one experiment 
(Expectation).  
Of course, the boundary between stochastic system and chaotic system was arbitrary. 
With more knowledge about behavior of system under study and more computing 
power, it became possible to simulate stochastic systems which could be analyzed as 
chaotic. Analysis of atmosphere was a typical case of such change. About 200 years 
ago, weather forecast was primary based on probability of past events, thus was 
purely stochastic. At that time numerical (deterministic) forecasting was almost 
impossible. However, with the advancement of atmospheric modeling and 
computing, now atmosphere system could be simulated as chaotic (at least in the 
short term) and the accuracy of numerical forecasting was greatly improved. 
Current paradigm of developmental biology was mostly deterministic. An ultimate 
goal of many researchers was trying to determine ontogeny of various adult cell type 
by generate fate maps all the way up to zygote, or at least to totipotent inner cell 
mass (ICM). This paradigm was proven on lower animal and yielded many 
important insights on embryonic development of higher animals. However, this 
paradigm had some shortcomings when applied to more complex species. It had 
difficulty explain variation of embryonic development. For example, E11.5 AGM 
roughly contained only one definitive HSC. If definitive HSC generation was 
deterministic, some kind of HSC suppression mechanism must existed to maintain 
correct number of definitive HSC in AGM region by killing off excessive definitive 
HSCs. But such mechanism was yet discovered although it could be easily revealed 
by knock-out screening.   
On the other hand, stochastic model could explain observed variation of embryonic 
development. In stochastic model, there is no roadmap of development exist. 
Generation of cell numbers of different types follow respective distribution. Rare 
embryos that did not have enough cells generated simply died. Embryos had too 
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much dHSC would have no problem in development because those extra HSCs 
would differentiate due to lack of niche.   
The stochastic nature of embryonic development was introduced by “cellular 
automaton”. That is, every cell decided its action based on its state of its gene 
regulatory network (or in a mathematical word, cell state) and signals received from 
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